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is PLGA, the remainder PLCL for single polymer microfibers ranging in diameter from 6.0 to 15 
µm. Error bars represent a 95% confidence interval...................................................................... 48 
 
Figure 2-25: New grounded collection electrode setup to minimize risk of damage of single 
polymer microfibers fabricated for tensile testing (a) Rectangular aluminum frames were cut 
from a square hollow tube of aluminum. The outline shown on the top right was cut from cardstock 
and attached to both sides of the aluminum frame. Each square window is nominally 12 mm wide. 
The large semi-circular cutout is for attachment of the metal frame to a rotator via a split-bolt 
connector. (b) Fibers, represented in green, were electrospun directly onto the cardstock attached 
to the frame which acted as the grounded collection electrode. After at least one week of drying 
time, fibers were adhered at each end of the 12 mm window to the cardstock using a droplet of 
epoxy represented in red. Each square window was cut from the cardstock carrying one freely 
suspended adhered fiber. (c) Each fiber secured to this square oak tag window was mounted to the 
grips of the tensile tester, represented in grey, such that the larger side of the window cutout was 
in the top grip. This ensures greatest sensitivity in the Keysight Technologies UTM T150. Uniaxial 
tension was applied by pulling upward on the fiber to generate stress-strain curves..................... 49 
 
Figure 2-26: Young’s modulus inversely correlated to fiber diameter Scatterplot of Young’s 
modulus vs. fiber diameter for (a) fibers within diameter range selected for final calculation and 
(b) all fibers tested. Legend represents relative compartmentalization with respect to the percentage 
of PLGA present in the fiber, the remainder being the relative size of the PLCL compartment... 50 
 
Figure 2-27: Manifold improves jet stability when 3D jet writing bicompartmental structures 
comprised of PLCL and PLGA Disk manifold, shown above, having a single channel as the 
outlet (as opposed to a bicompartmental needle) improves jet stability for fabrication of polymer 
supports made of bicompartmental fibers. Each fiber consists of one compartment of PLGA (blue) 
and another compartment of PLCL (green). Scale bars 25 µm...................................................... 52 
 
Figure 2-28: Bicompartmental fibers tend to curl after tensile testing Although difficult to 
collect after tensile testing, the larger broken fiber segments could be located for imaging. 
Bicompartmental fiber segments consisting of PLGA and PLCL were visualized using scanning 
electron microscopy. The ratio of compartment size for PLGA to PLCL varied from (a-b) 25:75 
(c) 50:50 and (d) 75:25. (a, c, d) Scale bar 500 µm. (b) Scale bar 5 µm........................................ 53 
 
Figure 2-29: Bicompartmental fibers comprised of PLGA in one compartment and PLCL in 
the other tend to coil after stress-relaxation Bicompartmental fibers were elongated to the 
indicated strain values. Compartmentalization was either 25:75, 50:50, or 75:25 PLGA to PLCL. 
Fibers at 75:25 PLGA to PLCL are too brittle to elongate to strains of 0.2 and above. 50:50 fibers 
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break before reaching a strain of 1. Image credit: Stress relaxation and photography completed by 
Robert Stinson............................................................................................................................... 54 
 
Figure 3-1: Structure and binding sites of fibronectin Leiss et al. depict the fibronectin (Fn) 
dimer distinguishing between the three repeat units, fibronectin-1 (FnI) in blue, fibronectin-2 
(FnII) in brown, and fibronectin-3 (FnIII) in green. Two disulfide bonds form at the C-terminus. 
Sites along the protein that interact with integrins, bacteria, Fn itself, or other proteins are 
indicated. A, B, and V mark the alternatively spliced extradomains. [Illustration credited to Leiss 
et al.3]............................................................................................................................................ 60 
 
Figure 3-2: Cell-mediated fibronectin fibrillogenesis Mao et al. describe the cell-mediated 
assembly of fibronectin matrix in three steps. The first, shown in (a), is the binding of a solubilized 
Fn dimer to integrins at the cell surface shown in gold. The red subunits represent self-association 
sites that mediate Fn intermolecular interactions. The cytoskeleton represented by green lines in 
(b) begin to reorganize such that the translocation of the integrins at the cell surface imparts tension 
to the bound Fn dimer causing the protein to unfold and expose the self-association sites. At the 
same time, signaling activities commence within the cell as a result of its attachment to Fn 
(represented by silver circles). (c) As neighboring Fn molecules approach the unfolded integrin 
bound Fn, intermolecular interactions facilitate the assembly of a Fn matrix. [Illustration credited 
to Mao et al.4]................................................................................................................................ 61 
 
Figure 3-3: Hydrodynamically induced fibronectin fibrillogenesis Schematic illustrating the 
process of hydrodynamically induced fibronectin fibrillogenesis. A membrane or textured 
substrate, represented by a blue grid, is secured at the interface of a three-phase system with air 
and a solution of plasma fibronectin. Although a variety of membranes or substrates can provide 
the solid support needed to create supported engineered cFn (ecFn), 3D jet writing scaffolds are of 
focus. As the scaffold is exposed to repeated shearing of the air-solution interface (achieved using 
a rotisserie rotator), fibrils of fibronectin suspend across the scaffold pores resulting in the final 
product, a network of cFn fibrils termed supported ecFn............................................................... 66 
 
Figure 3-4: Protein is required for cell adhesion to polymer scaffolds The first column verifies 
the adsorption of fibronectin (green), and/or laminin (red) onto the surface of the polymer scaffold 
(blue) prior to the seeding of cells. The second column shows GFP expressing cells (green) adhered 
to the polymer scaffolds (blue) only when containing protein whether it is fibronectin alone, 
laminin alone, or a 50:50 mixture of both after only one day of culture time. The third column 
shows the same scaffolds in culture with the GFP expressing cells adhered to the polymer scaffolds 
after four days of culture. Note that in the second and third columns, the protein was not stained 
for and is therefore not visible in the LSCM images. The length and width of each 3D volume 
bounding box is 213.44 µm............................................................................................................ 71 
 
Figure 3-5: Determining optimal conditions to achieve hydrodynamically induced 
fibrillogenesis (a) Representative sections of the polymer scaffold (blue) and tethered fibronectin 
(green) show some fibril formation using an orbital shaker to create fluid flow during either a 2 
hour or 24 hour incubation at either room temperature or 37ºC. (b) Webs of fibronectin fibrils 
(green) are far more apparent using a rotisserie rotator compared to the orbital shaking motion as 
a means of fluid flow during either a 2 hour or 24 hour incubation of the polymer scaffold (blue) 
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in fibronectin solution. Little to no difference was observed with respect to the protein network at 
either room temperature or 37ºC. (a-b) 3D volume bounding box in all images is a square of length 
213.44 µm...................................................................................................................................... 72 
 
Figure 3-6: Optimal fluid motion and temperature determined as rotisserie rotation at 30ºC 
Prior to this time optimal conditions were two hours of incubation under rotisserie rotation at 37ºC. 
However, extensive fibrillar networks of Fn (green) resulted at 30ºC. This lower temperature was 
preferred to keep the PLGA scaffold (blue), well below the glass transition temperature of 45-
50ºC............................................................................................................................................... 73 
 
Figure 3-7: Dynamic incubation conditions are necessary for hydrodynamically induced 
fibrillogenesis (a) Time sequence characterized by SEM showing increasing amounts of Fn 
tethered to the polymer scaffold with time. (b) SEM and LSCM images showing large scale view 
of supported ecFn (left) produced by hydrodynamically induced fibrillogenesis in contrast to 
(right) the scaffold after a static incubation in pFn solution. The solution concentration, incubation 
time, and temperature are consistent between the supported ecFn and the statically adsorbed Fn at 
100 µg/mL, 2 hours, and 30ºC. Fluorescence images show Fn in the green channel and the polymer 
scaffold in blue. (a-b) Note defects in SEM images may be due to the dehydration process which 
occurs during SEM sample preparation.  (c) Quantification of the mass of Fn loaded onto the 
polymer scaffold under hydrodynamically induced fibrillogenesis indicating that equilibrium is 
reached after 120 minutes, i.e. max protein loading is achieved after two hours. These time points 
correlate to the images shown in (a). (d) Mass of protein loaded onto polymer scaffold is at least 
12 times higher for supported ecFn (white bars) compared to the conformal coating (grey bars) 
that results from a static incubation of the polymer scaffold in pFn solution of the same 
concentration, for the same amount of time, and at the same temperature. Moreover, mass loading 
onto the scaffold is not a function of pore size. (c-d) Quantification of protein mass conducted by 
µBCA assay................................................................................................................................... 75 
 
Figure 3-8: Hydrodynamically induced fibrillogenesis is not limited to 3D jet writing 
scaffolds Mesh screening made of either polyester or nylon were exposed either to static 
incubation in pFn solution or the hydrodynamically induced fibrillogenesis process (dynamic 
incubation). In contrast to 3D jet writing scaffolds characterized by square pores 500 μm wide with 
a wall diameter of 8-12 μm and an open area greater than 95%, the polyester mesh screening had 
square pore openings of 530 μm, wall diameter of 220 μm, and an open area of 50%, and the nylon 
mesh screening carried square gap openings of 500 μm, wall diameter of 225 μm, and an open area 
of 47%. Still, results are consistent with Fig. 3-6(b) indicating that whether the support is a 3D jet 
writing scaffold, polyester mesh or nylon mesh screening, static incubation results only in a 
conformal coating of Fn whereas supported ecFn require hydrodynamic shearing. Scale bars 1000 
μm. Note this study was conducted prior to final optimization of the process conditions for 
hydrodynamically induced fibrillogenesis..................................................................................... 77 
 
Figure 3-9: Textured but not porous surface is required for hydrodynamically induced 
fibronectin fibrillogenesis SEM of fibronectin conformally coated onto tissue culture polystyrene 
(TCPS) via (a) static adsorption in contrast to (b) hydrodynamic deposition of Fn using the same 
method as when producing supported ecFn. (c) Representing a textured but non-porous substrate, 
sanded TCPS was exposed to the hydrodynamically induced fibrillogenesis process resulting in 
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protein deposition of a different morphology. SEM of sanded TCPS prior to hydrodynamic 
shearing is shown. (d) For comparison supported ecFn at the same scale as (a-c) is shown after 
hydrodynamic deposition of Fn onto a 3D jet writing scaffold. (a-d) Scale bars 1 µm................. 78 
 
Figure 3-10: Protein morphology, conformation, and insolubility validates the cellular nature 
of supported ecFn (a) High resolution SEM of Fn as it appears from the top surface of supported 
ecFn. Scale bar 1 µm. (b) Comparison of supported ecFn (green) as it is suspended on the polymer 
scaffold (blue) shown on the left to Fn secreted by human mammary fibroblasts cultured to 
confluency on a glass slide and subsequently decellularized. Scale bars 25 µm. (c) Split channel 
view of supported ecFn, irrespective of conformation (green) and specifically the FnIII domain 
(purple) across the large scale of the 3D jet writing scaffold, indicating that the ecFn is in an 
unfolded, extended conformation as it is in vivo. Overlay image of the two channels shown on the 
left. Scale bar 500 µm. (d) Supported ecFn remains intact despite treatment with Triton X-100 
detergent, showing detergent-insolubility. Scale bar 25 µm........................................................... 80 
 
Figure 3-11: FnIII domains exposed on supported ecFn as it is in cell-secreted Fn Fibronectin 
(green) as secreted by human mammary fibroblasts cultured on glass and subsequently 
decellularized showing exposure of FnIII domains (purple). Overlay of the two channels shown in 
left column. (b-d) Overlay of channels (left), Fn stained irrespective of exposed domains (green, 
center), and specifically the FnIII domain (purple, right) for plasma fibronectin: (b) suspended as 
ecFn across a 3D jet writing scaffold to form supported ecFn, (c) conformally coated onto a 3D jet 
writing scaffold and (d) conformally coated onto glass via static adsorption. Scale bars 25 µm. All 
images taken at the same laser power and imaging settings via LSCM. Strong overlap of green and 
purple appear white in overlay image (left images in (a) and (b)). Saturated pixels in the FnIII 
channel of (a) appear pink in color................................................................................................. 82 
 
Figure 3-12: Shear-driven hydrodynamic deposition is not limited to fibronectin (a) 
Fibronectin (top), laminin (middle), and collagen I isolated from rat tail (bottom) 
hydrodynamically deposited onto 3D jet writing scaffolds. SEM images of protein either at the 
crosshairs of the polymer microfibers or within the 500 µm open square pores. (b) Fibronectin 
(green) and laminin (orange) combined to form a supported eECM. (a-b) Scale bars 25 µm. Blue 
channel indicates polymer scaffold. Credit: Collagen I isolated from rat tail and generously 
donated by the Chun Lab at the University of Michigan................................................................ 84 
 
Figure 3-13: Expanded library of proteins for supported eECM include niche protein 
tenascin-C (a) (left column) Fibronectin (FN), laminin (LAM), and collagen I (COL) as secreted 
by human mammary fibroblasts when cultured on tissue culture polystyrene. (middle column) FN, 
LAM, and COL as suspended on 3D jet writing scaffolds to form supported eECM. (right column) 
SEM images of supported eECM comprised of either FN, LAM, or COL at 10,000x magnification. 
(b) Zoomed out view showing larger scale visualization of FN (green) in combination with 
tenascin-c (red) on a supported eECM at a ratio of 5:95 tenascin-C to Fn. (c) Higher magnification 
of sample shown in (b) with split channel view of Fn (green) and tenascin-C (red) including the 
overlay image on the left. Credits: Collagen I isolated from rat tail and generously donated by the 
Chun Lab at the University of Michigan. Tenascin-C contributed by the Lawlor Lab at the 
University of Michigan in a collaborative project including students Elizabeth Pedersen and 
Allegra Hawkins............................................................................................................................ 86 
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Figure 3-14: Small loadings of tenascin-C are sufficient to distribute the protein across the 
open pores of the polymer scaffold Distributions of fibronectin and tenascin-C at ratios of 95:5 
or 90:10 provide sufficient tenascin-C to the system for hydrodynamically induced fibrillogenesis 
to carry the tenascin-C along with the fibronectin to form fibrillar structures spanning across the 
open pores of the polymer scaffold. Fibronectin in green channel, tenascin-C in red, overlay image 
shown on the far left in both cases shown. Scale bars 25 µm. Credit: Tenascin-C contributed by 
the Lawlor Lab at the University of Michigan in a collaborative project including students 
Elizabeth Pedersen and Allegra Hawkins...................................................................................... 87 
 
Figure 3-15: Supported ecFn facilitates formation of 3D cell volumes (a) Conformal protein 
coat that results from static incubation of the polymer scaffold in pFn solution. Fn adsorbs only 
onto the microfibers with little to no bridging of Fn across or within the pores of the scaffold. (b) 
In contrast to (a), supported ecFn is an array cFn fibrils bridging across the open pores of the 
polymer scaffold. (c) After three days of culturing NIH-3T3 mouse fibroblasts on statically Fn 
coated polymer scaffolds, cells only tend to adhere along the polymer fibers. (d) However, three 
days on supported ecFn was sufficient for fibroblasts to fill all scaffold pores to depths several cell 
diameters thick indicating the supported ecFn yields superior cell proliferation and rapid 
microtissue formation. (e) 3D volume view showing depth of tissue created by cells in culture 3 
days on supported ecFn. (f) Top view showing interconnectivity of cells and cell-cell contacts on 
supported ecFn. Channels: blue, polymer microfibers; green, fibronectin; red, actin; cyan, cell 
nucleus. Scale bars: (a-d) 500 μm (e-f) 25 μm............................................................................... 89 
 
Figure 3-16: Protein network facilitates formation of 3D cell volumes irrespective of the 
choice of scaffold (a-c) NIH-3T3 fibroblasts after 22 days of culture on polymer scaffolds 
statically incubated in pFn solution to form a conformal layer of Fn on all surfaces prior to cell 
seeding. Polymer scaffolds are (a) 3D jet writing microfiber construct, (b) polyester mesh 
screening, (c) nylon mesh screening. (d-g) NIH-3T3 fibroblasts form extensive 3D cell volumes 
after three days in culture on supported ecFn produced via hydrodynamically induced 
fibrillogenesis on both (d, f) polyester and (e, g) nylon mesh. All cell nuclei stained blue, and actin 
stained green. (a-e) Scale bars 1000 μm. (f, g) Scale bars 50 μm.................................................. 90 
 
Figure 3-17: Supported ecFn enables observation of protein secreted by cells during culture 
(a) MDA-MB-468 breast cancer cells cultured four days on supported ecFn form cell-cell and cell-
ECM contacts. Fn shown in green and cell-secreted laminin in orange. Scale bar 25 µm. (b) After 
four days of culture, MDA-MB-468 cells were removed from the supported ecFn, and the 
remaining protein was stained for all fibronectin (green) and endogenously secreted laminin 
(orange). Scale bar 25 µm. (a-b) Channels: green, fibronectin; orange, laminin; cyan, cell nucleus; 
red, actin........................................................................................................................................ 91 
 
Figure 3-18: MDA-MB-231 human breast cancer cells break down protein of supported ecFn 
(a) MDA-MB-231 (231s) human breast cancer cell line cultured on tissue culture polystyrene 
(TCPS). Cells cultured on TCPS have a more artificial flattened morphology and make fewer cell-
cell contacts. Cell nucleus in purple, actin in green. Laser scanning confocal microscope (LSCM) 
image at 60x magnification. (b) 231s cultured and imaged on supported ecFn at 60x magnification 
on LSCM. Cell nucleus in cyan, actin in green. Supported ecFn promote cell-cell contacts in 3D 
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space to form a thriving microtissue in vitro (b-c) compared to the same cell type cultured on TCPS 
for the same amount of time in (a). (c) 231s after six days of culture form a confluent volume of 
tissue on supported ecFn. (d) After 10 days of culture on supported ecFn, 231s are no longer 
tethered to the protein but rather migrate off the scaffold into solution. (Subsequent experiments 
show that these cells are still 98% viable in solution.) At 10 days, the ecFn is no longer visible 
indicating that the cells have broken down or remodeled the proteinaceous environment as they 
move off into solution.................................................................................................................... 92 
 
Figure 3-19: Supported ecFn may be a potential model of breast cancer metastasis (a) 
Bioluminescence was used to quantify the relative number of MDA-MB-231 breast cancer cells 
adhered to the supported ecFn at various time points during a 10-day culture. Initially, cells are 
proliferating but at day-8 the cells transition to a migratory state leaving few cells adhered to the 
supported ecFn by day-10. (b) Schematic of the hypothesis regarding the possibility of supported 
ecFn to serve as a model of metastasis. Cancer cells are first seeded onto the supported ecFn where 
they form 3D cell volumes. Upon reaching a critical confluency, cells become more aggressive 
and migrate off into solution, remaining viable. This is a topic for future investigation............... 93 
 
Figure 3-20: Supported eECM provides a means to probing the effect of different ECM 
composition on cell response Demonstration of culture of MDA-MB-231 human breast cancer 
cells on supported eECM of varying composition: (a) laminin (LAM) only (cell nucleus in purple; 
actin in red; polymer microfibers in blue; protein not stained), (b) collagen I (COL) only (cell 
nucleus in blue; actin in green; collagen I in red), (c) Fn and LAM in combination (cell nucleus in 
purple; actin in red; polymer microfibers in blue; protein not stained), and (d) Fn only (cell nucleus 
in blue; actin in green). (e) Growth curves plotting normalized cell proliferation against time for a 
10-day culture of 231s on supported eLAM in contrast to Fn and LAM combined. Credits: 
Collagen I isolated from rat tail and generously donated by the Chun Lab at the University of 
Michigan....................................................................................................................................... 95 
 
Figure 3-21: Ewing sarcoma cells restructure supported ecFn matrix TC32 Ewing sarcoma 
cells were cultured on supported ecFn for nine days. Fn adopted a different morphology after cells 
resided within the matrix for seven days. All images at the same scale. Scale bar 25 µm. Channels: 
cell nucleus (blue), actin (green), fibronectin (purple). Credit: TC32 cells contributed by the 
Lawlor Lab at the University of Michigan in a collaborative project including students Elizabeth 
Pedersen and Allegra Hawkins...................................................................................................... 97 
 
Figure 3-22: Ewing sarcoma cells restructure ecFn and appear to degrade tenascin-C when 
cultured on supported eECM comprised of both proteins TC32 Ewing sarcoma cells were 
cultured on supported ecFn either without (Fig. 3-21) or with the addition of tenascin-C for nine 
days. Cells grew confluent on both types of microenvironments. Fn adopted a different 
morphology after cells resided within the matrix for seven days. All images at the same scale. 
Scale bar 25 µm. Channels: cell nucleus (blue), actin (green), fibronectin (purple), tenascin-C 
(red). Credit: Tenascin-C and TC32 cells contributed by the Lawlor Lab at the University of 
Michigan in a collaborative project including students Elizabeth Pedersen and Allegra 
Hawkins......................................................................................................................................... 98 
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Figure 3-23: Proliferation of TC32 Ewing sarcoma cells is not affected by incorporation of 
tenascin-C into supported ecFn TC32 Ewing sarcoma cells were cultured seven days on 
supported ecFn (blue line) or supported eECM comprised of both cFn and tenascin-C (red line). 
Fibronectin and tenascin-C were incorporated at a mass ratio of 95:5 in solution to form the 
supported eECM. Luminescence measurements were collected over time to represent a relative 
cell number adhered to the supported eECM. No difference between the two types of 
microenvironments were observed. Credit: Tenascin-C and TC32 cells contributed by the Lawlor 
Lab at the University of Michigan in a collaborative project including students Elizabeth Pedersen 
and Allegra Hawkins..................................................................................................................... 99 
 
Figure 3-24: Time sequence of Ewing sarcoma cells either expressing or knocked down for 
tenascin-C cultured on supported ecFn TC32 Ewing sarcoma cells that were either (a) 
expressing tenascin-C i.e. non-silencing or (b) under a tenascin-C knockdown were cultured four 
days on supported ecFn. Scaffolds were imaged 6 hours after seeding, two days, and four days as 
indicated. Non-silencing cells, having tenascin-C expression, had more drastically degraded the 
protein matrix relative to the tenascin-C knockdown cells by the fourth day. Credit: TC32 cells 
contributed by the Lawlor Lab at the University of Michigan in a collaborative project including 
students Elizabeth Pedersen and Allegra Hawkins...................................................................... 100 
 
Figure 3-25: Supported eECM provides a means of visualizing cell-induced protein matrix 
breakdown in vitro Two groups of TC32 Ewing’s sarcoma cells were cultured on supported ecFn, 
one group expressing the oncogene tenascin-C (non-silencing cells shown on the left) and the other 
having had a tenascin-c knockdown (shown on the right). Shown are zoomed out views, and in the 
insets zoomed in views of the scaffolds after four days of culture. Channels: fibronectin in purple; 
cell nucleus in blue; actin in green. Credit: TC32 cells contributed by the Lawlor Lab at the 
University of Michigan in a collaborative project including students Elizabeth Pedersen and 
Allegra Hawkins.......................................................................................................................... 101 
 
Figure 3-26: Cell type versatility of supported ecFn (a-c) MDA-MB-231 breast cancer cells on 
supported eECM of (a) collagen I and (b, c) fibronectin at six days. (d-f) Sum159 breast cancer 
cells on supported ecFn after (d) one day and (e, f) four days of culture. (g-i) Pancreatic cancer 
cells on supported ecFn. (g) Pancreatic cancer cells from the UM53 epithelial patient-derived cell 
line after two-day culture. (h, i) ASPC1 mesenchymal pancreatic cancer cell line cultured four 
days. (j-l) Human umbilical vein endothelial cells cultured for seven days do not grow on supported 
eECM composed of (j) laminin only (nor fibronectin only – data not shown) but cells thrive well 
when (k, l) laminin and fibronectin are combined. Whereas cancer cells form confluent volumes 
across the scaffold (c, f, i) HUVECS remain in lower density bridged structures as shown in (l). 
(a, b, d, e, g, h, j, k) Scale bars 25 µm. (c, f, i, l) Scale bars 500 µm. (a-l) Channels: cyan, cell 
nucleus; red, actin. (j-l) Channels: blue, polymer scaffold; cyan, cell nucleus; red, actin. Credits: 
Collagen I isolated from rat tail and generously donated by the Chun Lab at the University of 
Michigan. Pancreatic cancer cells generously donated by the Simeone Lab at the University of 
Michigan..................................................................................................................................... 103 
 
Figure 4-1: Supported ecFn enhances tumor engraftment efficiency in a mouse breast cancer 
model (a) Representative 3D CLSM of AT-3 mouse breast cancer tissue formed in vitro after three 
days on supported ecFn. Section thickness is approximately 70 µm. Scale bar 25 µm. (b) Large 
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scale view of AT-3 tissue cultured three days on supported ecFn as in a. Cells proliferate and fill 
the 3D space within the protein network across the scaffold. Scale bar 500 µm. (a-b) Channels: 
cyan, cell nucleus; red, actin. (c) Bioluminescence image of immune-competent mice showing 
tumor formation 21 days after AT-3 cells were orthotopically implanted (image exposure time 10 
seconds). The two mice on the left have had about 30,000 AT-3 cells on supported ecFn implanted 
into the mammary fat pads indicated by arrows (group 1). The right mammary fat pad received an 
injection of approximately the same number of cells in the area indicated by circles (group 2). The 
third mouse on the right is a positive control having received the group 3 supported ecFn in the 
left mammary fat pad (arrow), and the group 4 injection in the mammary fat pad on the right, each 
delivering 200,000 AT-3 cells. Previous studies have concluded that a minimum of 200,000 AT-3 
cells are required for tumor formation by cell injection5. (d) Mason’s Trichrome staining of a tumor 
graft that formed after 21 days at the implant site of the group 1 30,000 AT-3 cells on supported 
ecFn; AT-3 cells invaded surrounding tissues. Scale bar: 25 μm. (e) Quantification of the 
CD29+/CD24+ cells identifying the AT-3 population capable of self-renewal. Cells were cultured 
three days on TCPS, TCPS with fibronectin conformally adsorbed (Fn on TCPS), or supported 
ecFn. Single star indicates that the supported ecFn result is statistically different from TCPS and 
Fn on TCPS; double star indicates that TCPS and Fn on TCPS are statistically similar. P<0.05 (f) 
Quantification of the CD29+/CD24+/CD90.2+ AT-3 cells identifying the tumor initiating 
population after three days of culture on TCPS, TCPS with fibronectin conformally adsorbed (Fn 
on TCPS), and supported ecFn. Single star indicates that the supported ecFn is statistically 
different from TCPS and Fn on TCPS; double star indicates that TCPS and Fn on TCPS are 
statistically similar. Credits: The Luker Lab at the University of Michigan conducted all animal 
studies, and designed and contributed AT-3 cells to this collaboration. Flow cytometry done in the 
Wicha Lab at the University of Michigan.................................................................................... 115 
 
Figure 4-2: Supported ecFn promotes a tumorigenic phenotype in AT-3 mouse breast cancer 
cells (a) LSCM of AT-3 mouse breast cancer cells at the crosshair of the scaffold microfibers after 
three days of culture on supported ecFn. (b) LSCM image after three days of culture showing (left) 
top view and (right) side view of the AT-3s forming multicellular structures as they span up into 
the open pore of the supported ecFn scaffold. (a-b) Channels: blue, polymer support; cyan, cell 
nucleus; red, actin. Scale bars 25 µm. (c) Growth curve for AT-3 cells cultured on TCPS (dotted 
line, criss-cross marker) or supported ecFn (solid line, square marker). (d) Quantification of the 
CD90.2+ population of AT-3 cells after three days of culture on TCPS, fibronectin conformally 
coated on TCPS (FN on TCPS), or supported ecFn. Single star indicates that the ecFn network 
result is statistically different from TCPS and FN on TCPS; double star indicates that TCPS and 
FN on TCPS results are statistically similar. P<0.05 Credits: The Luker Lab at the University of 
Michigan conducted all animal studies, and designed and contributed AT-3 cells to this 
collaboration. Flow cytometry done in the Wicha Lab at the University of Michigan................. 117 
 
Figure 4-3: Supported ecFn shows successful tumor engraftment in AT-3 mouse breast 
cancer model throughout the course of three weeks Bioluminescence image of immune-
competent mice two, seven, and 21 days after orthotopic implantation of AT-3 cells. Four groups 
were examined: (1) 30,000 cells on three-millimeter-wide supported ecFn disks (2) 30,000 cells 
directly injected (3) 200,000 cells on a supported ecFn disk and (4) 200,000 cells directly injected 
as a positive control being the minimum number of cells required for tumor formation by direct 
injection5. The two mice on the left have group 1 in the left mammary fat pad as indicated by 
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arrows and group 2 in the contralateral mammary fat pad on the right indicated by dashed circles. 
The third mouse on the right is a positive control carrying group 3 in the left mammary fat pad 
indicated by an arrow and group 4 in the contralateral right mammary fat pad. Exposure time for 
each bioluminescence image is indicated. Credits: The Luker Lab at the University of Michigan 
conducted all animal studies, and designed and contributed AT-3 cells to this collaboration...... 118 
 
Figure 4-4: Supported ecFn increases the tumor-initiating population in MDA-MB-468 
human breast cancer cells (a) MDA-MB-468 breast cancer cells cultured four days on supported 
ecFn form cell-cell and cell-ECM contacts. Scale bar 25 µm. (b) MDA-MB-468 cells form 
confluent volumes at large scale across supported ecFn scaffolds after four days. Scale bar 500 
µm. (a-b) Channels: green, fibronectin; orange, laminin; cyan, cell nucleus; red, actin. (c-d) 
Population of MDA-MB-468s on supported ecFn (black solid line and square marker), TCPS 
(black dotted line and criss-cross marker), or fibronectin adsorbed conformally onto TCPS (grey 
line and triangular marker) that are (c) CD44+/CD24- and (d) CD44+/CD24-/ALDH+ measured 
over time via flow cytometry. The starred time point is statistically different from the other three 
time points within the supported ecFn dataset. Credits: Flow cytometry done in the Wicha Lab at 
the University of Michigan.......................................................................................................... 120 
 
Figure 4-5: Proliferation trends and ALDH expression for MDA-MB-468 cells are similar 
across different cell culture substrates (a) Normalized proliferation measured by net 
mitochondrial activity of MDA-MB-468 cells shows little to no difference amongst supported 
ecFn and control substrates despite observed changes in tumorigenicity. (b) Early timepoints show 
increased fractions of ALDH+ (aldehyde dehydrogenase) cells on supported ecFn relative to TCPS, 
and FN on TCPS, but ALDH populations across the three cell culture substrates converge and 
increase together from the fourth to sixth day in culture. (a-b) Supported ecFn (black solid line and 
square marker), TCPS (black dotted line and criss-cross marker), and TCPS conformally coated 
with fibronectin or FN on TCPS (grey line and triangular marker). Credits: Flow cytometry done 
in the Wicha Lab at the University of Michigan........................................................................... 121 
 
Figure 4-6: T47D and Sum159 human breast cancer cells proliferate on supported ecFn 
Normalized proliferation gives fold increase in cell number over the course of five days in culture 
on either supported ecFn (black solid line and square marker) or TCPS (black dotted line and criss-
cross marker). Supported ecFn is able to support growth of human breast cancer cells as with (a) 
T47d and (b) Sum159 cell lines. As with MDA-MB-468s in Figure 4-5(a), the growth profile on 
TCPS is similar to that of supported ecFn.................................................................................... 122 
 
Figure 4-7: Supported ecFn enables expansion of patient breast cancer cells and enrich the 
tumor-initiating cell population in an epithelial to mesenchymal transition (a-b) Supported 
ecFn maintains culture of heterogenous cell populations taken from Patient E ascites sample. 
LSCM volume views taken after four days of culture. Channels: cyan, cell nucleus; red, actin; 
yellow, cytokeratin 5. (a) 3D cell structures form within the pores and along the microfiber walls 
of the scaffold. Scale bar 25 µm. (b) Patient E cells fill supported ecFn scaffold at large scale across 
many 500 µm square pores. Scale bar 500 µm. (c) Proliferation measured via mitochondrial 
activity for ascites sample from Patient A is far increased on supported ecFn (black solid line and 
square marker), with little to no growth on fibronectin adsorbed conformally onto TCPS (grey line 
and triangular marker), or TCPS (black dotted line and criss-cross marker). Inset shows 
xxvii 
 
representative images of Ki67 staining of Patient B cells cultured on either TCPS or supported 
ecFn. Darker color indicates that the cells are in a proliferative state on supported ecFn but 
senescent on TCPS. (d) Flow cytometry measurement of CD24 and CD44 in the ascites sample 
from Patient E where the original sample is shown in red and the same sample after six days of 
culture on supported ecFn is shown in blue. Original spread in cell phenotype concentrated towards 
CD44+/CD24- status after culture on ecFn networks. (e-h) Flow cytometry measurements of the 
percentage of lineage negative cells that are (e) CD44+/CD24- (f) EpCAM+ (epithelial cell 
adhesion molecule) (g) ALDH+ (aldehyde dehydrogenase) and (h) CD44+/CD24-/ALDH+ within 
ascites samples from Patients E and F, and a pleural effusion sample from Patient G. Grey bars 
represent the original patient sample and white bars indicate result after cells were cultured on 
supported ecFn in vitro for six days. Credits: Patient cells were obtained through the Luker Lab 
and Hayes Lab at the University of Michigan. Flow cytometry done in the Wicha Lab at the 
University of Michigan................................................................................................................ 124 
 
Figure 4-8: Supported ecFn provide a microenvironment for the expansion of patient pleural 
effusion and ascites samples ex vivo while maintaining receptor status (a-c) Pleural effusion 
samples from (a-b) Patient I and (c) Patient H cultured on supported ecFn and imaged via LSCM 
showing heterogeneity, scalability, formation of 3D cell structures, and separation of cells by cell 
type into different areas of the same scaffold. (d) Population shifts in favor of cancer cells marked 
by cytokeratin in ascites sample from Patient J cultured either five days or ten days on supported 
ecFn. Representative LSCM images taken at the microfiber crosshair of the 3D jet writing polymer 
scaffold. (a-d) Channels: cyan, cell nucleus; red, actin; yellow, cytokeratin 5. Scale bar (a, c, d) 25 
µm, (b) 100 µm. (e) Pleural effusion sample from Patient F was made into a cytospin, stained, and 
quantified for positive signals of human epidermal growth factor receptor 2 (HER2), estrogen 
receptor (ER), and progesterone receptor (PR). This analysis was performed on cells from the 
original patient sample (grey bars) and after six days of culture on supported ecFn (white bars). 
Hospital data reported that this patient’s receptor status was HER2+ER-PR-. Error bars represent 
standard deviation of % of receptor positive cells measured from three to four microscope fields 
of view. Credits: Patient cells were obtained through the Luker Lab and Hayes Lab at the 
University of Michigan................................................................................................................ 126 
 
Figure 4-9: Six-day culture on supported ecFn enriches breast cancer cell population in 
patient pleural effusion or ascites samples (a) Percent of total sample that are cancer cells 
indicated by the lineage negative population as measured directly from the patient (grey bars) and 
after six days of culture on supported ecFn (white bars). (b) Percent of Patient E lineage negative 
cells that are ALDH+ (aldehyde dehydrogenase) after culture on supported ecFn or TCPS as 
compared to the original ascites sample. (c-e) Representative flow cytometry scatterplots for 
Patient E comparing the original ascites sample to cells cultured on supported ecFn for six days. 
The (c) CD24-/CD44+ (d) EpCAM+ (epithelial cell adhesion molecule) and (e) ALDH+ cells within 
the lineage negative population were quantified. Credits: Patient cells were obtained through the 
Luker Lab and Hayes Lab at the University of Michigan. Flow cytometry done in the Wicha Lab 
at the University of Michigan...................................................................................................... 128 
 
Figure 4-10: Patient ascites cells grow on tissue culture polystyrene if first expanded on 
supported ecFn (a) Ascites sample from Patient E cultured first on supported ecFn for two days 
then trypsinized and re-plated onto tissue culture polystyrene (TCPS) dish. (b) Brightfield 
xxviii 
 
microscope image of cells from the same patient sample as in (a) plated directly from the patient 
onto TCPS. Image taken after one day of culture showing cells do not survive. Scale bars 25 µm. 
Credits: Patient cells were obtained through the Luker Lab and Hayes Lab at the University of 
Michigan..................................................................................................................................... 131 
 
Figure 5-1: Stromal cell-derived factor 1α (SDF-1α) loaded into core of core-shell PLGA 
microfibers SDF-1α-Cherry fluoresces red in the core of microfibers comprised of a PLGA shell 
labelled blue. (a) Volume view of aligned fibers collected on a rotating wheel during the 
electrospinning process. (b) Single fiber bundle collected on a rotating wheel indicating cross 
sectional views to emphasize the SDF-1α-Cherry core within the PLGA shell. All scale bars 25 
µm. Credit: Fiber fabrication done by Gokcen Ukuser. SDF-1α-Cherry generously donated by the 
Luker Lab at the University of Michigan..................................................................................... 140 
 
Figure 5-2: MCF7 breast cancer cells show increased ALDH positive population when 
cultured on supported eECM of laminin relative to fibronectin (top) ALDH expression 
increased from 1.48% on fibronectin to 2.34% on laminin for MCF7 human breast cancer cells 
cultured on supported eECM. (bottom) MCF7 human breast cancer cells cultured 10 days on 
supported eLAM and imaged in an area of (a) high cell density and (b) low cell density. MCF7s 
were also cultured 10 days in parallel on supported ecFn and imaged in an area of (c) high cell 
density and (d) low cell density. (a-d) Scale bar 25 µm. Cell nucleus in cyan, and actin in red. 
Credits: Flow cytometry done in the Wicha Lab at the University of Michigan.......................... 144 
 
Figure 5-3: Sum159 human breast cancer cells show strong affinity towards fibronectin 
immediately upon seeding Sum159 human breast cancer cells preferentially seeded onto 
supported ecFn within scaffold pores rather than the polymer microfibers. Cells formed thick 
volumes within the pore by the fourth day in culture. Volume thickness reduced in areas on or near 
the polymer microfibers. This is a phenomenon was uniquely observed with this cell type. Scale 
bars 100 µm................................................................................................................................. 145 
 
Figure 5-4: Matrix metalloproteinase expression increases at a later timepoint in MDA-MB-
231 culture when cells have migrated off the scaffold remaining viable in solution Matrix 
metalloproteinase 2 (MMP2) was quantified alongside E-cadherin for MDA-MB-231 human 
breast cancer cells on supported ecFn. MMP2 indicates proteolytic activity characteristic of 
invasive cells and a mesenchymal phenotype. E-cadherin expression results from formation of 
cell-cell contacts, known to be downregulated in EMT............................................................... 147 
 
Figure 5-5: Study of EMT and MET is not limited to breast cancer – cells cultured on 
supported ecFn for a pancreatic cancer model system (a) ASPC1 pancreatic cell line, 
mesenchymal by nature and (b) UM53 patient-derived pancreatic cells, epithelial by nature, at a 
low cell density area of the scaffold showing how cells proliferate and shirt off the polymer 
microfibers and into the open pore areas at the six-day culture timepoint. Large scale scaffold at 
low magnification showing (c) ASPC1 after four days and (d) UM53 after two days of culture on 
supported ecFn. (e) Zoomed in view showing individual cells from (c). (f) Zoomed in view 
showing individual cells from (d). (a-b, e-f) Scale bars 25 µm. (c-d) Scale bars 500 µm. Cell 
nucleus in cyan, actin in red. Credits: Pancreatic cancer cells generously donated by the Simeone 
Lab at the University of Michigan............................................................................................... 148 
xxix 
 
 
Figure 5-6: Supported eECM provides cells large open area for formation of 3D cell 
structures demonstrated by endothelial cells (a) HUVECs (human umbilical vein endothelial 
cells) starting to branch out into the center of the scaffold pore. (b) Area of scaffold showing higher 
cell confluency as opposed to low cell density areas shown in (c) and (d) where formation of 
tubular structures are more easily visualized. All scale bars 25 µm. All supported eECM comprised 
of fibronectin and laminin. Cells cultured one month. Cell nucleus shown in blue; actin shown in 
green............................................................................................................................................ 150 
 
Figure 5-7: Supported ecFn demonstrates potential for vasculogenesis in a co-culture system 
of endothelial cells and fibroblasts HAMEC (human adipose microvascular endothelial cells) 
and HNDF (human dermal fibroblasts) cultured on (a) supported ecFn and (b) 3D jet writing 
scaffolds coated conformally with Fn. (a) Both cell types seeded onto scaffold at the same time. 
Image taken after 14 days of co-culture. Scale bar 100 µm. (b) HAMECs seeded first onto scaffold 
and cultured three days before HNDFs were seeded. Image taken after eight days of co-culture or 
11 days of total culture time. Scale bar 200 µm. Endothelial cells (HAMEC) in green, and 
fibroblasts (HNDF) in red. Credits: Fabrication of 3D jet writing scaffold done by Lahann Lab at 
University of Michigan. All other procedures including protein deposition, cell culture, and 
imaging done by Ariel Szklanny of the Levenberg Lab at Technion Israel Institute of 
Technology.................................................................................................................................. 151 
 
Figure 5-8: Co-culture of fibroblasts and human breast cancer cells by layering three 
scaffolds (a) Full top view of three scaffolds stacked onto one another. The two outer scaffolds 
were seeded with NIH-3T3 mouse fibroblasts, which should appear blue under the nuclear stain. 
The center scaffold carries GFP-MDA-MB-231 human breast cancer cells which fluoresce green 
but also contain a red stain for cytokeratin. Scale bar 500 µm. (b) Zoomed in angled and side view 
of scaffold stack shown in (a) at a depth of only 53 µm which does not encompass the entire 
thickness of the sample. All cells are marked in a blue nuclear stain, while the cancer cells are 
labelled in both green and red (GFP and cytokeratin). All cultures done on supported ecFn. Scale 
bar 25 µm..................................................................................................................................... 152 
 
Figure 5-9: Expansion of fibroblasts from healthy and breast cancer patients on supported 
ecFn Fibroblasts obtained from either human breast cancer patients (a) or healthy patients 
undergoing breast reduction surgery (b) were expanded on supported ecFn. Future studies on the 
effect of stromal cells on tumor progression will consider use of these cell types. Blue channel 
marks the cell nucleus, green channel indicates actin. Credits: All cells generously donated by the 
Wicha Lab at the University of Michigan.................................................................................... 153 
 
Figure 5-10: Segregation of cell types in co-culture of T47D human breast cancer cells with 
mouse NIH-3T3 fibroblasts on supported ecFn Five and ten day timepoint of a co-culture of 
human breast cancer cells of the T47D cell line with mCherry (red) with mouse GFP-NIH-3T3 
fibroblasts (green) at a seeding ratio of 4:1. The segregation of the two cell types is evidenced in 
these live culture images of a cross sectional view (left) and volume view (right). Scale bars 30 
µm............................................................................................................................................... 153 
 
xxx 
 
Figure C-1: Dimensions of metal frame used to secure polymer support in 2-mL tube during 
hydrodynamically induced fibrillogenesis or cell culture in 24-well plates................................. 157 
 
Figure C-2: Proper positioning of 2-mL tube containing mounted polymer support and protein 
solution on tumbling rotator......................................................................................................... 160 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxxi 
 
 
List of Appendices 
 
 
 
Appendix A: Decellularization Protocol .................................................................................... 154 
Appendix B: Dehydration Protocol ........................................................................................... 155 
Appendix C: Preparation of supported protein networks .......................................................... 156 
  
xxxii 
 
 
Abstract 
 
In the current shift away from 2D tissue culture polystyrene and towards 3D cell culture models, 
several important design criteria have yet to be considered: (1) provision of large open areas where 
cells can create their own niche (2) fabrication of a scaffold that is chemically and mechanically 
tunable and (3) presentation of proteins that mimic native extracellular matrix (ECM). Polymer 
scaffolds fabricated by 3D jet writing provide extensive void space for maximum cell-cell and cell-
ECM interactions. This work expands on such electrospinning technologies to establish a 
micromanufacturing process that modulates the flow of various polymer solutions through a 
manifold. The resulting scaffolds contain spatially distinct domains that can be customized to 
exhibit specific bulk or surface properties. Such tunability is not limited to the synthetic design 
space. We have discovered that hydrodynamically induced fibrillogenesis can yield remarkably 
stable networks of protein fibrils suspended across a support or scaffold that recapitulate important 
structural and functional hallmarks of cell-secreted ECM. These engineered networks of 
fibronectin serve as a breast cancer microenvironment, making it possible to culture an 
unfractionated patient sample (n=14), where less than 5% are cancer cells, into a self-selected 
composition of differentiated cancer cells, stem-like cancer cells, and various stromal cells. An 
average of 40% increase in the tumor-initiating population and at least a 7-fold increase in the 
cancer cell population was observed after six days (n=3). This user-defined 3D cell culture 
platform will enable investigation into the bidirectional relationship between cells and the ECM, 
not just for breast cancer but a variety of diseased or healthy tissue types.
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Chapter 1 
The Complete Design Space of 3D Cell Culture 
 
 
 
1.1 The problem at hand 
 
In both healthy and pathological states, cell behavior is dictated by chemical and 
mechanical cues that are derived from soluble signals, and cell-cell or cell-extracellular matrix 
(ECM) interactions1, 6-9 as shown in Figure 1-1. Physiologically, cells actively remodel the ECM: 
breaking down existing and secreting new proteins, or changing protein conformation to alter the 
biological activity of the protein6. Fibronectin (Fn), for example, exposes different binding sites as 
it is restructured from a soluble state (plasma fibronectin or pFn) to an extended fibrillar 
conformation (cellular fibronectin, or cFn)3, 10-14. Furthermore, different tissues and diseased states 
are characterized by specific ECM compositions7, 15. For instance, laminin is primarily found in 
basement membranes whereas mesenchymal tissues are largely composed of fibronectin9. In the 
case of breast cancer, primary tumors are largely composed of collagen16, whereas fibronectin has 
been identified as a major constituent of the pre-metastatic niche17. 
Tissue engineering and 3D cell culture relies on the structural support of a biocompatible 
scaffold on which cells are grown in vitro. The scaffold acts as the ECM otherwise would in vivo1, 
8, 18-20. Given that cells sense and respond to their local environment, the performance of the 
scaffold is closely correlated with how well it mimics physiological conditions in regards to 
composition, architecture, protein conformation and mechanical properties19, 21-23. For instance, 
drug response has been shown to be a function of dimensionality, where cells are more sensitive 
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on 2D than 3D environments24. Yet, much of biological research is still conducted on flat 
polymeric surfaces such as tissue culture polystyrene (TCPS), or proteinaceous mediums such as  
 
Figure 1-1: Extrinsic factors modulate cell behavior in vivo Cells interact with their 
native environment through soluble and non-soluble signals, and cell-cell interactions. 
These interactions drive the gene expression that dictates how the cell will behave and 
ultimate the fate of the cell. Of the various environmental cues, cells rely on the structural 
environment or extracellular matrix (ECM) for a supply of non-soluble signals. In parallel, 
when designing an in vitro cell culture scaffold, of the various environmental cues, the 
scaffold is responsible for providing non-soluble signals by presenting proteins in an ECM-
like fashion. [Illustration adapted from Lutolf et al.1] 
Matrigel that fail to recapitulate the structure and function of the native cell niche. Poor in vitro 
representations of the environment a cell would encounter in vivo can induce an artificial cell 
response that does not portray how the cell would respond to the same stimulus if in its native cell 
niche24, 25. This can greatly hinder efforts to understand and treat many diseases such as cancer 
metastasis, where not only the phenotype of the cell, but also the conditions of the 
microenvironment are what drive tumor cells to home in at a particular site for secondary tumor 
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formation16, 26-31. The need for a scaffold that mimics the structure and function of actual ECM is 
urgent given the extent of today’s biological research and efforts to engineer functioning tissues 
in vitro24, 32. 
Of equal importance when designing a scaffold for research is how well the technology 
will “drop-in” or readily replace current cell culture models to enable quick and widespread 
adoption. An ideal culture system will be versatile in regards to compatibility with a diversity of 
cell types33, offer a means to independently investigate the effects of different environmental 
parameters including ECM composition8, 18 and how cells are remodeling the ECM19, while 
remaining amenable to standard culture and characterization techniques19, 24. Meeting this need 
calls for a system with independently tunable processing parameters that can produce a scaffold 
customized for its intended use. Researchers would select from a library of parameters that include 
geometries, materials, or ECM protein compositions for the manufacture of scaffolds outfitted to 
represent various permutations of environmental properties. This ability to decouple otherwise 
interconnected properties would allow researchers to run the controlled experiments needed to 
tease out the effect of a specific stimulus on cell response, or design and engineer specific tissues.  
 
1.2 State of the art 
 
Current 3D culture models such as electrospun mats34 rely on polymeric mimics of ECM 
that lack the cell binding motifs or proteolytic susceptibility of actual proteins, and allow cells little 
to no open area for migration19, endogenous protein secretion35, or formation of higher-order 
multicellular structures1. Randomly oriented fibers do not allow control of pore size, and pores can 
be as small as a few microns to nanometers which hinders cell infiltration22, 35. Even aligned 
electrospun fibers are limited in control of pore size and geometry35. Another approach is to culture 
cells in spheroids8, 36 or within a hydrogel19, 37, which can be made from common ECM proteins 
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such as fibrin, collagen or basement membrane extract gels22 ensuring material biocompatibility 
and providing cell binding sites. However, integration of cell-secreted protein and cell migration  
in hydrogels and spheroids are mass transport limited1. Hydrogels also offer little to no spatial 
control of chemical moieties and lack a defined architecture, which in conjunction to being largely 
composed of water results in poor mechanical properties38, scalability, and handleability16. 
Systems isolated from animal models or cell feeder layers1, 19 and decellularized matrices18 are 
frequently used. While these products are actual isolated ECMs, they give researchers few 
independent variables18, are plagued by a poorly-defined biochemical composition, and may 
introduce xenogenic or viral contamination1, 19. Such batch-to-batch variability and the presence 
of unidentified factors are particularly disadvantageous when working with cells that are highly 
sensitive to their environment such as stem cells39. 
Thus, there remains a clear need to design and demonstrate the successful use of a scaffold 
that: (1) is reproducible, chemically defined, and xenograft-free (2) uses whole proteins that 
provide binding sites for cell adhesion and are susceptible to proteolysis (3) has an architecture 
similar to the native cell niche (4) allows cells to secrete endogenous protein and remodel the ECM 
(5) offers independent definition and customization of environmental parameters (6) allows spatial 
control of chemical and mechanical properties (7) has a large open area to maximize cell 
interactions with other cells and ECM proteins, while minimizing cell and protein contact with 
synthetic material in order to preserve cell phenotype and protein conformation (8) is highly porous 
with tunable geometries and support of favorable transport properties and (9) is amenable to 
handling, imaging, and standard cell culture and characterization techniques1, 19, 21, 22, 40-46. 
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1.3 A composite solution 
 
Engineering an ECM in vitro requires use of whole proteins as opposed to peptides or 
specific binding sequences. The architecture and protein conformation and composition must be 
tuned to accurately recapitulate the structure and function of native ECM. At the same time, the 
ECM protein should be distributed in a way that facilitates cell infiltration, transport of oxygen 
and nutrients to the cells, and waste products away from the cells19, 40, 47. To ensure quick adoption 
of an engineered ECM into regular practice, it must maintain mechanical integrity at physiological 
temperatures despite forces exerted by cells,46 physical handling, or fluid convection in non-static 
cultures.19 The solution to meeting these requirements simultaneously is a material composed of 
both biological elements (ECM proteins) and a rigid scaffold that provides skeletal support to the 
protein matrix. Biodegradable polymers are an excellent material choice for such a scaffold, 
offering mechanical stability while ensuring biocompatibility and implantability should the 
engineered ECM mimic find application in in vivo studies or regenerative medicine6, 19.  
Still, fabricating a material that exhibits all the required properties using biological proteins 
and biodegradable polymers may appear a daunting task. How does one ensure the ECM mimic 
can be adequately tuned to represent the cell microenvironment of diverse tissue types including 
skin, muscle, cartilage and bone? Rather than designing a new ECM mimic for each tissue type 
and experimental study, as has been the current trend in the literature, this study establishes a 
system for the custom manufacture of a supported engineered ECM (eECM). Instead of designing 
a single material to meet each of the individual properties outlined in Section 1.2, geometry, 
material placement, and ECM protein composition will be set during manufacture to produce 
scaffolds with the chemical and mechanical properties of the cell niche of interest (Fig. 1-2). The 
first part of the micromanufacturing system is the polymeric skeletal support or scaffold, which 
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through geometric control, offers a high porosity to facilitate transport, and a tunable mechanical 
environment. The choice of scaffold can vary, however, in this study 3D jet writing scaffolds48 
were selected not only for precise geometric control, but also for the high percentage of open area, 
or the ratio of the volume of void space within the scaffold to the volume of the entire scaffold.  
 
Figure 1-2: Manufacture of a supported engineered extracellular matrix (eECM) via 
three main manufacturing capabilities A supported eECM is comprised of a porous 
polymeric scaffold and a network of ECM protein. Three major manufacturing capabilities 
allow for customization of this 3D cell culture model such that it exhibits features specific 
for its intended use. Here, the 3D jet writing process is used to fabricate 3D microfiber 
constructs with tunable pore shape and size. These scaffolds maintain mechanical integrity 
despite handling in dry or wet conditions while being composed of only ~4% material by 
volume, leaving the remainder of the volume as void space otherwise referred to as open 
area. Second is the spatial control of material composition which can be varied across the 
polymer scaffold in three-dimensional coordinate space. In addition to bulk material, 
changes in composition include surface functionalities for subsequent chemistries, or 
embedding of drugs or biomolecules for release. Third is the free suspension of a network 
of ECM proteins across and within the pores of the polymer scaffold. Proteins fill the open 
area of the scaffold, limiting contact with the synthetic material surface in effort to preserve 
protein conformation. 
The second part of the micromanufacturing system creates the ability to (1) independently vary 
one property of the polymer scaffold via bulk or surface composition at a time to observe how one 
specific change affects cell behavior in a controlled experiment and (2) pattern domains of distinct 
chemical compositions throughout the polymer scaffold in 3D space. With this development, 3D 
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jet writing scaffolds will be able to present bulk materials or composites, tethered ligands, or 
surface functionalities in a spatially selective manner, which can all be used to direct cell behavior 
much like soluble signaling in vivo6, 7, 19, 49. The third part of the micromanufacturing process 
suspends stable bridges of a single or combination of ECM proteins across and within the open 
pores of the polymer scaffold. This supported eECM serves as an in vitro microenvironment where 
cells are free to create their own cell niche with minimal interference from synthetic material by 
remodeling or secreting ECM proteins, and forming higher-order multicellular structures such as 
clusters, ducts or lumens.  
The overall goal of this micromanufacturing system is the fabrication of in vitro cell 
microenvironments where the protein composition, cell density and type, polymer scaffold 
geometry, pore size, pore shape, and three-dimensional distribution of distinct materials are all 
user-defined parameters. The number of possible permutations of these parameters enable the 
supported eECM to be tuned to probe specific research questions regarding cell response to a 
certain stimulus, or to model nearly any in vivo cell microenvironment, assuming the defining 
features of the physiological environment are known. Perhaps in future, this system or variations 
thereof will be adopted into mainstream cell cultures as a vast improvement over the ubiquitous 
petri dish. 
 
1.4 Specific aims of this study 
 
This work aims to establish a micromanufacturing system for expansion of the current scaffold 
design space and suspension of protein networks across scaffolds as a 3D cell culture environment for both 
in vitro and in vivo use. In application, the supported eECM serves as a breast cancer niche to observe shifts 
in cell populations expressing a certain phenotype and for the expansion of primary human cells obtained 
from breast cancer patients. These three specific aims are illustrated in Figure 1-3. Aim 1 focuses on further 
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development of the synthetic scaffold comprising the supported eECM. Building on previously existing 
technologies, electrospinning, electrohydrodynamic co-jetting, and 3D jet writing, the addition of a “micro-
manifold” allows complete control of the relative amount of each material confined within a single 
microfiber. Said microfibers are the building blocks for the 3D scaffolds that provide a skeletal support for 
the suspension of the eECM networks developed in Aim 2. With the manifold, these 3D jet writing scaffolds  
may now be manufactured with distinct domains controllably localized within the construct. In Aim 2, a 
process is developed for converting solubilized protein into stable fibrillar networks tethered across the 
polymer scaffold with a major emphasis on fibronectin. The fibronectin protein network is then shown to 
be in a bioactive conformation that mimics that of fibronectin secreted by cells, termed cellular fibronectin 
or cFn. Finally, Aim 3 takes advantage of the supported engineered cFn (ecFn) to expand primary breast 
cancer cells which are typically difficult to grow in vitro and to demonstrate the potential for supported 
ecFn to promote tumor graft formation. Beyond demonstrating a superior functionality of the scaffold 
manufactured via Aims 1 and 2, Aim 3 is largely motivated by the continuing need for more physiologically 
relevant tumor samples for drug screening, and the future promise of precision medicine. 
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Figure 1-3: Dissertation outline represented as a schematic of three specific aims Aim 
1 utilizes a “micro-manifold” to expand the design space of electrospun polymer 
microfibers and 3D scaffolds. Aim 2 develops a technique for the conversion of solubilized 
ECM protein into stable networks of fibrillar protein that is tethered to and suspended 
across the 3D polymer scaffold of Aim 1. Aim 3 demonstrates one of many possible 
applications of the supported eECM produced via the combination of Aims 1 and 2. Here, 
the supported eECM serves as a breast cancer microenvironment for the expansion of 
primary breast cancer patient cells towards ongoing efforts in precision medicine, and 
tumor graft formation for drug screening, and as a more physiologically relevant 3D cell 
culture model for fundamental studies. 
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Chapter 2 
Micromanufacturing Customizable Polymer Scaffolds 
 
 
 
2.1 Introduction 
 
2.1.1 Electrohydrodynamics and electrospinning 
Electrohydrodynamics (EHD) describes the transport of charges within a fluid under an 
applied electric field. As the charges move, they exert stresses which cause the fluid to move50. 
One of the earliest known investigations of EHD was done by Zeleny in 1917 where a fine jet was 
formed from a deformed droplet of charged fluid under an electric field51. Formhals first used this 
process to produce plastic fibers and received a patent for it in 193450. A general setup for 
producing fibers using EHD is shown in Figure 2-1. The process begins by pumping a semi- 
insulating polymer solution through a metal capillary which will serve as the high voltage  
 
 
Figure 2-1: Formation of a fluid jet via electrohydrodynamics A semi-insulating 
polymer solution is driven through a metal capillary using a syringe pump. The droplet that 
forms at the outlet of the capillary is initially spherical in shape under surface tension. With 
the application of an electric field, the droplet distorts into a conical shape, known as a 
Taylor cone. Increasing the voltage past a critical point results in the emission of a fluidized 
jet from the apex of the Taylor cone. The jet diameter decreases as it propels towards the 
ground electrode causing rapid evaporation of the solvent and leaving behind a solid 
polymer fiber. 
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electrode. A ground electrode is situated a known distance below the high voltage electrode to 
create a potential difference. This setup allows for the fascinating interplay of a number of driving 
forces including surface tension, Coulombic interactions, momentum driving forces, and electric 
stresses50, 52-54. Initially, if the potential difference is low or zero, then the surface tension of the 
fluid dominates and the drop emerging from the capillary at the air-solution interface maintains a 
hemispherical shape50. Electric fields induce fluid flow in dielectric fluids53. Since the polymer 
solution is semi-insulating, there is a potential difference between the top and bottom of the drop 
which causes a tangential electric field and interfacial electrical shear stresses acting on the drop 
that drive axisymmetric fluid flow52. The drop will remain hemispherical if surface tension 
dominates over these electric stresses or if the normal electric stress is uniform54. However, at a 
certain critical voltage, the electric stress increases sufficiently to distort the droplet into a conical 
shape termed a Taylor cone50. At this higher voltage, charges in the Taylor cone are strongly 
attracted towards the ground electrode and move towards the cone apex, increasing the surface 
charge density until the charge-charge repulsion is relieved by the ejection of excess charge 
through a fluid jet50. Although jet formation is an instability, the cone-jet construct itself remains 
stable over time due to a balance between the tangential stress and the axisymmetric fluid motion50. 
After a jet has formed, the charges within the polymer solution continue to traverse the 
distance towards the ground electrode, moving the fluid with it. Hence, the jet is propelled towards 
the grounded collector reducing the diameter by several orders of magnitude55. The fine jet has an 
increased surface area facilitating the rapid evaporation of the solvent leaving behind a solidified 
polymer microfiber, which is collected on a grounded electrode55. Charges are removed from the 
fiber during jetting due to corona discharge, humidity, or solvent evaporation, or at the point of 
collection where the fiber discharges to the ground electrode; however, some residual charges may 
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remain50. In this way, nano- and microfibers are produced from EHD jetting. Typically during jet 
propulsion towards the ground electrode, a bending or whipping instability develops where the 
lower end of the jet undergoes a growing oscillatory circular deflection54, 56. Whipping results in 
further thinning of the jet to submicron scales which increases surface area and decreases the time 
needed for solvent evaporation. The remaining polymer fiber is deposited at the ground electrode 
as a non-woven mat of interconnected fibers21 ranging from 20 nm to 5 µm50. This process is 
known as electrospinning and can be used to generate fibers from polymer solutions or melts50. 
 
2.1.2 3D jet writing 
A major drawback of electrospinning is that the fibers are randomly deposited on the 
grounded collection electrode since the process by which the fiber diameter is reduced to 
submicron scales, the whipping instability, is inherently unstable50. While efforts have been made 
to control the alignment and orientation of electrospun fibers on the collection electrode20, 57, 58, 
repulsive Coulombic forces between the depositing fiber and the fiber mat can make precise fiber 
deposition50 and the spinning of a fiber mat thicker than 1.5 - 2 mm difficult57. Additionally, failure 
to modulate the electric field as needed and/or the whipping instability can preclude control over 
fiber placement. Such problems have been resolved for microfibers in the Lahann Lab by 
implementing an electrostatic lens to focus the electric field which keeps the depositing fiber 
directly beneath the Taylor cone. A moving stage is used to reposition a flat plate which serves as 
the collection electrode during jetting such that a single continuous fiber is patterned into a 
computer controlled geometry and stacked onto itself to create a third dimension48. This process, 
termed 3D jet writing, allows fabrication of polymer microfiber supports from the FDA approved 
biodegradable polyester, poly(lactide-co-glycolide) or PLGA59 (Fig. 2-2), and can be extended to 
include other materials by adjusting process and polymer solution parameters.  
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Figure 2-2: 3D jet writing produces three-dimensional microfiber scaffolds By 
increasing the viscosity of the polymer solution and implementing an electrostatic lens to 
focus the position of the fiber jet, 3D jet writing affords precise deposition of a single 
electrospun fiber in a computer-controlled pattern onto a grounded collection plate. The 
fiber is stacked onto itself to create a third dimension (inset). The scaffold shown here 
contains square-shaped pores 500 µm wide. Scale bars are 500 µm (left, zoomed out view) 
and 25 µm (right, inset). 
Scaffolds fabricated via 3D jet writing enhance transport properties through large open 
pores of user-defined shape and size, and minimal use of material. 3D jet writing scaffolds feature 
open areas as large as 96% by volume while maintaining mechanical integrity during handling, 
under convective fluid flow, and in long term cell culture. Such minimal amounts of synthetic 
material limits the extent of protein denaturation due to adsorption onto solid surfaces12, and 
creates large volumes of space free of synthetic material where cells will only interact with 
biological compounds such as proteins, growth factors, and other cells. Large synthetic-free voids 
also provide cells freedom to degrade existing ECM or build their own ECM. Adherent cells have 
been observed to form “microtissues” or volumes several cell diameters thick that span the open 
framework. Other cell architectures have also been observed such as clusters and lumens. It is 
hypothesized that cells residing within the open pores will tend to display a more native or less 
artificial phenotype, as is often induced by 2D cultures where the entire cell surface is spread out 
on and in contact with a hard plastic surface60, 61. Practically, the control of overall physical 
geometry afforded by 3D jet writing is convenient for laboratory uses such as fitting into well 
plates, or to match the size and shape of a patient’s defect if implanted for tissue regeneration19. 
When applied as a cell culture matrix, 3D jet writing scaffolds are secured between two metal 
frames and attached to a spacer such that the physical scaffold is free standing within the cell 
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media. This ensures easy handling or transfer and maintains the three-dimensionality as opposed 
to a 2.5D culture where the scaffold sits directly on a hard plastic substrate. 
Still, the 3D jet writing system has its limitations in regards to achieving control of where 
specific materials are localized within the microfiber construct. Such capability would expand the 
design space by allowing domains with distinct properties (surface functionality, elasticity, 
degradability, etc.) to be embedded within a single polymer scaffold. It would also further decouple 
defining features of the material and extend the level of tunability of the final product, empowering 
researchers with additional tools for probing the effect of changes in the microenvironment on cell 
behavior. Chapter 2 demonstrates how this limitation is resolved through the design and 
implementation of a “micro-manifold.” 
 
2.1.3 Electrohydrodynamic co-jetting 
Electrohydrodynamic (EHD) co-jetting is an electrospinning-based technique developed 
in the Lahann Lab for the fabrication of multicompartmental electrospun micro- and nanofibers. 
Figure 2-3(a) shows how multiple capillaries, each carrying a distinct polymer solution, are 
connected in parallel for form a single spinneret2. The polymer solutions are driven by a single 
syringe pump to form a droplet that spans the outlets of all capillaries. Under an applied electric 
field, the droplet distorts into a Taylor cone where each polymer solution remains in a distinct 
compartment. In fact, the arrangement of the capillaries is conserved in regards to material 
placement within the Taylor cone and the ejected fluid jet. The solvent then evaporates from the 
fluid jet, leaving behind a polymer fiber with a cross section that mirrors that of the bundled 
capillaries within the spinneret (Fig. 2-3(d))2. Increases in solution viscosity and elastic forces, or 
a decrease in charge density can effectively dampen the instability20 enabling fiber alignment to 
produce bundles of fibers as shown in Figure 2-3(b)2. Two distinct compartments within each 
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bicompartmental fiber are indicated by red and blue fluorescent dye in Figure 2-3(c)2. Up to seven 
compartments have been realized (Fig. 2-3(d))2. 
      
Figure 2-3: EHD co-jetting pioneered in the Lahann Lab enables fabrication of 
multicompartmental fibers (a) Electrohydrodynamic (EHD) co-jetting setup for 
production of multicompartmental microfibers showing the connection of multiple 
capillaries or needles to form a single spinneret. (b) Scanning electron micrograph (SEM) 
of an aligned bundle of bicompartmental microfibers. (c) Laser scanning confocal 
micrograph (LSCM) of bicompartmental fiber bundle showing two compartments in each 
fiber, one labeled in red and the other in blue fluorescent dye. (d) The placement of each 
needle relative to the other is conserved in compartment placement within each single fiber. 
Shown are the bundled capillaries used as the spinneret to produce each set of fibers. Scale 
bars 20 µm. [Figure adapted from Bhaskar et al.2] 
The major advantage of EHD co-jetting is the ability to embed different materials in 
distinct compartments within the fiber or attribute the surface of each compartment with a distinct 
functionality. This system affords many possibilities for rationally designed fibers (as well as 
micro- or nanoparticles) such as the encapsulation of cells, drugs, or biomolecules, or tethering of 
ligands to select sections of the fiber or particle surface62-64. Fiber compartments may be comprised 
of various polymers and additives by optimizing the properties of the polymer solution in order to 
stably electrospin the material(s) of interest. Finding the right mix of solvents can be a challenge 
since the ease with which a polymer solution electrospins is dictated by several process and 
solution parameters including polymer solubility, solvent miscibility, vapor pressure, viscosity, 
conductivity, and dielectric constant. Still, a major limitation of EHD co-jetting is the number of 
capillaries or needles required for control of compartment size. Relative compartmentalization 
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refers to the relative size of each compartment within a fiber. This is best understood in Figure 2-
4 where to fabricate a bicompartmental fiber where the two compartments are in a size ratio of 
60:40, five needles are required, a ratio of 70:30 requires 10 needles, and so on. In addition to a 
loss of jet stability, a spinneret comprised of such large numbers of needles limits relative 
compartmentalization to discrete values only. Chapter 2 demonstrates how this limitation is 
resolved through the design and implementation of a “micro-manifold.” 
 
Figure 2-4: Traditional EHD co-jetting has limitations in the relative ratio of 
compartment size or relative compartmentalization Relative compartmentalization 
within bicompartmental fibers can only be achieved in discrete ratios with the traditional 
EHD co-jetting setup. The need for a spinneret comprised of many needles quickly 
compromises jet stability and fiber quality. Here each of two compartments is represented 
by either blue or red polymer solution flowing through the bundled capillaries in a way that 
would theoretically allow fabrication of a fiber with the indicated relative 
compartmentalization. 
Control of compartment bulk composition in EHD co-jetted fibers also allows for control 
of mechanical properties. This was first seen in bicompartmental fibers comprised of poly(lactide-
co-caprolactone) or PLCL in one compartment and PLGA in the other65. The Young’s modulus of 
the fiber could then be manipulated by varying the ratio of the two materials within a single fiber 
by modulating relative compartmentalization. While PLGA is a stiffer polymer, PLCL is 
considered an elastomer, having greater flexibility than the frequently-used component polymers 
of PLGA, PLA (polylactic acid) or PGA (polyglycolic acid), and still being biodegradable66, 67. 
Overall, a library of biomaterials exhibiting an array of mechanical properties would greatly 
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benefit the biomedical community. Mechanical stimuli are frequently employed to regulate cell 
phenotype67 or stem cell differentiation46. Scaffolds used for 3D cell culture or biomaterials used 
in clinical applications must be able to maintain mechanical integrity under a range of conditions 
from material processing to implantation. Furthermore, clinical applications require both 
flexibility and durability at the same time66, 67. Hence developing fibers than can be used as 
building blocks for textiles or 3D structures via the 3D jet writing process with tunable mechanical 
properties would prove advantageous in a variety of biomedical applications. 
 
2.2 Materials and Methods 
 
 2.2.1 Materials 
Poly(D,L-lactide-co-glycolide) or PLGA (85:15 lactide:glycolide, MW 50,000 – 75,000 
g/mol, Tg 45-50°C), poly(D,L-lactide-co-caprolactone) or PLCL (DL-lactide 86 mol%, MW 
~100,000 g/mol, Tg 16°C) chloroform, and N,N-dimethylformamide (DMF) were purchased from 
Sigma-Aldrich. Fluorescent polymers are often added to the PLGA solution: (1) Methoxy-
polyethylene glycol (PEG)-rhodamine (MW 5,000 g/mol), red dye, was purchased from Creative 
PEG Works (2) poly[(m-phenylenevinylene)-alt-(2,5-dihexyloxy-p-phenylenevinylene)] 
(PMPDHPV), blue dye, and (3) poly[tris-2,5-bis(hexyloxy)-1,4-phenylenevinylene)-alt-(1,3-
phenylenevinylene)] (PTDPV), green dye, were purchased from Sigma-Aldrich. Tensile tests were 
performed on the UTM T150 from Keysight Technologies. Laser scanning confocal microscopy 
(LSCM) was performed on a Nikon A-1 confocal microscope (Nikon Corp., Minato, Tokyo, 
Japan). 
 
2.2.2 Scaffold fabrication via 3D jet writing 
3D jet writing scaffolds are fabricated as previously described48. Briefly, a 30 wt% PLGA 
solution is prepared with chloroform and DMF at a ratio of 93:7. This solution is then driven 
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through a 20-gauge needle from which it is propelled as a fluidized EHD jet onto a grounded 
collection plate under an applied electric field. The plate is attached to an x-y stage that makes 
computerized movements to precisely deposit the electrospun fiber in a prescribed pattern, 
enabling control of overall geometry, and pore shape and size. Repeatedly stacking the 
continuously produced fiber onto itself in the same pattern repeatedly creates a third dimension. 
Process parameters include solution flow rate at 0.4 mL/hr, needle voltage at 15 kV, ring voltage 
at 9 kV, distance from needle to ground at 4.8 cm, and distance between ring and ground at 2 cm. 
All process parameters are susceptible to change with environmental conditions, choice of 
grounded collection electrode, and variations in equipment setup. 
 
2.2.3 Fabrication of single fibers and fiber bundles 
 In addition to patterning into 3D structures, EHD co-jetted fibers can also be collected as 
aligned bundles or individual single fibers. Such fibers, when comprised of PLGA, may be 
produced via the same solution formulation used for 3D jet writing at 30 wt% and a ratio of 
chloroform to DMF of 93:7. However, PLGA single fibers or fiber bundles presented in this 
chapter were produced at 35 wt% and the same ratio of chloroform to DMF of 93:7. This is because 
when producing bicompartmental fibers where one compartment is PLGA and the other is PLCL, 
this PLGA formulation was found to be more stable; for consistency, the 35 wt% PLGA 
formulation is used in all single fibers or fiber bundles presented in Chapter 2. Originally, PLCL 
solution formulation was comprised of chloroform, cyclohexane, and DMF at a ratio of 45:50:5 
and 25 wt%. However, better jet stability was achieved when PLCL was prepared at 30 wt% and 
a chloroform to cyclohexane to DMF ratio of 45:45:10. All fibers containing PLCL presented in 
Chapter 2 were prepared using this updated formulation. Increasing the polymer concentration of 
PLGA and the DMF content in the PLCL solution effectively improved the extensibility of the 
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fiber jet, i.e. how far the jet can stretch without breaking. When PLCL and PLGA were blended 
into a monocompartmental fiber, appropriate masses of each polymer were combined into the same 
solution at 37.5 wt% and a ratio of chloroform to DMF of 88:12. 
 When fabricating bicompartmental fibers of PLCL and PLGA using the manifold, jet 
initiation was most optimal at an applied needle voltage of ~6 kV whereas fiber collection occurred 
at ~4.5 kV. Net flow rate was 80 μL/hr. Fibers composed purely of PLGA were prepared at ~10 
kV and 40 μL/hr with a 20 gauge needle. Fibers composed purely of PLCL were prepared with an 
initial voltage of ~6-6.5 kV, and a collection voltage of ~3 kV with a flow rate of 40 μL/hr. 
Monocompartmental blends of the two polymers, PLGA and PLCL, were fabricated with an 
initiation needle voltage of ~9 to 10 kV and a variable collection voltage as low as ~3.5 kV with a 
flow rate of 40 μL/hr. Relative humidity was kept within the range of 20 to 30% and temperature 
was maintained between 25 and 27°C. Single fibers or fiber bundles for imaging were collected 
on a glass coverslip attached to a rotating drum covered in aluminum foil. Single fibers for tensile 
testing were collected on aluminum frames 15.1 cm long, 7.5 cm wide, with a frame thickness of 
0.5 cm and a depth ranging from 0.4 to 0.9 cm. A sheet of oak tag with square cutouts 12 mm 
nominal wide was secured to both sides of the frame, and one single fiber was deposited over each 
square cutout. Frames were necessary to keep the fiber freely suspended rather than wrapping the 
fiber around a solid drum where the fiber would contact a hard surface, flatten at the point of 
contact, and dry in the curvature of the drum. Fibers dried with curvature would undergo pre-
stresses as they are straightened for mounting into the tensile testing machine. Fibers freely 
suspended across the 12 mm square cutouts were directly glued to the oak tag and tensile tested 
without having to remove the fiber, minimizing fiber damage and pre-stress. After fabrication and 
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one week of drying at ambient conditions, a drop of epoxy was placed at each end of the fiber to 
secure the fiber to the oak tag. Epoxy was allowed to cure for 24 hours. 
 
2.2.4 Fiber characterization and tensile testing 
 Single fibers adhered to and suspended across the 12 mm square cutouts were imaged with 
a brightfield microscope. Four images were collected for each fiber, one at either end of the fiber, 
and two more images at different locations along the fiber length. Images were cropped such that 
the fiber axis was in either a horizontal or vertical orientation and fiber diameters were measured 
using ImageJ. For each image, two measurements were taken for a total of eight measurements of 
fiber diameter per fiber. An average fiber diameter was then computed for each fiber over the eight 
measurements. After two weeks of drying at ambient conditions from the point of fiber fabrication, 
each square cutout carrying the epoxy-secured fiber was cut from the oak tag sheet. The fiber, now 
suspended over the square window, was mounted to the tensile tester. ASTM standard C1557 for 
measuring the tensile strength and Young’s modulus of fibers was adhered to as closely as possible. 
The tensile testing instrument, Keysight Technologies T150 was designed in compliance with 
ASTM C1557. Actual gauge length was measured with calipers prior to mounting the sample to 
the tensile tester, and taken as the length of the fiber between the two points of adhesive. ASTM 
C1557 requires a strain rate sufficiently high to break the fiber within 30 seconds. However, the 
diversity of fiber compositions being tested did not allow for a single test rate that would apply to 
all types of fibers. Recognizing that the test rate impacts the mechanical behavior of the polymer 
fibers, it was preferred to maintain a consistent strain rate amongst all experimental groups. The 
fibers composed purely of PLGA were selected as the standard test group for which a strain rate 
was determined that would comply with ASTM C1557. This rate would be low enough to avoid 
instant breakage of the brittle PLGA fibers, but as high as possible to so break the more elastic 
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fibers in the least amount of time. Fibers were tested at 0.0015 s-1 which resulted in PLGA fiber 
failure after an average of 11.3 seconds. Young’s modulus was calculated from stress-strain curves 
by inputting gauge length and fiber diameter into the NanoSuite software accompanying the tensile 
tester from Keysight Technologies. 
 The relative size of fiber compartments was quantified using 3D volume LSCM images. 
Surfaces were created over the fiber compartment residing in each channel using Imaris x64 8.3.0 
software. The volume encapsulated within each surface was quantified. Relative volumes 
represented relative compartmentalization. 
 
 2.3 Results and Discussion 
  
2.3.1 Manifold device: concept and design 
As incorporation of PLCL into a bicompartmental PLGA fiber attributes more elastomeric 
properties65, having different polymers in distinct domains within the same 3D construct produces 
a material with different properties in each spatially separate domain. Conceptually, varying the 
polymer(s) and/or additives comprising the bulk composition can yield a different stiffness or 
elasticity, surface texture or topography, degradability, charge density, and functional groups 
available at the surface for any follow-up chemistries. A single material sporting spatially distinct 
sets of properties was initially beyond the synthetic material design space of any electrospun fiber 
scaffold. As such, there was need for a micromanufacturing system that would allow deposition of 
a specific material into the desired domain within a 3D polymer scaffold.  
Since 3D jet writing scaffolds are effectively a single microfiber stacked onto itself, 
fabrication of scaffolds with distinct material domains requires a fiber that changes in composition 
along its length. Said fiber would need to be generated simultaneously with the 3D jet writing 
process so that it may be immediately patterned into the desired three-dimensional geometry. This 
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can be achieved by preparing a different solution for each bulk composition of interest, and 
modulating which solution is fed into the Taylor cone at a given time. The idea of several polymer 
solutions going into a system that has only one outlet, the spinneret from which the Taylor cone 
would form, describes an already existing device, a manifold. A manifold would have (1) several 
inlets where different polymer solutions can be fed (2) a single outlet from which a fiber would be 
electrospun (3) a method of regulating which polymer solutions are outputted at a given time and 
(4) the ability to create compartmentalized fibers as done with EHD co-jetting. The second 
property requires that the manifold is sufficiently conductive to propagate charges from a power 
supply to the polymer solution for Taylor cone and fluid jet formation. Use of the manifold for 
solution based electrospinning also requires a material resistant to organic solvents. 
Since 3D jet writing requires a continuously depositing fiber, the manifold device must 
have a constant feed of solution from at least one of the inlets to the outlet. Hence, in order to 
modulate the composition of the depositing fiber along its length, fluid flowing from the inlets to 
the outlet would have to be switched on or off, or diverted to a collection reservoir when not in 
use. The number of inlets is determined by the number of distinct materials to be embedded within 
the polymer support. In this study, the number of inlets was set to four. If fewer inlets are needed, 
the same solution would be pumped to more than one inlet rather than having an empty inlet that 
could leak air into the system or provide areas to accommodate fluid back flow. Early manifold 
design considerations included the size and shape of the inlet and outlet channels, pump 
arrangements (whether to have one pump applied to all channels and modulate flow on/off by 
valves, or have multiple pumps – one for each channel), the possible integration of valves to 
modulate flow, material choice, and the minimization of dead volume or the amount of fluid that 
is held within the device at a given time. Smaller dead volume would directly lead to shorter time 
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between switches in outlet solution composition given that the outlet flow rate is constant in the 
3D jet writing process. In other words, the solution that occupies the space within the device will 
be dispensed first, then a new solution carrying a different material composition can enter the outlet 
line. Ensuring that the outlet was composed of a single channel as opposed to the multi-capillary 
spinnerets used in EHD co-jetting was expected to maintain unbiased flow from all feeding inlet 
lines to the Taylor cone. This would minimize risk of (1) the fiber composition differing from that 
of the outlet flow and (2) instabilities due to a Taylor cone shared unevenly amongst the capillaries. 
In the end, much of these design considerations were limited by in-house manufacturing 
capabilities. Hence, the next step was to take the design considerations as a concept and move into 
prototyping. 
 
2.3.2 Manifold device prototyping 
Two major challenges arose in designing and prototyping a manifold: (1) the limited 
availability of microfabrication methods for prototypes compatible with organic solvents such as 
chloroform and dimethylformamide and (2) the minimization of “switch time” and therefore dead 
volume within the device. “Switch time” refers to the amount of time required to “switch” which 
polymer solution is being delivered from the Taylor cone to the fluid jet at a given moment. This 
is a direct reflection of the dead volume, or the amount of solution that is contained within the 
device outlet channel. For example, when switching from solution A to B, all of A must be pumped 
through the device outlet and out from Taylor cone before the following solution B can take its 
place in the outlet flow and fluid jet. 3D jet writing of one isotropic PLGA scaffold takes 
approximately seven minutes, implying that the switch time must be no more than seven minutes 
to be realized. In an alternative approach, this dead volume can be pumped out of the device by 
writing a portion of the scaffold, then pausing to write a sacrificial structure expelling unwanted 
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fluid volume, and returning to the construct of interest after the switch has been made. This 
alternative approach led to the final successful manifold prototype. In future, switch time can be 
minimized by using a pump that can dispense as well as retract fluid, so to more quickly alternate 
which solution is flowing to the manifold outlet. Prior to obtaining a working manifold device, 
several device iterations were prototyped as described below. 
PDMS microfluidic device 
In order to quickly generate manifold prototypes testing different microchannel patterns, it 
was thought that casting polydimethylsiloxane (PDMS) over a mold and bonding the PDMS to a 
glass slide would give some insight into whether the manifold concept was feasible. Fabrication 
of PDMS based microfluidic devices is a well-established technique, largely used by the group of 
Professor Nagrath at the University of Michigan. A collaboration with the Nagrath Lab was 
initiated to design a couple of prototypes around the conceptual manifold design shown in Figure 
2-5 where four channels are used for inlet flow (A-D) and the center channel, E, will carry the  
 
Figure 2-5: First manifold design for manufacture as a PDMS microfluidic device 
Schematic for manifold with four inlets labelled as channels A, B, C, and D. The outlet is 
indicated by a yellow ring at the center of channel E where a needle would be inserted in 
the plane of the page such that it intersects perpendicularly with the channel E flow. 
Solution would flow from channel E into the needle and be delivered to the needle outlet 
where it will be electrospun. Red and blue colors represent different polymer solutions. 
combined solution flow streams to an outlet indicated by the yellow ring. The inlet flows of A-D 
would each carry a single electrospinning polymer solution. Multi-solution flow begins where the 
input channels merge into channel E where they are expected to remain separated under laminar 
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flow conditions; minimal diffusive mixing is expected at the interface. The output from channel E 
is a needle, which also serves as the spinneret, intersecting channel E flow perpendicular to the 
plane of the device itself. Each inlet flow can be driven by a separate syringe pump at different 
flow rates, or multiple inlets can be simultaneously driven by one pump at the same rate. Currently, 
3D jet writing of bicompartmental fiber scaffolds is performed with two 26 gauge needles (one for 
each compartment) each at a flow rate of 0.04 mL/hr for a total volumetric flow rate of 0.08 mL/hr 
which was therefore set as the flow rate for output channel E. It was decided that an 18 gauge 
needle would be used due to previous successful jetting experiences in the Lahann Lab with this 
size needle. The inner diameter of an 18 gauge needle is 0.838 mm which set the max width of the 
outlet channel (channel E in Figure 2-5), thereafter taken to be 0.8 mm. A standard channel depth 
(or height) in PDMS microfluidic devices is 0.1 mm, which was set for all channels. With the 
width and flow rate of channel E set, the respective values for channels A-D were set to half that 
of channel E since these channels require half the volumetric capacity of channel E for 
bicompartmental fibers. 
Given these constraints on channel geometries, the length of each channel was next to be 
determined, where a shorter length for channel E was thought to be optimal. Reynolds number was 
estimated to be on the order of 10-4 for channel flow and 10-5 for needle flow where the solution 
viscosity was approximated as that of glycerol, which was sufficiently representative of the 
viscosity of a PLGA solution, the standard polymer for EHD co-jetting. Some diffusive mixing 
will occur at the interface of the two flows, but this has not been a problem previously in the 
Lahann Lab when creating multicompartmental fibers2. Nevertheless, diffusive mixing could be 
limited by reducing the length of the channel E and using the shortest commercially available 18 
gauge needle (i.e. reducing the time the different fluid flows spend in contact before reaching the 
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Taylor cone). Another motivation to minimize the length of channel E was to minimize the dead 
time of the device, or the time it would take to observing a change in solution within the Taylor 
cone from switching which inlet channels were in operation (by turning one syringe pump off and 
another on). Additionally, it was thought that shorter channels would be preferred to minimize 
pressure drop, but from a simple Poiseuille flow calculation of pressure drop in a rectangular 
channel it was found that even at relatively large channel lengths, the pressure drop was at most 
on the order of 1 kPa. This is less than microfluidic channel pressure drops seen in the literature 
of 10 kPa68, 40 kPa69, and 5 kPa70. Longer channels, at least for channels A-D, are preferred since 
the further apart the inlet streams are from each other the less likely are interfering Coulombic 
interactions to occur between tubing feeding into the device. Also, longer streams will make the 
device larger and thus easier to handle when setting up the jetting system. Given these 
considerations, there were no hard constraints on the lengths of any of the device channels. Since 
the fabrication of PDMS microfluidic devices first requires making a master which can be used to 
make several different devices at once, it was concluded that devices of varying channel lengths 
would be made, and the various devices experimentally tested to determine which channel lengths 
minimized mixing, dead time, and pressure drop while maximizing the overall size of the device 
(Fig. 2-6(a-b)).  
Since PDMS is known to swell when in contact with chloroform and many other organic 
solvents71, 72, these PDMS devices were prototyped first using glycerin solutions carrying different 
optical dyes rather than the chloroform-based PLGA solution (Fig. 2-6(c)). Glycerin has a similar 
viscosity to the PLGA solution typically used. Although the glycerin did not readily form a jet 
sufficiently stable to produce fibers, a Taylor cone formed at the outlet of the needle. This was 
sufficient to determine as a proof-of-concept that the two solutions were kept separate while  
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Figure 2-6: Rapid prototyping of various microchannel patterns for manifold 
manufactured as a PDMS microfluidic device (a) Autocad image of six different 
schematics drawn for production of a master that would be used to generate PDMS devices. 
(b) Representative microfluidic device demonstrating how needle is positioned in the 
middle of the center channel as an outlet flow line and spinneret. (c) Tubing run into the 
four holes punched out for the four inlet streams using optical dye to trace the movement 
of fluid in the device. Device orientation is upside-down in (b-c). Credit: PDMS devices 
fabricated in collaboration with Hyeun Joong Yoon of the Nagrath Lab at the University 
of Michigan. 
flowing through the device as shown in Figure 2-7 where the red and blue compartments are 
clearly kept unmixed. In the traditional EHD co-jetting setup, a bicompartmental Taylor cone 
could only be achieved using two needles combined in parallel to form the spinneret. Next, four 
distinctly colored solutions were loaded into the device: red, blue, green, and yellow. After 
producing a 50/50 red/blue Taylor cone, the red/blue syringe pump was turned off and at the same 
instant, the green/yellow syringe pump turned on. After five to seven minutes, the Taylor cone had 
changed from red and blue, to green and yellow. Several switches back and forth were made 
successfully, demonstrating as a proof of concept that the device design effectively changes the 
solution fed to the Taylor cone while keeping distinct solutions partitioned. Finally, to verify that 
this device design could electrospin fibers, polyethylene oxide (PEO) at 600,000 kDa, a water-
soluble polymer, was dissolved into an aqueous electrospinning solution at 7 wt%, and found to 
produce microfibers from the PDMS microfluidic device (Fig. 2-8). Next, the selected PDMS 
device design A (Fig. 2-6(a)), having the shortest channels, will be fabricated out of glass by 
a 
 b
c 
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etching or aluminum by milling so to achieve the same fluid flow patterns and eliminate solvent 
compatibility issues. 
 
Figure 2-7: First demonstration that the Taylor cone remains partitioned in manifold 
device Photos show the distortion of the bicompartmental droplet emitting from the single 
needle of a PDMS microfluidic manifold device. Typically in EHD co-jetting this 
partitioned cone is achieved through the use of two needles in parallel. Glycerin solutions 
carrying either red or blue optical dye were pumped into the manifold and flowed in parallel 
without a solid at the fluid interface. The two fluids moved together through the center 
channel of the device and through the outlet needle remaining partitioned from droplet to 
Taylor cone. Bicompartmental separation in the droplet was re-established 5-7 minutes 
after a compositional switch that changed the outlet droplet through a series of greens and 
yellows. 
 
 
Figure 2-8: Proof of concept that PDMS microfluidic manifold effectively electrospins 
microfibers Polyethylene oxide (PEO) dissolved in an aqueous solution electrospun from 
the PDMS microfluidic manifold into microfibers. Fibers are aligned as they are deposited 
onto a grounded high speed rotating collection electrode. 
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Aluminum microchannel device 
The PDMS device design guided the production of a similar design in aluminum as shown 
in Figure 2-9. Although material-solvent compatibility was no longer a problem, two other major 
issues arose preventing successful implementation of this manifold. Firstly, making the “world-to-
chip” connections necessary to feed electrospinning solution into the device inlets was a challenge.  
 
Figure 2-9: CAD drawing of manifold device modeled like the PDMS microfluidic 
manifold but made from aluminum Computer aided design (CAD) drawing done in 
Solidworks of assembled aluminum manifold device (left) and engraved channels (right). 
This device is an aluminum mimic of the PDMS microfluidic manifold device that was 
effective at switching solution composition and electrospinning microfibers. 
For organic solvents, Teflon tubing must be used, in contrast to the Tygon tubing typically used in 
the PDMS microfluidic devices. Inserting Tygon tubing into holes punched out of PDMS was a 
secure connection based on friction alone. Teflon tubing is both tougher and smoother, and 
aluminum being a hard, smooth surface does not exert much frictional force to hold the Teflon 
tubing in a liquid-tight connection throughout the electrospinning process. Furthermore, fixing the 
needle into the center channel in a metal-metal connection required an adhesive which would 
quickly wear out under the use of organic solvents (Fig. 2-10). A similar problem arose in the 
metal-metal connection between the top and bottom parts of the aluminum manifold which were 
held together by screws. Application of vacuum grease assisted in creating a seal between the two 
parts and preventing leakages, but this was still insufficient over longer-term use. The second 
major challenge was charging effects. The applied voltage necessary to charge the electrospinning 
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solution was often dissipated throughout the aluminum device, reducing the likelihood of droplet 
distortion into a Taylor cone, and causing a charge build up in the device and any conductive 
material in the surrounding environment. Fabricating the same design in glass was next attempted 
so to maintain solvent compatibility, but eliminate device fabrication from a highly conductive 
material. 
 
Figure 2-10: PDMS microfluidic manifold device fabricated in aluminum (left) 
Aluminum manifold in operation showing tubing feeding PLGA solution composed of 
organic solvents into the device and flowing out of the needle that is secured to the device 
by adhesive. (right) One of the two pieces that comprise the aluminum manifold. This part 
has channels engraved into the aluminum that mimic the pattern of the most successful 
PDMS microfluidic manifold device. A hole was added to the middle of the center channel 
where a needle is attached as a spinneret. The four large holes around the center hole are 
for screws to attach this part to a larger flat plate (as shown in left photo) which acts as the 
glass slide that the PDMS device would be otherwise bonded to. The four holes at the ends 
of each of the four channels are for inlets for feed lines.  
Glass-etched microfluidic manifold 
 To create a glass manifold, the same channels designed for molding out of PDMS were 
etched into a glass wafer as shown in Figure 2-11. Each device was diced out of the wafer to 
obtain the individual devices (six devices were printed on a single wafer). The devices were sealed 
to a glass slide using a UV-glue and holes were bored into the device for the inlets and outlet using 
electrochemical drilling. This glass device had great potential to be a success, however, like the 
aluminum manifold, making world-to-chip connections was difficult, especially with respect to 
attaching the metal needle to serve as the spinneret in a liquid-tight fashion. 
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Figure 2-11: Design of PDMS microfluidic manifold device fabricated in glass (left) 
Entire wafer with six devices showing channels that mimic the patterns of the initial PDMS 
microfluidic manifold devices etched to a depth of 100 µm. (right) Zoomed in image of 
etched channels on a single sheet of glass after etching and dicing. Credit: Device 
fabrication done in collaboration with Brian Johnson of the Burns Lab at the University of 
Michigan. 
Iterating through several more manifold device prototypes 
 Several more device designs were prototyped shown in Figure 2-12. One of the more 
promising options was to return to the PDMS device, applying sol-gel technology73, to coat the 
walls of the microfluidic channels with a solvent resistant layer of silanes that slows the migration 
of organic solvents out of the channel, delaying the swelling of the PDMS. Although this approach 
worked, devices could not be re-used, and the time required to fabricate each one would make 
manifold-based electrospinning impractical (Fig. 2-12(e)). With the difficulties in in-house 
fabrication, the possibility that a device may exist commercially that would serve the purpose of 
the manifold was explored. It was hoped to find a commercially existing rotary valve manifold, as 
sketched in Figure 2-13(a) that would cut off flow from a given inlet by rotating a knob, thereby 
minimizing dead time. The flow valve from Hamilton (Reno, NV), shown in Figure 2-13(b) was 
found to be the most similar device to this design on the market. Although much detail was not 
available on the inner workings and volume within the device from the manufacturer, the device 
was purchased and prototyped. Shown in Figure 2-14, testing this device with PLGA solutions 
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containing optical dyes revealed the gradient that occurs between switches, but also indicated that 
a large dead volume was contained within the device itself that would require nearly an hour of 
sacrificial jetting time for each solution switch, rendering this manifold device impractical. 
 
Figure 2-12: Several manifold prototypes (a) (left) Glassblown manifold with metal luer-
locking connectors (right) Glassblown manifold in operation (b) (left) Commercially 
purchased glass microfluidic device from Translume (Ann Arbor, MI) (right) in operation 
(c) PDMS-microfluidic manifold device inspired a similar design in Teflon. CAD drawing 
of (left) top part showing engraved microchannels and (middle) bottom part with groove 
for top part to fit into. (right) Photo of top and bottom parts after manufacture. (d) Four-
way needle manifold made by connecting four metal capillaries combined to be the 
manifold outlet and spinneret. Four dispensing tips attached by tubing to the outlet 
capillaries form the manifold inlets. (e) (left) Laboratory setup showing multi-syringe 
pump required to complete the sol-gel process intended coat PDMS microchannels with a 
network of silanes for delayed swelling under contact with organic solvents. (right) Final 
sol-gel treated PDMS microfluidic manifold showing PDMS bonded to another piece of 
PDMS rather than the typical glass slide. 
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Figure 2-13: First attempts to find a commercially available product that would 
function as a manifold device (a) CAD design drawn in Solidworks of a cross sectional 
view of a rotary valve manifold. The center piece (in lighter grey) will rotate to open to the 
inlet channel desired to flow to the outlet at a given time. Image credit: Clark Teeple for 
CAD drawing. (b) Commercially obtained flow valve from Hamilton (Reno, NV) that is 
sufficiently similar to the conceptual design in (a). 
 
 
Figure 2-14: Gradient observed switching from blue to red optically dyed PLGA 
solution in rotary valve manifold Flow valve commercially obtained from Hamilton 
reveals the gradient that develops in switching from a blue-dyed PLGA solution to a red-
dyed. Given the large size of the device (circular channels of diameter 1.5 mm), the dead 
volume led to a switching time of nearly an hour. 
Final successful prototypes 
Now, the initial expectations on what a manifold would be capable of in conjunction with 
the 3D jet writing system were revisited. At the start of this project it was hoped that changes in 
composition along the length of a fiber could be made in distinct segments under one millimeter. 
However, this patterning resolution is beyond the limit of electrospinning-based technologies 
given the “dead” volume within the Taylor cone itself. Estimating the cone to range from 
approximately one to four millimeters in height, gives a range of cone volumes from 0.1 to 0.4 
(a)                                                   (b) 
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microliters of polymer solution (based on a 23 gauge bicompartmental needle). This translates to 
about 15 to 60 centimeters of fiber. Therefore, the original desired patterning resolution for single 
fibers is infeasible, however, the benefit of the manifold lies in the 3D scaffold design space. Many 
distinct domains can be embedded within a 3D jet writing scaffold, which on average requires 
about 660 cm of fiber to produce a 10-stack scaffold with 500 µm wide square pores (including 
lead-in fiber lengths which are afterwards cut off to obtain the final scaffold as applied for cell 
culture). As such, use of the manifold for creating changes in composition along a fiber length 
would most effectively be realized in 3D jet writing microfiber scaffolds. 
With new information gained from each manifold prototype, a theoretical design for an 
optimized manifold was generated, illustrated by the sketch in Figure 2-15. This manifold is 
essentially an assembly of five stainless steel needles welded together around a central cylindrical 
chamber. The four needles about the larger top cylinder are inlet channels, and the larger single 
needle positioned perpendicularly to the four inlet needles is both the outlet and spinneret. The 
entire device would be made of a conductive metal, such as stainless steel, that is compatible with 
the range of organic solvents that may be of interest for solution-based electrospinning. There 
would be no need for assembly and no potential for leaks as it is all one piece welded together. 
Unlike the aluminum manifold, which was also made entirely of a conductive metal, charge 
buildup is not expected since the channels are made of metal tubing, minimizing the amount of 
material in contact with the high voltage electrode, in contrast to the etching of microchannels into 
a larger bulk piece of metal. Conceptual operation of this manifold is demonstrated in the cross-
sectional view in Figure 2-15. Distinct polymer solutions, represented in blue and red are loaded 
into individual inlets of the device. Initially, only the blue solution is pumped into the outlet flow 
channel. Shortly after, the pump driving the blue solution is turned off as that of the red solution 
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is turned on, allowing red to flow into the outlet channel behind the blue. As this process of 
switching which solution is driven into the outlet channel is repeated, “plugs” of each solution are  
 
 
Figure 2-15: Optimized manifold device (top) Cartoon schematic showing cross- 
sectional view of disk manifold in operation to switch the composition of an electrospun 
fiber along the fiber length where different compositions are indicated in red and blue color. 
(bottom) Photo of successful and most capable, disk manifold. Entirely made of stainless 
steel, this manifold essentially unites four 20 gauge needles as inlet flows (about the central 
top-most cylinder) with an 18 gauge needle (the outlet flow and spinneret). Teflon tubing 
shown fitting air-tight over the four manifold inlet channels. Manifold custom 
manufactured by Optics Technology (Pittsford, NY). 
generated within the outlet channel consecutively. Electrospinning of a polymer fiber directly from 
the outlet channel which acts as the spinneret will then result in a fiber that changes composition 
along its length. Of course, this is a conceptual design – in reality, a gradient is expected in between 
different solutions in the outlet flow as opposed to actual “plugs” of each fluid.  
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Named the disk manifold, this design was custom manufactured by Optics Technology 
(Pittsford, NY) (Fig. 2-15). The first successful switch in polymer solutions at the outlet was 
realized at an average switch time of 18 minutes. The key features of this manifold that enable its 
function are the liquid tight connections between the inlet channels and the Teflon tubing feeding 
the polymer solution into the device. The diameter of each inlet channel was selected to be the size 
of a 20 gauge needle, after finding a Teflon tubing size that fits over this needle diameter in an air-
tight fashion. The outlet flow is the size of an 18 gauge needle and serves as the spinneret, 
connecting directly to the high voltage electrode without additional parts or wiring. The device is 
made to be as small as possible while still allowing long enough inlet channels for secure tubing 
attachment, and an outlet needle that is long enough to connect a power supply. It is also easy to 
clean after each use. Taking the approach of writing sacrificial structures to dispense excess fluid 
in between switches, this manifold was successfully used to fabricate 3D jet writing scaffolds 
where different polymer solutions, annotated by either a blue or red fluorescent dye, could be 
embedded within the same scaffold in distinct domains as represented in Figure 2-18. 
The fastest switch time occurs at the theoretical limit of a dead volume of zero. However, 
irrespective of device design dead volume will always exist within the Taylor cone. This concept 
led to the final design, the bicompartmental needle manifold which was simply two stainless steel 
tubes, removed from dispensing needles, and bound together by a plastic sleeve as traditionally 
done in the Lahann Lab for bicompartmental fibers (Fig. 2-16). Rather than pumping solution 
through both needles simultaneously as done in EHD co-jetting, the needle manifold operates by 
pumping a different solution through each needle separately. The key to operating this device is to 
carefully ramp down the flow rate of the solution to be switched out while ramping up that of the 
incoming solution such that a single stable Taylor cone remains spanning the outlet of both needles 
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during the switch. When turning on a syringe pump, one must consider the startup time required 
to get the solution pumping at the desired rate. To test the ability of the bicompartmental needle to  
 
Figure 2-16: Bicompartmental needle manifold An alternative successful manifold 
design, using simply the combination of two needles as the spinneret, where each needle 
is connected to a separate syringe pump. This device can function as a manifold, although 
is limited in its versatility due to the two-needle outlet and the metal interface separating 
the two polymer solutions that would otherwise be flowing in parallel in the disk manifold. 
switch which polymer solution is emitting from the outlet, red and blue fluorescently dyed PLGA 
solutions were prepared. Electrospinning of fibers onto a grounded rotating collector showed that 
switching from red to blue and blue to red was possible (Figure 2-17). By counting the number of 
fibers that were jetted during the switch from an all red to an all blue fiber (or vice versa) it was 
estimated at least in this early study that the switching time is as little as three minutes. This is the 
fastest switching ever observed in any of the previously tested devices – as is expected since the 
only dead volume is that of the Taylor cone. In operation, the needle manifold required six minutes 
safely or a minimum of three to four minutes, of sacrificial electrospinning to fully switch which 
solution is being fed from the Taylor cone to the fiber jet.  
A similar manifold design had been previously prototyped where four needles were 
combined to form the spinneret, and each of the needles had a separate feed line (Fig. 2-12(d)). 
However, the spinneret, being composed of four round needles, greatly limited the stability of the 
Taylor cone over time. Polymer solution wicked into the gap formed in between the two needles 
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dried and hardened, causing greater separation between individual needles, and leading to 
disturbances in the steady flow of polymer solution to the Taylor cone, and on to the fiber jet.  
                         
 
Figure 2-17: Observed switch from blue to red and red to blue in aligned PLGA fibers 
using bicompartmental needle manifold Switches in which polymer solution was 
feeding to the fiber jet were observed using fluorescently labelled aligned PLGA fibers 
collected on a rotating collector and fabricated using the needle manifold. (top) Blue fibers 
were continuously collected as the device switched to red-dyed PLGA solution resulting 
in the disappearance of blue-dyed fibers and the appearance of red-fibers instead (bottom) 
Continuing from the top, fibers were then switched from red-dyed to blue as indicated by 
the disappearance of red and the appearance of blue fibers. Each switch occurred in three 
to four minutes. 
Another major challenge was maintaining a steady Taylor cone across an outlet that spanned the 
area and geometry of four combined needles during switches in solution. The most success with 
this four-way needle prototype was when constantly operating two needles at a time, which limits 
the capabilities afforded by the conceptual manifold illustrated in the cartoon of Figure 2-15 since 
only two distinct domains would be possible within a 3D jet writing scaffold. Two distinct domains 
require only two inlet feed lines, which is achieved by the bicompartmental needle manifold, 
shown in Figure 2-16. Although the bicompartmental needle manifold is capable of generating 
(a)              Merged 
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           Texas Red 
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3D jet writing scaffolds containing distinct domains such as those shown in Figure 2-18 with the 
lowest switch time possible, the extent of capabilities afforded by this manifold design is vastly 
limited compared to that of the disk manifold. Firstly, embedding of more than two distinct 
domains within a scaffold would require more than two inlet flows, in which case the 
bicompartmental needle manifold is of no use. Secondly, the disk manifold with four inlets allows  
 
Figure 2-18: Distinct domains realized in 3D jet writing scaffolds with 
implementation of manifold Switching between a fluorescently red-dyed and blue-dyed 
PLGA solution by fabrication of sacrificial structures in between switches enables a clean 
interface between distinct domains patterned into a microfiber construct using the manifold 
in 3D jet writing. 
fabrication of fibers containing compartments in any permutation of four distinct polymer 
solutions. For example, with four different materials being fed into the device, one into each of the 
four feed lines, the resulting fiber cross section may contain any one, two, three, or all four of the 
compartments at a given time. Moreover, the number of compartments within the fiber cross 
section at any point along the length of the fiber can be tuned with the disk manifold. Thirdly, the 
prospect of co-jetting different materials may pose challenges in terms of jet stability since 
different polymer solutions often most stably electrospin under different processing conditions. 
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Having a single needle outlet as with the disk manifold rather than a dual needle outlet will help 
minimize the risk of co-jetted polymer solutions splitting the Taylor cone into multiple cones of a 
single composition instead of the intended single Taylor cone composed of multiple materials. 
Finally, only the disk manifold allows for changing of the orientation of compartments along the 
length of a bicompartmental fiber, since four inlets would be required (Fig. 2-19). Demonstrating 
a shift in compartment orientation within a 3D jet writing scaffold is one of many future directions 
in further characterization of the capabilities of the disk manifold. 
 
Figure 2-19: Future work to demonstrate changes in compartment orientation within 
bicompartmental fibers using the disk manifold The next step in demonstrating the 
capabilities afforded by the disk manifold is to show changes in the orientation of 
compartments within a bicompartmental fiber as illustrated in the box at the top. To do 
this, the two materials to become each compartment (represented in red and blue) would 
be fed into two opposite inlets of the disk manifold and a fiber electrospun. A change in 
compartment orientation can be realized by then alternating to the other two opposite inlets 
such that the placement of the red and blue compartments within the outlet flow, Taylor 
cone, and resultant bicompartmental fiber changes to mimic the orientation of the feed 
lines. Compartment orientation control requires the use of a longer lead in time in the 3D 
jet writing scaffold process such that the fiber jet is completely unwound from any prior 
twisting before entering the area where the desired scaffold resides. 
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2.3.3 Controlling relative compartmentalization in microfibers 
With a successful manifold device, it is now possible to produce multicompartmental fibers 
where the relative size of each compartment, or relative compartmentalization, is controlled by 
flow rate. For a bicompartmental fiber, each solution is pumped through independent lines and fed 
into different manifold inlets. Although the net flow rate is kept constant, the ratio of the two 
independent flow rates controls the ratio of the compartment size in the resultant fiber. For 
instance, if the net flow rate is 0.06 mL/hour, then to achieve compartments whose sizes are in a 
1:2 ratio, then one solution should be pumped at 0.02 mL/hour while the other is pumped at 0.04 
mL/hour. This eliminates the need for large numbers of needles which would compromise jet 
stability, and enables a continuous spectrum of possible compartment size ratios (Fig. 2-20). 
Whereas with EHD co-jetting a bicompartmental fiber in a compartment size ratio of 7:3 would 
require ten needles, now with the manifold, the pumps driving each solution can be tuned to a flow 
rate ratio of 7:3 and the fiber can be electrospun directly from the manifold outlet (Fig. 2-20(a)). 
Certainly, more accurate pumps will correlate with the accuracy in relative compartmentalization. 
A series of PLGA bicompartmental fibers was electrospun using the manifold, with 10% 
increments in compartment size, and where each polymer solution was labelled with either a blue 
or red fluorescent tracer molecule. Representative cross sections of the fibers are shown in Figure 
2-20(b), starting from a fiber with a compartment size ratio of red to blue of 1:9 and ending with 
9:1. Visually, the steady increase in one compartment can be seen to correlate with the decrease in 
the other compartment. Using Imaris x64 8.3.0 software, surfaces were generated over the 
compartment residing in each fluorescent channel. The volume within each surface was quantified 
to generate the plot shown in Figure 2-20(b) where the expected relative compartmentalization or 
compartment size scales with the fraction of the net flow rate that was driving the corresponding  
 
42 
 
 
 
Figure 2-20: Manifold enables non-discrete ratios of compartment sizes with single 
outflow capillary (a) Sketch contrasting traditional EHD co-jetting with multiple needles 
combined to form a spinneret to a manifold with two inlets and one outlet. For EHD co-
jetting the number of needles required to achieve the indicated compartment size ratios are 
drawn for bicompartmental fibers. For the manifold setup, two pumps at flow rates F1 and 
F2 are sketched as feed lines to each of the two inlets. The Taylor cone and cross section of 
the fluid jet are drawn for F1 greater than F2. (b) LSCM of bicompartmental fiber cross 
sections where the flow rate of red compartment increased (and blue compartment 
decreased) by 10% in each subsequent fiber moving from left to right. Red and blue 
channels indicate PLGA. Scale bar 10 µm. 
a 
b 
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polymer solution. This result demonstrates the continuous spectrum of relative 
compartmentalization now achievable with the manifold. 
Moreover, these fibers contribute a new level of tunability to the 3D jet writing scaffold 
design space where the user can change the bulk fiber composition independently of other scaffold 
properties. In order to incorporate changes in relative compartmentalization within a 3D jet writing 
scaffold, the fiber must change composition in situ during the electrospinning process. Since 3D 
jet writing scaffolds are produced by stacking one fiber onto itself, any desired changes in relative 
compartmentalization must occur at the right time during fabrication. To visualize the ability to 
continuously change fiber composition and compartmentalization, PLGA was dissolved in a 
solution including either red or blue optical dye. Starting with a fiber jet of 100% red-dyed PLGA 
solution, the flow rate of the red solution was steadily reduced by 2.5% while that of the blue was 
simultaneously increased by 2.5%. Fiber bundles were collected on a grounded rotating collector 
for about 30 seconds at each flow rate ratio until the fluid jet was comprised of only blue-dyed 
PLGA solution. The result was a series of aligned fiber bundles that shifted from red to blue in 
color through a gradient as visible by eye (Fig. 2-21(a-b)). With the ability to realize changes in 
the fiber compartmentalization during the electrospinning process in situ, a similar shift from a red 
fluorescently dyed PLGA to a blue could be realized through a gradient in a 3D jet writing scaffold 
(Fig. 2-21(c)). Furthermore, relative compartmentalization control is not limited to 
bicompartmental fibers. As shown in Figure 2-22, fibers comprised of three and four 
compartments can be tuned for relative compartmentalization and compartment architecture. 
These new capabilities can be projected for future use in modulating the outer area of each fiber 
presenting a certain ligand or surface functionality, the amount of a drug or biomolecule loaded 
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into a fiber by the relative size of the drug-loaded compartment, or the bulk composition of the 
fiber – an example of which is presented in the next section. 
 
Figure 2-21: Changes in compartmentalization can be made continuously during 
electrospinning using the manifold (a) PLGA solutions were prepared carrying either a 
red or blue optical dye. Using the manifold, red fibers were first electrospun and collected 
on a grounded rotating wheel. By increasing the flow rate of the blue solution and 
simultaneously decreasing that of the red solution by 2.5%, continuous collection of a fiber 
revealed a switch from red to blue fibers moving through a color gradient. Scale bar 5 mm. 
(b) SEM of fiber bundle from (a). Scale bar 10 µm. (c) 3D jet writing scaffold made using 
the manifold to switch from red-dyed PLGA fibers at the bottom stack to blue at the top 
stack moving through a color gradient. Red and blue channels are PLGA. Scale bar 25 µm. 
Image credit: Fibers fabricated and imaged by Jeffery Noble. 
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Figure 2-22: Compartmentalization can be controlled via manifold in fibers 
comprised of more than two compartments Multicompartmental fibers are made using 
the manifold with (a) three compartments shown in volume view and (b) four 
compartments shown by fiber cross section where grey compartment marks no dye. Fibers 
are composed of entirely PLGA but carrying different polymer dyes in each compartment. 
Green dye is often aggregated due to poor solubility in electrospinning solutions. Scale bar 
25 µm. Image credit: Fibers fabricated and imaged by (a) Jeffery Noble and (b) Clark 
Teeple. 
 
 
 
 
a 
b 
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2.3.4 Tuning fiber mechanical properties through bulk composition 
Thus far, the capabilities of embedding multiple distinct compartments within a single 
microfiber, and controllably varying relative compartmentalization has only been shown using 
different fluorescent dyes mixed within solutions of the same polymer, namely PLGA. However, 
the ability to tune fiber compartment size yields the ability to tune fiber mechanical properties 
through the incorporation of different materials into a single fiber. The manifold was used to co-
jet bicompartmental fibers at three compartment size ratios, where one compartment was 
composed of PLGA and a blue fluorescent tracer dye and the other compartment of poly(lactide-
co-caprolactone) (PLCL) along with a green fluorescent tracer dye (Fig. 2-23). Considered an  
 
Figure 2-23: Bicompartmental fiber bundles comprised of PLGA and PLCL are 
fabricated using manifold Bicompartmental fibers having two materials: PLGA and 
PLCL are produced in bundles at the indicated ratio where the blue channel is PLGA and 
the green PLCL. Scale bars for images of fiber cross sections 10 µm; scale bars for 3D 
renderings 25 µm. 
elastomer, PLCL is expected to reduce the stiffness of otherwise purely PLGA fibers, as can be 
quantified by Young’s modulus. Five types of fibers were fabricated for tensile testing and 
determination of Young’s modulus: bicompartmental fibers where the ratio of PLGA in one 
compartment to PLCL in the other were 100:0, 75:25, 50:50, 25:75, or 0:100. Since calculation of 
Young’s modulus requires the sample cross sectional area, single fibers as shown in Figure 2-
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24(a) were fabricated using the manifold rather than fiber bundles so that a definite cross sectional 
area could be identified. 
Tensile testing of single polymer microfibers is a delicate task. In order to minimize risk 
of fiber damage, a new grounded electrode setup was designed to collect fibers directly on the 
substrate where they will be adhered for tensile testing (Fig. 2-25). Rectangular frames were 
individually cut from a hollow cube of aluminum using a horizontal band saw, and sheets of 
cardstock were attached to each side of the aluminum frame. Windows were cut from each 
cardstock sheet, and the entire ground electrode was connected to a rotating wheel. The polymer 
solutions needed to be optimized in order to jet stably on this new ground collector setup since the 
fluid jet required greater elasticity to span the distance from the spinneret to the bottom of the 
rotating rectangular frame. The final optimized solutions were PLGA at 35 wt% in a solution of 
chloroform to dimethylformamide at 93:7, and PLCL at 30 wt% in a chloroform to cyclohexane 
to DMF ratio of 45:45:10. Finally, fibers were electrospun onto the cardstock, allowed to dry at 
least a week, and a droplet of epoxy was placed on both ends of the fiber to secure the fiber in 
place (Fig. 2-25). Each window could now be cut out of the cardstock sheet with the single polymer 
microfiber freely suspended. Brightfield images were collected for each fiber at four different 
regions along the fiber length. Fiber diameter was measured from each brightfield image using 
ImageJ. Fiber diameters were found to range from 3.6 to 30.0 µm. After two weeks of drying at 
ambient conditions, fibers were mounted to the tensile tester, the cardstock windows were snipped, 
and the fiber was pulled uniaxially from one end at a strain rate of 0.0015 s-1. Since Young’s 
modulus was found to correlate with fiber diameter (Fig. 2-26), only fibers with a diameter within 
the reduced range of 6.0 to 15 µm were selected for the final representation of Young’s modulus, 
as plotted against the fraction of the fiber bulk that is comprised of PLGA in Figure 2-24(b). As  
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Figure 2-24: Controlled compartment size can be leveraged for tuning of fiber 
elasticity by incorporating different bulk materials (a) Single fibers fabricated using the 
manifold consisting of one compartment PLGA (blue) and the other PLCL (green). Single 
fibers are preferred over fiber bundles for tensile testing and calculation of Young’s 
modulus. 3D render scale bar at 25 µm. Cross section scale bar at 10 µm. (b) Young’s 
modulus scales with the compartment fraction that is PLGA, the remainder PLCL for single 
polymer microfibers ranging in diameter from 6.0 to 15 µm. Error bars represent a 95% 
confidence interval. 
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Figure 2-25: New grounded collection electrode setup to minimize risk of damage of 
single polymer microfibers fabricated for tensile testing (a) Rectangular aluminum 
frames were cut from a square hollow tube of aluminum. The outline shown on the top 
right was cut from cardstock and attached to both sides of the aluminum frame. Each square 
window is nominally 12 mm wide. The large semi-circular cutout is for attachment of the 
metal frame to a rotator via a split-bolt connector. (b) Fibers, represented in green, were 
electrospun directly onto the cardstock attached to the frame which acted as the grounded 
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collection electrode. After at least one week of drying time, fibers were adhered at each 
end of the 12 mm window to the cardstock using a droplet of epoxy represented in red. 
Each square window was cut from the cardstock carrying one freely suspended adhered 
fiber. (c) Each fiber secured to this square oak tag window was mounted to the grips of the 
tensile tester, represented in grey, such that the larger side of the window cutout was in the 
top grip. This ensures greatest sensitivity in the Keysight Technologies UTM T150. 
Uniaxial tension was applied by pulling upward on the fiber to generate stress-strain 
curves. 
 
 
 
Figure 2-26: Young’s modulus inversely correlated to fiber diameter Scatterplot of 
Young’s modulus vs. fiber diameter for (a) fibers within diameter range selected for final 
calculation and (b) all fibers tested. Legend represents relative compartmentalization with 
respect to the percentage of PLGA present in the fiber, the remainder being the relative 
size of the PLCL compartment. 
 
expected, the larger the compartment of PLGA, the higher the Young’s modulus and hence, the 
stiffer the fiber. This result demonstrates the use of the manifold for tuning the stiffness of 
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electrospin microfibers, and the possibility for custom-designed fibers where the relative 
compartmentalization in PLCL/PLGA bicompartmental fibers is dictated by a desired elasticity. 
With the manifold, fiber stiffness or elasticity is now a user-defined parameter when 
fabricating single fibers, or constructs composed of single fibers such as fiber bundles or polymer 
scaffolds. Given a desired Young’s modulus, the required compartmentalization of PLCL and 
PLGA can be determined. In regards to 3D jet writing scaffold design, use of the manifold to 
produce scaffolds comprised of bicompartmental fibers of PLCL and PLGA will enable tuning of 
scaffold mechanical properties through bulk composition. However, 3D jet writing of 
bicompartmental PLCL and PLGA structures has long been plagued by jet instability and poor 
fiber alignment since the two polymers electrospin at different voltages: ~3-5 kV for PLCL and 
~8-10 kV for PLGA. Using the manifold eliminates the metal interface between the two solutions 
otherwise present in the EHD co-jetting setup. It was hypothesized that flowing the two solutions 
in parallel along the length of the manifold outlet and into the Taylor cone without a solid surface 
at their interface would help stabilize the fluid jet. Indeed, the two solutions remained partitioned 
in the Taylor cone and the bicompartmental fluid jet stability was improved relative to using a two-
needle capillary. Although the fluorescent tracer dyes are poor due to recent changes in equipment, 
Figure 2-27 illustrates well-aligned fiber stacks within 3D jet writing polymer supports comprised 
of bicompartmental fibers of PLGA and PLCL at 50:50 and 75:25. The ability to modulate scaffold 
modulus is a required design feature for 3D cell culture matrices considering that different tissues 
vary in stiffness19, 22, 46. In recapitulating specific cell niches, the mechanical environment must 
also be matched. Tumors, for example are generally stiffer than healthy tissue74. Additionally, the 
mechanical environment should be modifiable in order to observe stiffness induced cell 
responses22, 46, 49. Important to note is that the Young’s modulus measurements reported in Figure 
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2-24(b) are for dry single fibers. Once applied in cell culture, the mechanical properties of these 
fibers will change upon immersion in aqueous fluids or incubation at physiological temperatures. 
 
Figure 2-27: Manifold improves jet stability when 3D jet writing bicompartmental 
structures comprised of PLCL and PLGA Disk manifold, shown above, having a single 
channel as the outlet (as opposed to a bicompartmental needle) improves jet stability for 
fabrication of polymer supports made of bicompartmental fibers. Each fiber consists of one 
compartment of PLGA (blue) and another compartment of PLCL (green). Scale bars 25 
µm. 
Interestingly, the bicompartmental nature of the single fibers comprised of PLCL and 
PLGA, and the difference in elasticity between the two materials resulted in fiber curling when 
stressed to failure as done in tensile testing. Shown in Figure 2-28, although the tightness or pitch 
of the curls varied, the concavity of the loop on the inside consistently remained concave while 
the outside of the fiber remained convex. Curling was more controllably observed when the fiber 
was stressed to a fixed strain and relaxed rather than stressed to failure (Fig. 2-29). (It is often 
difficult or impossible to collect the broken pieces of a microfiber after a tensile test to failure.)  
53 
 
 
Figure 2-28: Bicompartmental fibers tend to curl after tensile testing Although 
difficult to collect after tensile testing, the larger broken fiber segments could be located 
for imaging. Bicompartmental fiber segments consisting of PLGA and PLCL were 
visualized using scanning electron microscopy. The ratio of compartment size for PLGA 
to PLCL varied from (a-b) 25:75 (c) 50:50 and (d) 75:25. (a, c, d) Scale bar 500 µm. (b) 
Scale bar 5 µm. 
Fiber curling was restricted to bicompartmental fibers; fibers comprised of a monocompartmental 
blend of PLGA and PLCL at equal masses or purely PLCL were not observed to coil. Future 
studies may point towards stress-relaxation of these fibers as a means of fabricating polymer 
“microsprings.” Such springs could be characterized by first stressing the fiber to get the Young’s 
modulus, and allowing the fiber to relax into a coiled morphology. Applying strain to the now 
coiled fiber would give a spring constant, K1, rather than a Young’s modulus. Continuously 
repeating this stress-relaxation would yield a spring constant for each stress-strain cycle: K2, K3, 
K4... Would the value of the spring constant change over time? How many cycles can the coiled 
fiber withstand without plastic deformation? Are all K values equal or is there any hysteresis in 
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the force vs. distance curves? Can the properties of the spring be tuned by modulating the relative 
compartmentalization of the PLGA/PLCL fibers? 
 
Figure 2-29: Bicompartmental fibers comprised of PLGA in one compartment and 
PLCL in the other tend to coil after stress-relaxation Bicompartmental fibers were 
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elongated to the indicated strain values. Compartmentalization was either 25:75, 50:50, or 
75:25 PLGA to PLCL. Fibers at 75:25 PLGA to PLCL are too brittle to elongate to strains 
of 0.2 and above. 50:50 fibers break before reaching a strain of 1. Image credit: Stress 
relaxation and photography completed by Robert Stinson. 
 
2.4 Conclusions and Implications 
 
The advent of the manifold has greatly expanded our electrospinning capabilities for single 
fibers, fiber bundles, and 3D jet writing scaffolds. Previously EHD co-jetting or 3D jet writing of 
bicompartmental fibers, where each compartment consisted of a different material has often posed 
jet stability challenges. In solution electrospinning, solvents are mixed at an optimized ratio to 
most stably maintain a fiber jet of polymer solution. However, when co-jetting two different 
materials, in two different solvent systems side-by-side using two needles joined to form a 
spinneret, instabilities can occur that result in fibers of only one of the two materials, multiple fiber 
jets simultaneously, or the inability to find a single set of processing parameters effective for both 
solutions. As in the case of PLGA and PLCL, independently, PLGA requires much higher voltages 
than PLCL in order to generate fibers. One way around this difference would be to fine tune the 
solvent mixtures each polymer is dissolved within such that the net properties of the polymer and 
the solvent allow for electrospinning of each material at the same voltage. Such a highly-designed 
polymer solution would require extensive experimental iterations, or simulations of polymer-
solvent interactions to determine the optimal solution properties including dielectric constant, 
volatility, and viscosity. A simpler approach to improving jet stability for two dissimilar polymer 
solutions in parallel is through the use of the manifold with a single needle as the outlet. As was 
shown for bicompartmental fiber scaffolds comprised of PLGA and PLCL, the disk manifold 
improved jet stability sufficiently to achieve fiber alignment in 3D jet writing scaffolds. Typically, 
a co-jet of these two materials results in an unstable jet and poor fiber alignment, leading to a 
scaffold that more closely resembles a non-woven mat than a 3D jet writing scaffold. With the 
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elimination of the metal partition between the two solutions, and the two-solution parallel flow 
through the outlet channel, the disk manifold reduced jet tendencies to split apart into two jets of 
the pure material. 
Furthermore, it has been demonstrated that independently varying the flow rate of each 
solution pumping into the manifold enables control of the relative compartmentalization within 
the resultant fiber as follows from the conservation of mass. As polymer solutions fed into the 
Taylor cone flow into the fiber jet and depositing fiber, relative compartmentalization is conserved. 
A related phenomenon was reported on by Yoo et al. where flow rates were used to mediate the 
diameter of isotropic alginate fibers75. Previously, with the EHD co-jetting system, control of 
relative compartmentalization was limited to ratios that could be achieved by modulating the 
number of needles carrying one solution relative to the number of needles carrying another solution 
in a multi-needle spinneret where all needles were driven at the same flow rate. This meant only 
discrete compartment size ratios were feasible, and even this was limited by the number of needles 
that can be combined to form a spinneret without compromising jet stability. Now, the manifold 
allows for a continuous spectrum of relative compartmentalization where the known limit in 
resolution is that of the accuracy of the syringe pumps driving each solution flow; this applies not 
only to bicompartmental fibers, but to three and four compartment fibers, and theoretically could 
apply to a fiber having as many compartments as there are inlet feed channels on the manifold. 
Controlling the size of each compartment relative to all other compartment within single fibers, 
fiber bundles, or 3D jet writing scaffolds does not only mean modulating the bulk composition of 
the fiber. This capability can be extended to control (1) how much of a fiber surface is 
functionalized for follow up chemistries such as tethering of ligands onto only a portion of the 
fiber surface or (2) the rate of degradation of or release from one compartment relative to another 
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or (3) the presentation of biomolecules at the fiber surface that were directly electrospun into the 
bulk of the fiber compartment or (4) the mechanical properties of the fiber by co-jetting polymers, 
elastomers, or composites into variably sized fiber compartments. 
Finally, the manifold was also designed to function in conjunction with the existing 3D jet 
writing technology. As shown, this allows for 3D jet writing scaffolds to be designed to incorporate 
domains of distinct composition. These domains may differ in bulk composition, surface 
functionality, loading and release of a drug or biomolecule of interest, degradation rates, and of 
course, relative compartmentalization, as shown moving through a gradient in Figure 2-21. Future 
work will entail demonstrating these capabilities, which includes expanding the library of materials 
that electrospin with sufficient stability to form fibers and 3D jet writing scaffolds. Additionally, 
producing 3D jet writing scaffolds with the current manifold technology is not as high throughput 
as it could be due to the sacrificial jetting time required to fully switch which feed solution is 
emitting from the spinneret. In future, this time can be reduced by using the syringe pump to retract 
the solution that is being switched out while ramping up the flow rate driving the incoming 
solution. Also, for each specific scaffold design, which syringe pumps are pumping or retracting 
at a given time, can be coordinated with the position of the x-y stage during both the pattering of 
the depositing fiber and sacrificial jet writing. The operation of the syringe pumps can be 
orchestrated with the movement of the x-y stage in order to observe the desired change in fiber 
composition or orientation at the desired position within the 3D jet writing scaffold. Through a 
computerized system such as Lab View, such orchestration can be automated, thereby requiring 
the same level of human interaction as in the 3D jet writing of isotropic scaffolds. 
The implications of these manifold benefits are best realized in the field of tissue 
engineering and 3D cell culture. For example, different tissues are characterized by different 
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elasticities19, 22, 46. Tuning the stiffness of electrospun fibers is one parameter that can be matched 
in a tissue engineering scaffold to the tissue being recapitulated. Using fibers of tunable stiffness 
as a building block for 3D jet writing scaffolds allows for tuning of the scaffold stiffness. Control 
of relative compartmentalization and the fabrication of scaffolds with distinct domains embedded 
relates directly to the bioactivity and cell signaling properties of the scaffold. For instance, certain 
domains of the scaffold may be made to resist cell or protein binding by PEGylation to achieve 
spatially controlled cell or protein patterning in 3D. Or, certain domains of the scaffold can be 
made to present modalities either covalently bound to the surface or releasing from within the fiber 
bulk that induce a certain cell behavior in one area of the scaffold but induce another cell response 
in other areas. In futuristic thinking, perhaps this capability can be adapted to spatially pattern 
different lineage commitments to stem cells cultured on the same scaffold. Applied as a platform 
for 3D cell culture in vitro or as an implant for in vivo use, these highly engineered scaffolds give 
the researcher a strongly hands-on approach to experimental design where the defining parameters 
of the scaffold, and hence, the cell microenvironment are independently tunable. For instance, with 
this technology, the elastic modulus of the skeletal support underlying the cell microenvironment, 
i.e. the scaffold, can be varied without interfering with other environmental properties. At the same 
time, 3D jet writing scaffolds provide an open framework that allows cells to experience a hands-
off environment where they are free to craft the niche as naturally as possible within an in vitro 
setting. The combination of 3D jet writing and the manifold allows for controlled deposition and 
patterning of distinct materials in three-dimensional space. The next step in translating our polymer 
scaffolds into a complete 3D cell culture platform is the addition of a native-like ECM which is 
explored further in Chapter 3. 
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Chapter 3 
Supported Engineered Extracellular Matrices 
 
 
Some material from this chapter has been adapted with permission from the following 
manuscript in preparation:  
 
S. Ramcharan, L. Solorio, S. McDermott, A. Fox, J.H. Jordahl, C. Dunlay, M. Brown, A. 
Xiao, M. Wicha, G.D. Luker, J. Lahann. “Engineered 3D cellular fibronectin networks 
serve as bioequivalent breast cancer tumor microenvironments for patient derived cells” 
In Preparation. 
 
 
3.1 Introduction 
  
3.1.1 Fibronectin and the extracellular matrix (ECM) 
The extracellular matrix (ECM) is the insoluble, proteinaceous, non-cellular component of 
tissues7, 76. It provides a microenvironment for formation of interconnected 3D multicellular 
structures, and non-soluble signaling cues through dynamically modulated architecture, 
composition, and protein conformation10, 77. Such structural properties of the cell niche guide 
cellular organization, and provide extrinsic factors that influence cell behaviors such as migration, 
differentiation, and proliferation6, 7, 19, 78, 79. Trans-membrane molecules such as integrins directly 
bind the cell cytoskeleton to the ECM enabling transduction of environmental parameters into cell 
signals7, 22, 46. Integrins are comprised of α and β subunits which dictate the specific proteins a cell 
is able to interact with80; for instance, 20 known integrins bind to Fn with the most prominent 
being α5β1 and αVβ323, 81. Which integrins a protein can interact with depends, amongst other 
factors, on which binding sites are exposed and hence the conformation of the protein81. The cross 
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talk between cells and ECM proteins via integrins is bidirectional, meaning binding of the cell to 
the protein via integrins can lead to events within the cell, or alternatively, lead to restructuring of 
the protein to regulate its conformation and biological activity80. In addition to interacting with 
cells, an ECM protein may interact with itself, other proteins, growth factors and bacteria as 
indicated for Fn in Figure 3-176, 82. Fn can interact with a number of proteins including collagen, 
heparin, fibrin, tenascin and decorin9, 76, 80, 83, 84. In fact, interactions with Fn is key to the assembly 
of many ECM proteins including fibrinogen and collagen I and III3, 76. As will be seen in Chapter 
3, in addition to cell-ECM interactions, supported eECM with its open framework also enables 
visualization of protein-protein interactions, one of many possible routes for future applications. 
 
Figure 3-1: Structure and binding sites of fibronectin Leiss et al. depict the fibronectin 
(Fn) dimer distinguishing between the three repeat units, fibronectin-1 (FnI) in blue, 
fibronectin-2 (FnII) in brown, and fibronectin-3 (FnIII) in green. Two disulfide bonds form 
at the C-terminus. Sites along the protein that interact with integrins, bacteria, Fn itself, or 
other proteins are indicated. A, B, and V mark the alternatively spliced extradomains. 
[Illustration credited to Leiss et al.3] 
Changes in ECM protein structure at molecular or cellular scales can drive biological 
function in both healthy and diseased states6, 85. For example, stiff, unfolded Fn is characteristic of 
breast tumor stroma and can promote tumorigenesis85, 86 as well as epithelial to mesenchymal 
transitions (EMT)87. In vivo, Fn exists either as (1) a soluble, compact plasma protein (plasma Fn, 
pFn) typically found at high concentration of ~ 0.3 mg/mL or (2) a detergent-insoluble, extended 
ECM protein known as cellular fibronectin (cellular Fn, cFn) that exposes cryptic binding domains 
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not available in pFn76, 77, 83, 85, 88, 89. Fn can take on up to 20 different isoforms in humans90, 
impacting integrin binding activity and specificity that drive differential cell responses or protein-
protein interactions13, 14, 85. Although cFn is found in many isoforms, the mechano-sensitive 
fibronectin-3 domain (FnIII) is consistently exposed, which promotes conversion of the protein 
into fibrils and ECM assembly10, 11. To assemble cFn, cells activate the protein mechanically by 
translocation of Fn-bound integrins on the cell surface, imparting tension to unfold FnIII. This 
exposes self-association sites within the protein that mediate Fn-Fn intermolecular interactions 
which lead to fibrillogenesis10, 11, 13, 77, 89 (Fig. 3-2). Detailed mechanisms underlying Fn fibril 
assembly and detergent-insolubility are still lacking in the literature4, 91. The linkages between  
 
Figure 3-2: Cell-mediated fibronectin fibrillogenesis Mao et al. describe the cell-
mediated assembly of fibronectin matrix in three steps. The first, shown in (a), is the 
binding of a solubilized Fn dimer to integrins at the cell surface shown in gold. The red 
subunits represent self-association sites that mediate Fn intermolecular interactions. The 
cytoskeleton represented by green lines in (b) begin to reorganize such that the 
translocation of the integrins at the cell surface imparts tension to the bound Fn dimer 
causing the protein to unfold and expose the self-association sites. At the same time, 
signaling activities commence within the cell as a result of its attachment to Fn (represented 
by silver circles). (c) As neighboring Fn molecules approach the unfolded integrin bound 
Fn, intermolecular interactions facilitate the assembly of a Fn matrix. [Illustration credited 
to Mao et al.4] 
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individual Fn dimers to form large multimeric structures may be due to covalent disulfide bond 
formation92-94 or non-covalent but stable intermolecular forces95. In the non-covalent case, partial 
beta sheet unfolding within FnIII has been seen to promote Fn self-polymerization suggesting the 
possibility that intermolecular beta sheet formation stabilizes Fn matrix and renders it detergent-
insoluble96. Although pFn can be assembled into fibrils as in thrombus growth in the case of injury, 
intramolecular interactions maintain pFn in a soluble form in blood to prevent fibrillar formation 
and blockage97-99. Still, much of the cFn found in ECM originated as pFn100 as did the cFn networks 
described in Chapter 3. 
Fn (440 kDa) has been observed in its extended form to have a contour length of 120 to 
160 nm and an average diameter of 2 nm101. Once in an extended fibrillar state, cFn fibrils are 
initially about 5 nm in diameter, and later cluster to form bundles about 25 nm in diameter102, 103 
though the cFn matrix is continuously remodeled by cells104. Fn is a dimeric molecule comprised 
of distinct repeated domains referred to as fibronectin-1 (FnI), fibronectin-2 (FnII) (Fig. 3-1), and 
the previously mentioned FnIII which can be arranged in tandem within the same molecule and 
includes the commonly used cell binding domain arginine-glycine-aspartic acid or RGD83, 105, 106. 
FnI and FnII serve to encapsulate the hydrophobic core of the Fn molecule which is exposed when 
FnIII is unfolded4, 77, 102. Certain subunits of FnI and FnIII are known to play a role in 
fibrillogenesis4, 107, 108. However, FnIII in particular is responsible for the extensibility of Fn, as it 
can be reversibly extended from a folded length of about 4 nm to 29 nm (7-fold extension). Such 
unfolding takes a theoretical 3.5 to 5 pN of force which is in reasonable range of the force generated 
by a single kinesin or myosin molecule within a cell106. 
Beyond fibronectin, there are numerous ECM proteins, each making its own contribution 
to the cell niche, either independently or in concert with other proteins. Different ECM protein 
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compositions characterize different tissues or disease states7, 15, making composition control of 
major importance when designing a versatile in vitro cell microenvironment. Contactins, for 
instance, are strictly found in the nervous system109. More common proteins include vitronectin, 
elastin, osteopontin, thrombospondin, fibrinogen, tenascin, laminin, and collagen7, 110-112 of which 
the latter three are explored further in Chapter 3. Although all collagens take the form of a triple 
helix, there are a number of different types of collagen (types I-III, V, IX, XI, XII, XIV, XVI, 
XIX- XXII, XXIV and XXVII) that take on different higher order structures as it relates to the 
molecule serving distinct biological purposes112. Collagens I – III are the major fibrillar collagens 
and are the foundation of connective tissue in mammals80, 112; collagen I isolated from rat tails is 
of focus in Chapter 3 as it is the most significant and abundant80. In addition to fibronectin, laminin 
is one of the most studied noncollagenous ECM glycoproteins, is strictly found in basement 
membrane, and is a major component of the widely used cell culture medium, Matrigel9, 60. 
Tenascin, on the other hand, and tenascin-C in particular, is a more specialty protein, being most 
well-known for its role during certain stages of development, and in mediating the effects of other 
ECM proteins on cell responses such as adhesion and differentiation9. 
 
3.1.2 Protein adsorption 
The spontaneous adsorption of whole proteins to a surface prior to cell culture is a common 
attempt to present cells with signaling and cell adhesion moieties. Whole proteins are 
advantageous over peptides alone having more active sites and being susceptible to proteolysis6. 
Establishing a uniform layer of adsorbed protein on 3D scaffolds or 2D surfaces involves a number 
of different parameters which influence the interactions between the protein and the solvent it is 
dissolved in, the protein and the solid substrate, and the solvent and the substrate. Whether or not 
a protein will adsorb to the substrate, remain adsorbed or re-enter solution, or undergo a change in 
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conformation either in the adsorbed or solvated state depends on these interactions which can 
include van der Waals forces, hydrogen bonding, hydrophobic and electrostatic interactions.113, 114 
Environmental conditions, contact time, protein solution concentration, and the properties of the 
protein, solvent, and substrate dictate which interactions are dominant and determine the resulting 
adsorbed protein morphology, adhesion strength, and the amount, density, and orientation of 
adsorbed proteins113-115. Such characteristics of the protein coat are critical since changes in protein 
conformation or steric hindrance could lead to denaturation or make binding sites inaccessible114, 
115. Despite the controls afforded by process conditions, proteins adsorbed onto a solid 2D substrate 
are not well-suited for cell culture applications due to a lack of porosity and extremely high 
Young’s moduli compared to physiological conditions66. Instead, in Chapter 3, a hydrodynamic 
process is innovated for the free suspension of whole proteins across and within the open pores of 
polymer supports fabricated by 3D jet writing. Various contact times, incubation temperatures, 
protein solution concentrations, and fluid-flow patterns were iterated in development of this 
technology.  
In general, the interior of the protein tends to host hydrophobic domains while hydrophilic 
domains are found on the exterior116. Longer contact time is preferred to allow proteins to move 
interior hydrophobic domains to the exterior for enhanced protein adhesive forces113, 115. Longer 
times also allow the protein coated substrate to reach an equilibrium state; protein adsorption can 
be reversible although the protein may not necessarily return to its original conformation115. Such 
reversibility implies that the protein solution concentration is another driving force in adsorption. 
Nakanishi et al. report that lower concentrations show no major impact on adsorbed protein 
conformation. This remains true at higher concentrations initially, but at longer times, a second 
round of proteins which have undergone conformational change may replace the first round of 
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weakly adsorbed proteins115. This idea is similar to the Vroman effect where smaller proteins 
rapidly diffuse and adsorb to the surface but are later replaced by larger proteins with more 
potential binding sites and a stronger binding affinity116. Allowing proteins time to unfold 
increases the molecular footprint and hence, the adhesion strength. Nakanishi et al. also state that 
higher temperature generally favors larger amounts of adsorbed proteins115 which is probably due 
to enhanced protein flexibility enabling the protein to make the conformational changes necessary 
for adsorption. Hence, in developing a process to suspend proteins across a porous 3D scaffold, 
higher solution concentration, longer contact time, higher temperature, and incubation under 
convective fluid flow are preferred in order to maximize the amount of adsorbed protein, and 
ensure that the protein morphology and conformation has equilibrated prior to the introduction of 
cells. 
 
3.1.3 Cell-free fibronectin fibrillogenesis 
When cells form fibrillar cFn matrix in vivo, the protein is first put under mechanical 
tension, which stretches the protein and exposes self-association sites that facilitate the 
intermolecular interactions necessary for fibrillogenesis. In vitro, a range of different stimuli 
including electrical, chemical, mechanical and interfacially active denaturants have been used to 
expose the same self-association sites needed to form Fn fibrils from pFn without the use of cells77, 
117-119. For example, the drawing of fibers by skimming a pointed tip across the surface of a pFn 
solution12, 120, or formation of Fn fiber mats about the shaft of a stirrer at the air-pFn solution 
interface120.  
Interestingly, in both these examples, fibrillogenesis occurs at a three-phase interface of 
air, pFn solution, and a solid object. In fact, Fn has been shown to accumulate as a sheet of soluble 
protein at the air-solution interface13. Forcing the interface through a micropillared substrate 
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resulted in insoluble fibronectin fibrils suspended within the interpillar space13. In this sheet-to-
fiber transition, shear force serves as a protein denaturant, exposing the binding sites responsible 
for the Fn-Fn interactions that facilitate fibrillogenesis14. We sought to take a similar approach to 
engineering networks of Fn fibrils. Because of the reversibility of the FnIII domain unfolding121, 
a heterogeneous interface containing a scaffold support was required where extended fibronectin 
fibrils could be permanently secured for the time-scales of a cell culture experiment (Fig. 3-3). 
Interfacial forces at the air-water interface induce pFn deformation which facilitates self-
association amongst protein molecules13, 14. The scaffold will then promote intermolecular 
interactions between partially unfolded protein molecules by locally confining the protein within 
the pores. Additionally, the large open pores minimize denaturation of the protein due to contact 
with synthetic surfaces, maximizing the likelihood that the deposited protein remains in a native, 
biologically active conformation12. While being comprised of minimal synthetic material, the ideal 
scaffold must maintain mechanical integrity both at ambient and cell incubation conditions. 
 
Figure 3-3: Hydrodynamically induced fibronectin fibrillogenesis Schematic 
illustrating the process of hydrodynamically induced fibronectin fibrillogenesis. A 
membrane or textured substrate, represented by a blue grid, is secured at the interface of a 
three-phase system with air and a solution of plasma fibronectin. Although a variety of 
membranes or substrates can provide the solid support needed to create supported 
engineered cFn (ecFn), 3D jet writing scaffolds are of focus. As the scaffold is exposed to 
repeated shearing of the air-solution interface (achieved using a rotisserie rotator), fibrils 
of fibronectin suspend across the scaffold pores resulting in the final product, a network of 
cFn fibrils termed supported ecFn. 
Such a scaffold is best achieved by poly(lactide-co-glycolide) (PLGA) microfiber 
constructs fabricated by 3D jet writing48. 3D jet writing scaffolds consist of approximately 4% 
material by volume while ensuring structural integrity. Scaffold size and geometries are tunable, 
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but those reported here are 5.8 mm by 6 mm, made by stacks of ten fibers (8-12 µm in diameter), 
patterned into a grid array of square pores 500 µm wide unless otherwise noted. Each pore offers 
large open areas that can contain upwards of 35,000 cells, allowing cells to secrete their own ECM 
and form multicellular structures, while limiting interference from synthetic material on cell 
behavior and protein conformation. Although the biodegradable PLGA scaffolds fabricated by 3D 
jet writing are most optimal and of focus throughout this dissertation, the technique described in 
Chapter 3 for cell-free formation of supported engineered ECM (eECM) is versatile and can be 
applied to any roughed, textured, or porous substrate or membrane. 
  
3.2 Materials and Methods 
 
 3.2.1 Materials 
Human fibronectin (Corning, Corning, NY), rat tail Collagen Type I (Corning, Corning, 
NY), mouse laminin (Life Technologies, Carlsbad, CA), Dulbelco’s Modified Eagle Medium 
(DMEM), non-essential amino acids (NEAA), antibiotic-antimycotic, Micro-BCA kit, anti-
cellular fibronectin clone FnIII (Abcam, Cambridge, MA), and Dubelco’s Phosphate Buffered 
Saline (DPBS) were obtained from Fisher Scientific and used as received. Siliconized low-
retention microcentrifuge tubes by Biotix were purchased from VWR. Stainless steel frames were 
custom fabricated by Microphoto, Inc. (Roseville, MI). 
 
 3.2.2 Formation of supported eECM  
A 3D jet writing scaffold was first secured in a custom-made stainless-steel frame. The 
framed scaffold was then placed at the center of a 2-mL microcentrifuge tube containing 900 μL 
volume of a 110 μg/mL solution of human fibronectin such that the air, scaffold, and solution 
formed a three-phase interface when the tube was laid on its side. The tube was placed on a 
rotisserie rotator at 30°C and 8 rpm (for an interface velocity of 10.4 mm/s) for a period of 2 h. 
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The protein-loaded scaffold was then washed 3 times in DPBS and stored at 4°C up to one week 
until use. The same process was applied for laminin at a temperature of 26ºC and concentration of 
400 µg/mL. For collagen, 900 μL of collagen I dissolved in 33 mM acetic acid at 2.7 mg/mL was 
combined with 100 μL of DMEM and 140 μL of 0.34 N NaOH in a 2-mL microcentrifuge tube. 
The solution should turn from yellow to pink with the addition of base. All collagen preparations 
were performed on ice. The framed scaffold was then secured in the 2-mL tube to form a three-
phase interface and rotated for four hours at 27ºC. See Appendix C for detailed protocols. 
 
 3.2.3 Characterization of supported eECM 
Proteins were fluorescently labelled using standard primary and secondary antibody 
staining protocols, and were imaged using a Nikon A-1 confocal microscope (Nikon Corp., 
Minato, Tokyo, Japan). SEM micrographs were taken with a Helios 650 Nanolab SEM/FIB by 
FEI of Thermo Fisher Scientific at voltages ranging from 2 to 5 kV. Prior to SEM, samples of cells 
or proteins were dehydrated by soaking for 20 minutes in a series of ethanol solutions increasing 
in concentration. The sample was then transferred to a microcentrifuge tube and tertbutanol was 
added to cover. The tube was placed in liquid nitrogen for two minutes then lyophilized overnight. 
(See Appendix B for detailed protocol.) A µBCA assay (Pierce Biotechnology, Rockford, IL) was 
used to measure the mass of protein deposited onto the scaffolds. First, the PLGA was degraded 
in a 0.9 M NaOH solution for 1 h, and then the solution was neutralized in a 0.9 M HCl solution. 
The mass of protein was determined by measuring the absorption at 562 nm after a 1 h, 60°C 
incubation, in the µBCA working reagent and referenced to a standard curve of known masses. 
 
 3.2.4 Culturing cells on supported eECM 
The desired number of cells to be seeded were suspended in a 100 µL droplet and carefully 
pipetted onto the supported eECM within a 24-well plate. The plate was placed in an incubator at 
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37ºC and 5% CO2 for four hours for cell adhesion. Cell media was then added for a final volume 
of 1 mL followed by an overnight incubation. The supported eECM, now seeded with cells, was 
transferred to a clean well with 1 mL of media for the remainder of the culture time. 
Immunohistochemical analysis was performed as previously described48. Briefly, cells on the 
supported eECM were fixed with a 2% paraformaldehyde overnight. Cells were then 
permeabilized with a 0.1% Triton X-100 solution for 5 minutes. The fixed cells were then exposed 
to a 5% BSA blocking solution for 1 h before application of the antibodies. Cells were imaged 
using a Nikon A-1 confocal microscope (Nikon Corp., Minato, Tokyo, Japan). 
If cells were removed from supported cFn networks to visualize the remaining protein 
matrix, samples were decellularized in a protocol adapted from Lu et al.122. Samples were washed 
with PBS, then DI water, and immersed in a solution of 0.1% Triton X-100 with 1.5 M KCl in 50 
mM Tris buffer at 4ºC on a slow-moving shaker for two hours. Samples were washed in 10 mM 
Tris buffer, followed by DI water for one hour each. See Appendix A for detailed protocol. 
  
3.3 Results and Discussion 
 
 3.3.1 Developing and characterizing supported eECM 
Adherent cells must anchor to the insoluble proteinaceous environment surrounding them 
to survive requiring cell binding sites when culturing cells on synthetic material6, 46, 115. Laminin, 
collagen I and IV, and fibronectin are major ECM proteins37, 115 which each contain recognition 
sites or particular peptide sequences such as arginine-glycine-aspartic acid (RGD) that cells are 
able to bind to through integrin receptors7. This phenomenon was seen in an early attempt to adsorb 
fibronectin and laminin onto the PLGA microfiber scaffolds fabricated by 3D jet writing. These 
polymer scaffolds either contained no protein, fibronectin, laminin, or a 1:1 ratio of both, and were 
subsequently seeded with cells expressing green fluorescent protein (GFP). As shown in Figure 
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3-4, polymer scaffolds on their own did not facilitate cell adhesion, but cell adhesion was observed 
on the first day to the fourth and last day of culture for polymer scaffolds with fibronectin and/or 
laminin. This confirms the need to incorporate protein elements into the synthetic polymer scaffold 
in order to create an in vitro 3D cell culture model. 
Although systems exist in the literature that incorporate specific peptide binding sequences 
into a polymeric support, we chose instead to focus on whole ECM proteins. Many cells are able 
to remodel the ECM through proteolysis and secretion of new proteins6, 19, 22, 123. Incorporating 
whole ECM proteins onto the polymer scaffolds would give cells the freedom to customize the 
protein environment in contrast to peptide sequences which are less susceptible to proteolysis and 
remodeling. However, simply adsorbing whole proteins to the surface of the scaffold is a poor 
mimic of native ECM morphology, which is characterized by more fibrillar or spongy structures 
of interconnected pores. Building on previous studies demonstrating cell-free fibrillogenesis, 
several experimental conditions governing the hydrodynamically induced fibrillogenesis sketched 
in Figure 3-3 were tested to find the most optimal process. Using fibronectin, the effect of contact 
time, temperature, protein solution concentration, and static versus dynamic incubation conditions 
were examined for the formation of a web-like network of protein suspended across and within 
the scaffold pores. However, the mode of fluid flow proved to be the most crucial to achieving 
complete coverage of the scaffold with fibrillar protein networks (Fig. 3-5). Two modes of fluid 
flow were employed during incubation, orbital shaking (Fig. 3-5(a)) and rotisserie rotation (Fig. 
3-5(b)) at for either 2 hours or 24 hours. Rotisserie rotation consistently resulted in more uniform 
protein networks across the open pores of the polymer scaffold. This result further confirms the 
criticality of the three-phase interface in hydrodynamically induced fibrillogenesis of Fn. In orbital 
shaking, the scaffold is first entirely submerged within the bulk pFn solution in a well-plate. As  
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Figure 3-4: Protein is required for cell adhesion to polymer scaffolds The first column 
verifies the adsorption of fibronectin (green), and/or laminin (red) onto the surface of the 
polymer scaffold (blue) prior to the seeding of cells. The second column shows GFP 
expressing cells (green) adhered to the polymer scaffolds (blue) only when containing 
protein whether it is fibronectin alone, laminin alone, or a 50:50 mixture of both after only 
one day of culture time. The third column shows the same scaffolds in culture with the 
GFP expressing cells adhered to the polymer scaffolds after four days of culture. Note that 
in the second and third columns, the protein was not stained for and is therefore not visible 
in the LSCM images. The length and width of each 3D volume bounding box is 213.44 
µm. 
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Figure 3-5: Determining optimal conditions to achieve hydrodynamically induced 
fibrillogenesis (a) Representative sections of the polymer scaffold (blue) and tethered 
fibronectin (green) show some fibril formation using an orbital shaker to create fluid flow 
during either a 2 hour or 24 hour incubation at either room temperature or 37ºC. (b) Webs 
of fibronectin fibrils (green) are far more apparent using a rotisserie rotator compared to 
the orbital shaking motion as a means of fluid flow during either a 2 hour or 24 hour 
incubation of the polymer scaffold (blue) in fibronectin solution. Little to no difference 
was observed with respect to the protein network at either room temperature or 37ºC. (a-b) 
3D volume bounding box in all images is a square of length 213.44 µm. 
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movement commences, the fluid is circled around the well while the scaffold remains submerged. 
At sufficiently high orbit speeds, the air-pFn solution interface may form on the scaffold as fluid 
is centripetally thrusted to the outer edges of the round well. In these instances, a three-phase 
contact line is formed with the scaffold, air, and the pFn solution; it is most likely that in these 
instances some fibrils of Fn are observed on the resulting scaffold. In contrast, the rotisserie rotator 
consistently shears the air-pFn solution interface along the scaffold from on end to the next 
repeatedly during the course of the incubation time. As shown in Figure 3-5, the rotisserie rotator 
results in far fuller coverage of the Fn fibrils across the scaffold, further evidencing the integrality 
of the three-phase interface in hydrodynamically induced fibrillogenesis. Continuing with 
rotisserie rotation as the mode of fluid flow, and given that longer time and warmer temperatures 
promote stronger protein adhesion and allow establishment of an adsorption equilibrium, we 
attempted protein network formation for 24 hours but at 30ºC. The lower temperature was 
preferred to keep the PLGA scaffold well below the reported bulk glass transition temperature of 
45-50ºC (Sigma-Aldrich). This penultimate iteration, shown in Figure 3-6, resulted in extensive  
 
Figure 3-6: Optimal fluid motion and temperature determined as rotisserie rotation 
at 30ºC Prior to this time optimal conditions were two hours of incubation under rotisserie 
rotation at 37ºC. However, extensive fibrillar networks of Fn (green) resulted at 30ºC. This 
lower temperature was preferred to keep the PLGA scaffold (blue), well below the glass 
transition temperature of 45-50ºC. 
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engineered cFn networks (Fig. 3-6(a)) that spanned across entire 500 µm wide square pores of the 
polymer scaffold (Fig. 3-6(b)). Optimal pFn solution concentration was found to be 100 µg/mL 
(data not shown). 
Although the process conditions used to achieve the supported eECM shown in Figure 3-
6 suffice for formation of uniform fibrillar webs of protein, it was unknown whether 24 hours of 
incubation time was necessary. To understand the amount of time required to reach an equilibrium 
in regards to protein loading onto the scaffold, the hydrodynamically induced fibrillogenesis 
process was run for 15, 30, 60, 120, and 240 minutes. Figure 3-7(a) shows that after 15 minutes 
of hydrodynamic shearing at the three-phase interface at 30ºC, networks of insoluble cFn fibrils 
had freely-suspended across the entire polymer scaffold. With increasing time, the mass of protein 
loaded onto the scaffold increased until 120 minutes as shown by the plateau in the curve in Figure 
3-7(c). Submerging the scaffold in pFn-solution of the same concentration and temperature for the 
same length of time (two hours) but without fluid flow resulted in a conformal coating as this 
technique lacks hydrodynamic shearing and the three-phase interface (Fig. 3-7(b)). Relative to 
statically adsorbed Fn, the supported ecFn contained at least 12 times more protein irrespective of 
scaffold pore size (Fig. 3-7(d)). Supported ecFn consistently spanned across and within the entire 
area of the scaffold at a large scale of 5.8 by 6 mm. Supported ecFn was formed using a pFn 
solution at 0.11 mg/mL, in contrast to hydrogel matrices that take much higher concentrations: 1-
5 mg/mL of protein111. The ability to prepare supported eECM of various shapes and sizes 
enhances the versatility of this technology whether as an in vitro scaffold in a specific cell culture 
chamber or well plate, or to fit a certain shape or sized defect for tissue regeneration. Furthermore, 
pore sizes were found not to influence the hydrodynamically induced fibrillogenesis process, 
leaving scaffold pore size as another degree of freedom for rational supported eECM design (Fig.  
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Figure 3-7: Dynamic incubation conditions are necessary for hydrodynamically 
induced fibrillogenesis (a) Time sequence characterized by SEM showing increasing 
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amounts of Fn tethered to the polymer scaffold with time. (b) SEM and LSCM images 
showing large scale view of supported ecFn (left) produced by hydrodynamically induced 
fibrillogenesis in contrast to (right) the scaffold after a static incubation in pFn solution. 
The solution concentration, incubation time, and temperature are consistent between the 
supported ecFn and the statically adsorbed Fn at 100 µg/mL, 2 hours, and 30ºC. 
Fluorescence images show Fn in the green channel and the polymer scaffold in blue. (a-b) 
Note defects in SEM images may be due to the dehydration process which occurs during 
SEM sample preparation.  (c) Quantification of the mass of Fn loaded onto the polymer 
scaffold under hydrodynamically induced fibrillogenesis indicating that equilibrium is 
reached after 120 minutes, i.e. max protein loading is achieved after two hours. These time 
points correlate to the images shown in (a). (d) Mass of protein loaded onto polymer 
scaffold is at least 12 times higher for supported ecFn (white bars) compared to the 
conformal coating (grey bars) that results from a static incubation of the polymer scaffold 
in pFn solution of the same concentration, for the same amount of time, and at the same 
temperature. Moreover, mass loading onto the scaffold is not a function of pore size. (c-d) 
Quantification of protein mass conducted by µBCA assay. 
3-7(d)). Varying pore sizes will impact the mechanical environment cells experience when 
cultured on a supported eECM. 
The support used in this study is a poly(lactide-co-glycolide) (PLGA) microfiber scaffold 
fabricated by 3D jet writing48, consisting of approximately 4% material by volume48. While 3D jet 
writing affords widely tunable scaffold sizes and geometries, all scaffold used in this study fit an 
area of 34.8 mm2 and were comprised of ten stacked fibers (fiber diameter: 8-12 m) (as was 
shown in Fig. 2-2). The large open pores ensure mild denaturation of the protein due to limited 
contact with synthetic surfaces, maximizing the likelihood that the deposited protein remains in a 
biologically active state12. In addition, the scaffold maintains mechanical integrity both at ambient 
and cell incubation conditions. However, to verify that the hydrodynamically induced 
fibrillogenesis process is not limited to 3D jet writing scaffolds, mesh screening that was also of a 
porous grid pattern geometry was exposed to the same process. Although this study was performed 
prior to the final optimization of the hydrodynamically induced fibrillogenesis process conditions, 
the result clearly shows a webbed protein morphology resulting from hydrodynamic shearing at 
the three-phase contact line as opposed to a conformal coating produced by static submersion of 
the mesh in a pFn solution (Fig. 3-8). This confirms that the technique is not limited to 3D jet 
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writing scaffolds and further reinforces the requirement of hydrodynamic shearing of the three-
phase contact line formed by the solid support, air or perhaps another hydrophobic medium such 
as oil, and the aqueous pFn solution. 
 
 
Figure 3-8: Hydrodynamically induced fibrillogenesis is not limited to 3D jet writing 
scaffolds Mesh screening made of either polyester or nylon were exposed either to static 
incubation in pFn solution or the hydrodynamically induced fibrillogenesis process 
(dynamic incubation). In contrast to 3D jet writing scaffolds characterized by square pores 
500 μm wide with a wall diameter of 8-12 μm and an open area greater than 95%, the 
polyester mesh screening had square pore openings of 530 μm, wall diameter of 220 μm, 
and an open area of 50%, and the nylon mesh screening carried square gap openings of 500 
μm, wall diameter of 225 μm, and an open area of 47%. Still, results are consistent with 
Fig. 3-6(b) indicating that whether the support is a 3D jet writing scaffold, polyester mesh 
or nylon mesh screening, static incubation results only in a conformal coating of Fn 
whereas supported ecFn require hydrodynamic shearing. Scale bars 1000 μm. Note this 
study was conducted prior to final optimization of the process conditions for 
hydrodynamically induced fibrillogenesis. 
To further understand the criteria of substrates or membranes that can be applied as a 
support in the hydrodynamically induced fibrillogenesis process, and as a further control 
experiment, tissue culture polystyrene (TCPS) was exposed to three-phase hydrodynamic 
shearing, or static incubation in pFn-solution, both resulting in conformally adsorbed protein (Fig. 
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3-9(a-b)). This suggests that either porosity or topographical features are necessary to locally 
confine the protein, promoting intermolecular interactions as FnIII domains unfold under tension. 
To represent a non-porous but textured substrate, TCPS was roughed with sand paper to produce 
the surface shown in Figure 3-9. Roughened TCPS, although non-porous, was able to facilitate 
fibrillogenesis, forming networks of protein, but with a more sheet-like morphology (Fig. 3-9(c)) 
relative to 3D jet writing scaffolds (Fig. 3-9(d)). These results indicate that porosity is not 
necessary to draw cFn fibrils from pFn solution, but rather a non-smooth topography such as 
surface roughness is needed to nucleate the formation of cFn networks. Additionally, the stark  
 
 
Figure 3-9: Textured but not porous surface is required for hydrodynamically 
induced fibronectin fibrillogenesis SEM of fibronectin conformally coated onto tissue 
culture polystyrene (TCPS) via (a) static adsorption in contrast to (b) hydrodynamic 
deposition of Fn using the same method as when producing supported ecFn. (c) 
Representing a textured but non-porous substrate, sanded TCPS was exposed to the 
hydrodynamically induced fibrillogenesis process resulting in protein deposition of a 
different morphology. SEM of sanded TCPS prior to hydrodynamic shearing is shown. (d) 
For comparison supported ecFn at the same scale as (a-c) is shown after hydrodynamic 
deposition of Fn onto a 3D jet writing scaffold. (a-d) Scale bars 1 µm. 
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contrast in Fn morphology on roughened TCPS compared to 3D jet writing scaffolds suggests a 
potential avenue for regulating the protein network architecture by modulating pores or surface 
features. More recently, Dylan Neale of the Lahann Lab has demonstrated the formation of 
supported ecFn using grids fabricated by photolithography out of the photoresist, SU-8 having 
similar geometric parameters as a 500 µm square pore 3D jet writing scaffold. This further 
demonstrates that the membrane or substrate used to form the three-phase contact line in 
hydrodynamically induced fibrillogenesis can be made of various materials, in addition to the array 
of possible surface or pore features. 
  
3.3.2 Validating cellular nature of supported ecFn 
The overarching goal of Chapter 3 is to engineer an ECM that accurately mimics 
physiological ECM. Hydrodynamically induced fibrillogenesis successfully converts pFn into a 
webbed network of protein suspended across a polymer scaffold. The question remains whether 
this protein network is actually representative of native ECM, where fibronectin is known to (1) 
have a fibrillar architecture, (2) exist in an unfolded conformation that exposes the FnIII domain, 
and (3) be detergent-insoluble4, 76, 89, 107, 124, 125. Supported ecFn was therefore analyzed for these 
three characteristics. High resolution SEM of dehydrated supported ecFn reveals a 3D web-like 
matrix of fibronectin (Fig. 3-10(a)). To compare this structure with that of cell-secreted Fn, human 
mammary fibroblasts were cultured on glass substrates to confluency. The substrates were 
subsequently decellularized, and in parallel with supported ecFn, stained for human fibronectin. 
The cell-secreted Fn and supported ecFn both exhibited a fibrillar, porous morphology ((Fig. 3-
10(b)). Supported ecFn were also found to remain intact following treatment with deoxycholate or 
Triton X-100 detergent, rendering the protein network detergent-insoluble (Fig. 3-10(d)). In 
addition to being insoluble and having a fibrillar architecture as is that of ECM in vivo89, 124, 
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Figure 3-10: Protein morphology, conformation, and insolubility validates the 
cellular nature of supported ecFn (a) High resolution SEM of Fn as it appears from the 
top surface of supported ecFn. Scale bar 1 µm. (b) Comparison of supported ecFn (green) 
as it is suspended on the polymer scaffold (blue) shown on the left to Fn secreted by human 
mammary fibroblasts cultured to confluency on a glass slide and subsequently 
decellularized. Scale bars 25 µm. (c) Split channel view of supported ecFn, irrespective of 
conformation (green) and specifically the FnIII domain (purple) across the large scale of 
the 3D jet writing scaffold, indicating that the ecFn is in an unfolded, extended 
conformation as it is in vivo. Overlay image of the two channels shown on the left. Scale 
bar 500 µm. (d) Supported ecFn remains intact despite treatment with Triton X-100 
detergent, showing detergent-insolubility. Scale bar 25 µm. 
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exposure of the FnIII domain would confirm, not by morphology but rather biochemically, the 
cellular nature of supported ecFn. We adopted positive staining of the FnIII domain as a direct 
indication that hydrodynamically induced fibrillogenesis indeed transformed pFn into cFn10, 85, 126, 
127. We found that FnIII stained positively on supported ecFn throughout the large-scale area of 
the polymer scaffold as shown in Figure 3-10(c). As a control, the same trend was observed for 
decellularized human mammary fibroblast-secreted matrix (Fig 3-11(a-b)). Little to no FnIII 
signal was observed on glass or 3D jet writing scaffolds that were conformally coated with pFn 
via static adsorption, indicating that conformal coatings lack exposed FnIII domains and the 
associated biological activity10, 11, 94, 128 (Fig. 3-11(c-d)). The fact that static incubation does not 
present the protein in an unfolded conformation where the FnIII domain is exposed implies that 
hydrodynamic shearing at the three-phase interface effectively unfolds the protein and suspends it 
across the pores of the polymer scaffold in an extended, physiological conformation. Importantly, 
the impact of this result goes beyond asserting the ECM-like nature of supported ecFn. The 
procedure of static incubation is commonly used in the literature for coating TCPS dishes or glass 
substrates prior to cell culture in an attempt to expose cells to a more native environment, for cell 
anchorage, and to achieve desired signaling via integrin binding to the specific protein. However, 
the desired binding sites may remain sequestered within the protein when adsorbed conformally 
onto a solid surface as was FnIII after static incubation in pFn solution. Assuming full bioactivity 
of conformally adsorbed Fn may lead to inaccurate experimental conclusions, where a cell 
response is attributed to the protein or protein-induced cell signaling rather than another feature of 
the artificial environment.  
It is well known that protein structure is strongly correlated to functionality85, 111. In fact, 
varying degrees of protein unfolding impacts not only the availability of binding sites such as the  
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Figure 3-11: FnIII domains exposed on supported ecFn as it is in cell-secreted Fn 
Fibronectin (green) as secreted by human mammary fibroblasts cultured on glass and 
subsequently decellularized showing exposure of FnIII domains (purple). Overlay of the 
two channels shown in left column. (b-d) Overlay of channels (left), Fn stained irrespective 
of exposed domains (green, center), and specifically the FnIII domain (purple, right) for 
plasma fibronectin: (b) suspended as ecFn across a 3D jet writing scaffold to form 
supported ecFn, (c) conformally coated onto a 3D jet writing scaffold and (d) conformally 
coated onto glass via static adsorption. Scale bars 25 µm. All images taken at the same 
laser power and imaging settings via LSCM. Strong overlap of green and purple appear 
white in overlay image (left images in (a) and (b)). Saturated pixels in the FnIII channel of 
(a) appear pink in color. 
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mechano-sensitive α5β1, but also the stiffness of the protein coated surface which can be 
mechanotransduced to cause specific cell responses129. For example, matrix stiffening by means 
of protein unfolding mediates integrin activity, increasing vascular endothelial growth factor 
secretion and decreasing cell adhesion – supporting breast tumor development42, 86. Moreover, 
different tissues or diseased states are often characterized by the extent to which cFn is unfolded. 
Partially unfolded cFn was identified in obese tissue from mice129.  With the extreme flexibility 
and possible conformations of proteins, a best-case solution is to allow cells to remodel or 
restructure the protein matrix of their in vitro environment. Such a “hands-off” approach is 
achieved by supported eECM, where the bulk of the deposited protein is kept within the large 
pores of the 3D jet writing scaffold rather than adsorbed onto the walls. This design firstly keeps 
the majority of the protein freely suspended, surrounded only by cell media when in culture, and 
free from artificial restructuring due to contact with a solid surface. Secondly, the unconfined 
protein network is accessible only by cells in culture and therefore any remodeling of the protein 
structure or composition is governed only by cell activity. Cells seeded on supported eECM will 
eventually generate their own protein matrix promoting the natural bidirectional signaling between 
cells and ECM.  
Of course, in addition to a native-like architecture and conformation, a required feature in 
designing an in vitro ECM-mimic, is compositional control. Not only is hydrodynamic shearing 
effective for converting pFn to cFn, but it also successfully deposits 3D matrices of laminin (LAM) 
and collagen I (COL) onto the polymer scaffold as shown in Figure 3-12(a). LAM and COL within 
the matrix secreted by human mammary fibroblasts was found to be comparable to that of 
supported eECM but for the formation of thicker bundles in the shear-deposited protein than that 
of the decellularized matrix (Fig. 3-13(a)). The SEM images provide better resolution of the finer  
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Figure 3-12: Shear-driven hydrodynamic deposition is not limited to fibronectin (a) 
Fibronectin (top), laminin (middle), and collagen I isolated from rat tail (bottom) 
hydrodynamically deposited onto 3D jet writing scaffolds. SEM images of protein either 
at the crosshairs of the polymer microfibers or within the 500 µm open square pores. (b) 
Fibronectin (green) and laminin (orange) combined to form a supported eECM. (a-b) Scale 
bars 25 µm. Blue channel indicates polymer scaffold. Credit: Collagen I isolated from rat 
tail and generously donated by the Chun Lab at the University of Michigan. 
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features of the supported eECM revealing a porous and fibrillar architecture (Fig. 3-13(a)). In an 
early experiment prior to protocol optimization, it was also shown that proteins can be deposited 
onto the polymer scaffold in binary combinations as with Fn and LAM in Figure 3-12(b). A more 
specialty protein, tenascin-C, which is known to bind to Fn130, 131, could also be distributed 
throughout the supported eECM in combination with Fn at a ratio of only 5:95 tenascin-C:Fn (Fig. 
3-13(b)). Tenascin-C plays a major role in certain physiological phenomena including bone and 
cartilage development, secondary lung tumor formation in breast cancer132, and invasiveness, 
angiogenesis, and cancer cell viability in metastasis133. As such, including tenascin-C in the library 
of proteins that can be suspended across polymer scaffolds opens a new door to explore the effect 
of tenascin-C in various cell cultures or co-cultures. Practically, the ability to create a large-scale 
niche ECM that incorporates tenascin-C at amounts as low as 5% loading is cost effective given 
the higher prices of such specialty proteins (10% shown in Fig. 3-14). Combinations of more than 
two proteins has not been experimented with, but is a promising avenue for future engineered ECM 
design. The ability to visualize both proteins and their interactions with one another prior to 
seeding cells is yet another demonstrated advantage of supported eECM. For instance, Fn appeared 
to surround LAM in clusters (Fig. 3-12(b)) in contrast to the uniform distribution of Fn with 
tenascin-C (Fig. 3-13(c)). Interestingly, the two antiparallel beta sheets that form FnIII in Fn, is 
conserved in tenascin where it is folded identically to the FnIII of Fn105. Such similarities in protein 
structure between Fn and tenascin may explain why the two proteins disperse together throughout 
the supported eECM while Fn and LAM remained more separated. The interplay between 
tenascin-C and Fn is particularly interesting in the context of tumorigenesis where tenascin-C 
inhibits cell adhesion to and assembly of cFn matrix131; the effect of Fn with and without tenascin-
C on cancer cell behavior is one of many future applications of supported eECM. 
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Figure 3-13: Expanded library of proteins for supported eECM include niche protein 
tenascin-C (a) (left column) Fibronectin (FN), laminin (LAM), and collagen I (COL) as 
secreted by human mammary fibroblasts when cultured on tissue culture polystyrene. 
(middle column) FN, LAM, and COL as suspended on 3D jet writing scaffolds to form 
supported eECM. (right column) SEM images of supported eECM comprised of either FN, 
LAM, or COL at 10,000x magnification. (b) Zoomed out view showing larger scale 
visualization of FN (green) in combination with tenascin-c (red) on a supported eECM at 
a ratio of 5:95 tenascin-C to Fn. (c) Higher magnification of sample shown in (b) with split 
channel view of Fn (green) and tenascin-C (red) including the overlay image on the left. 
Credits: Collagen I isolated from rat tail and generously donated by the Chun Lab at the 
University of Michigan. Tenascin-C contributed by the Lawlor Lab at the University of 
Michigan in a collaborative project including students Elizabeth Pedersen and Allegra 
Hawkins. 
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Figure 3-14: Small loadings of tenascin-C are sufficient to distribute the protein 
across the open pores of the polymer scaffold Distributions of fibronectin and tenascin-
C at ratios of 95:5 or 90:10 provide sufficient tenascin-C to the system for 
hydrodynamically induced fibrillogenesis to carry the tenascin-C along with the fibronectin 
to form fibrillar structures spanning across the open pores of the polymer scaffold. 
Fibronectin in green channel, tenascin-C in red, overlay image shown on the far left in both 
cases shown. Scale bars 25 µm. Credit: Tenascin-C contributed by the Lawlor Lab at the 
University of Michigan in a collaborative project including students Elizabeth Pedersen 
and Allegra Hawkins. 
 
 3.3.3 Functionality of supported ecFn in various cell cultures 
The final validation of the supported eECM technology is to observe it in use for various 
cell culture applications. As a first baseline experiment, NIH-3T3 mouse fibroblasts were cultured 
on supported ecFn (Fig. 3-15(b)). In parallel for comparison, Fn statically adsorbed onto the same 
polymer scaffold (Fig. 3-15(a)) was also seeded with the same number of cells. After three days 
of culture, the fibroblasts had expanded across the entire area of the supported ecFn, forming a 3D 
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volume of cells or microtissue several cell diameters thick (Fig 3-15(d-f)). In contrast, cells had 
simply adhered to the surface of scaffolds with a conformal layer of protein with little to no cell 
bridging across pores (Fig. 3-15(c)). The suspension of ecFn across and within the large square 
pores of the polymer scaffold act as highways for cells to migrate away from the polymer 
microfibers and towards the softer proteinaceous matrix found in the pore as was evidenced by a 
live-cell time lapse video of GFP NIH-3T3 fibroblasts seeded onto supported ecFn; note that each 
500 µm wide pore of the polymer scaffold provides sufficient volume for cell numbers upwards 
of 60,000 cells. Cells can therefore embed themselves amongst the suspended webs of protein 
within 3D space, as opposed to forming a monolayer atop a conformal protein coating on a 2D 
substrate. Furthermore, the supported ecFn enabled rapid cell proliferation and expansion relative 
to the same polymer scaffold statically incubated in pFn solution. At the same three day timepoint, 
the coverage of cells across the supported ecFn far supersedes that of the statically adsorbed Fn. 
Even after 22 days, 57% of scaffold pores were not fully covered with cells when only statically 
incubated in pFn solution (Fig. 3-16(a)). To verify that this ability to rapidly generate cell volumes 
is due to the protein network and not the 3D jet writing scaffold, a similar study was done using 
polyester and nylon mesh screening as the membrane (Fig. 3-16). Again, static Fn adsorption onto 
either polyester or nylon mesh screening left nearly all pores with incomplete cell coverage, even 
after 22 days of culture time (Fig. 3-16(b-c)). At the same time, three days were sufficient to form 
cell volumes spanning nearly the entire area of the mesh screening when Fn was deposited via 
hydrodynamically induced fibrillogenesis for both polyester and nylon mesh screening (Fig. 3-
16(d-g)). Hence, the hydrodynamically induced fibrillogenesis technique is effective for forming 
3D cell culture matrices regardless of the source of solid support. This will be important in mass 
production of supported eECM should the technology transition from bench scale to commercial, 
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as we move towards the overarching goal of updating the most ubiquitous cell culture substrate, 
flat TCPS surfaces. 
 
Figure 3-15: Supported ecFn facilitates formation of 3D cell volumes (a) Conformal 
protein coat that results from static incubation of the polymer scaffold in pFn solution. Fn 
adsorbs only onto the microfibers with little to no bridging of Fn across or within the pores 
of the scaffold. (b) In contrast to (a), supported ecFn is an array cFn fibrils bridging across 
the open pores of the polymer scaffold. (c) After three days of culturing NIH-3T3 mouse 
fibroblasts on statically Fn coated polymer scaffolds, cells only tend to adhere along the 
polymer fibers. (d) However, three days on supported ecFn was sufficient for fibroblasts 
90 
 
to fill all scaffold pores to depths several cell diameters thick indicating the supported ecFn 
yields superior cell proliferation and rapid microtissue formation. (e) 3D volume view 
showing depth of tissue created by cells in culture 3 days on supported ecFn. (f) Top view 
showing interconnectivity of cells and cell-cell contacts on supported ecFn. Channels: blue, 
polymer microfibers; green, fibronectin; red, actin; cyan, cell nucleus. Scale bars: (a-d) 500 
μm (e-f) 25 μm. 
 
 
Figure 3-16: Protein network facilitates formation of 3D cell volumes irrespective of 
the choice of scaffold (a-c) NIH-3T3 fibroblasts after 22 days of culture on polymer 
scaffolds statically incubated in pFn solution to form a conformal layer of Fn on all surfaces 
prior to cell seeding. Polymer scaffolds are (a) 3D jet writing microfiber construct, (b) 
polyester mesh screening, (c) nylon mesh screening. (d-g) NIH-3T3 fibroblasts form 
extensive 3D cell volumes after three days in culture on supported ecFn produced via 
hydrodynamically induced fibrillogenesis on both (d, f) polyester and (e, g) nylon mesh. 
All cell nuclei stained blue, and actin stained green. (a-e) Scale bars 1000 μm. (f, g) Scale 
bars 50 μm.  
Protein bridges suspended across the open pores of the polymer scaffold have now been 
shown to facilitate cell outgrowth away from the polymer fibers and into the void spaces free of 
synthetic material. Once residing in the void spaces, cells can choose to remodel the deposited 
protein network by secreting new ECM proteins, and/or lysing or restructuring the existing ECM 
that was pre-deposited. In addition to visualizing protein synthetically deposited onto the polymer 
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scaffold, supported eECM allows researchers to visualize changes in the protein network due to 
cell activity. To demonstrate detection of specific cell secreted protein using supported eECM, 
MDA-MB-468 breast cancer cells were cultured four days on supported ecFn (Fig. 3-17(a)). The 
scaffolds were decellularized, and Fn and any endogenous LAM were fluorescently labelled and 
imaged to show that the MDA-MB-468s had secreted small amounts of LAM (Fig. 3-17(b)). In 
addition to endogenously secreting proteins, cells may also lyse the pre-deposited protein. This  
 
Figure 3-17: Supported ecFn enables observation of protein secreted by cells during 
culture (a) MDA-MB-468 breast cancer cells cultured four days on supported ecFn form 
cell-cell and cell-ECM contacts. Fn shown in green and cell-secreted laminin in orange. 
Scale bar 25 µm. (b) After four days of culture, MDA-MB-468 cells were removed from 
the supported ecFn, and the remaining protein was stained for all fibronectin (green) and 
endogenously secreted laminin (orange). Scale bar 25 µm. (a-b) Channels: green, 
fibronectin; orange, laminin; cyan, cell nucleus; red, actin. 
behavior was seen with the human breast cancer cell line, MDA-MB-231 (231s). 231s were 
cultured on TCPS (Fig. 3-18(a)) and supported ecFn (Fig. 3-18(b)). Supported ecFn fostered a 
higher degree of cell-cell contacts compared to the same culture on TCPS for the same amount of 
time. Cells cultured on TCPS also displayed a flattened morphology. After six days of culture on 
supported ecFn, 231s had formed confluent volumes within each pore of the polymer scaffold as 
shown in Figure 3-18(c). However, by the tenth day in culture, the cells had migrated off the 
scaffold, where the only cells remaining were adhered to the microfibers of the 3D jet writing 
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construct (Fig. 3-18(d)). The cells had also aggressively broken down the pre-deposited ecFn. The 
same behavior was quantified by observing the number of 231 cells adhered to the supported ecFn 
over time. The growth curve, shown in Figure 3-19(a), highlights that the 231s were proliferative 
until about the eighth day in culture when they transitioned to a more migratory phenotype such  
 
Figure 3-18: MDA-MB-231 human breast cancer cells break down protein of 
supported ecFn (a) MDA-MB-231 (231s) human breast cancer cell line cultured on tissue 
culture polystyrene (TCPS). Cells cultured on TCPS have a more artificial flattened 
morphology and make fewer cell-cell contacts. Cell nucleus in purple, actin in green. Laser 
scanning confocal microscope (LSCM) image at 60x magnification. (b) 231s cultured and 
imaged on supported ecFn at 60x magnification on LSCM. Cell nucleus in cyan, actin in 
green. Supported ecFn promote cell-cell contacts in 3D space to form a thriving microtissue 
in vitro (b-c) compared to the same cell type cultured on TCPS for the same amount of 
time in (a). (c) 231s after six days of culture form a confluent volume of tissue on supported 
ecFn. (d) After 10 days of culture on supported ecFn, 231s are no longer tethered to the 
protein but rather migrate off the scaffold into solution. (Subsequent experiments show that 
these cells are still 98% viable in solution.) At 10 days, the ecFn is no longer visible 
indicating that the cells have broken down or remodeled the proteinaceous environment as 
they move off into solution.  
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that by the 10th day, the number of cells still adhered to the supported cFn network is only slightly 
higher than the number of cells initially seeded. Follow up studies indicated that the 231s that had 
left the supported ecFn and found suspended in solution had remained 98% viable. Were these 
231s attempting to begin the metastatic cascade? Could supported ecFn also serve as a model of 
metastasis as illustrated in Figure 3-19(b)? Certainly, this is a topic for future studies.  
 
Figure 3-19: Supported ecFn may be a potential model of breast cancer metastasis (a) 
Bioluminescence was used to quantify the relative number of MDA-MB-231 breast cancer 
cells adhered to the supported ecFn at various time points during a 10-day culture. Initially, 
cells are proliferating but at day-8 the cells transition to a migratory state leaving few cells 
adhered to the supported ecFn by day-10. (b) Schematic of the hypothesis regarding the 
possibility of supported ecFn to serve as a model of metastasis. Cancer cells are first seeded 
onto the supported ecFn where they form 3D cell volumes. Upon reaching a critical 
confluency, cells become more aggressive and migrate off into solution, remaining viable. 
This is a topic for future investigation. 
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In addition to observing cell activity in matrix remodeling, supported eECM also allows 
ECM protein composition control. In designing a 3D cell culture matrix, a tunable ECM 
composition is required in order to recapitulate specific cell niches and tissues in both healthy and 
diseased states, and experimentally important in regards to probing the effect of a certain protein 
or combination of proteins on cell behavior. For instance, the protein breakdown observed when 
MDA-MB-231s were cultured on supported ecFn (Fig. 3-18–19(a)) was not observed when the 
same cells were cultured on supported eCOL. When cultured on collagen I, these cells did not 
migrate off the scaffold, nor did they lyse and break down the protein. Instead, 231s cultured on 
supported eCOL remained within the microenvironment in a proliferative phase. To exhibit the 
versatility of ECM composition in supported eECM, in addition to Fn, 231s were grown on LAM, 
COL, and a combination of Fn and LAM (Fig. 3-20(a-d)). Growth curves for 231s on LAM alone 
and the combination of Fn and LAM reveal the dependence of cell proliferation on the composition 
of the supported eECM. When cultured on suspended eECM of Fn and LAM, the number of 231s 
adhered to the scaffold grew up to about three times higher than that of LAM alone (Fig. 3-20(e)). 
This demonstrates the applicability of supported eECM in elucidating the impact of different 
protein compositions on cell behavior while providing a more physiologically relevant in vitro 3D 
culture environment. 
The ability to tune the protein composition of supported eECM is largely beneficial for 
recapitulating specific cell niches, as with the combination of Fn with tenascin-C. Tenascin-C is 
found in the stroma of most solid tumors, and has been considered an oncogene i.e. having the 
ability to transform a cell into a tumor cell132, 134. The Lawlor lab at the University of Michigan 
has found that tenascin-C plays a role in the childhood disease, Ewing sarcoma, where tenascin-C 
is required for tumor formation in a mouse model. Tenascin-C also facilitates migration and 
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invasion135, impacts cell colony formation, and promotes cell adhesion (data not shown). 
Observation of such cell behaviors is critical to understanding Ewing sarcoma which is not easily 
characterized by markers commonly used in cancer to identify cells of epithelial or mesenchymal 
phenotypes136. Supported eECM offers the ability to probe cell response to incorporation of 
tenascin-C into the synthetically deposited protein microenvironment. In parallel, cells cultured on 
supported eECM can be engineered to have either a tenascin-C knockdown, or normal expression  
 
 
Figure 3-20: Supported eECM provides a means to probing the effect of different 
ECM composition on cell response Demonstration of culture of MDA-MB-231 human 
breast cancer cells on supported eECM of varying composition: (a) laminin (LAM) only 
(cell nucleus in purple; actin in red; polymer microfibers in blue; protein not stained), (b) 
collagen I (COL) only (cell nucleus in blue; actin in green; collagen I in red), (c) Fn and 
LAM in combination (cell nucleus in purple; actin in red; polymer microfibers in blue; 
protein not stained), and (d) Fn only (cell nucleus in blue; actin in green). (e) Growth curves 
plotting normalized cell proliferation against time for a 10-day culture of 231s on supported 
eLAM in contrast to Fn and LAM combined. Credits: Collagen I isolated from rat tail and 
generously donated by the Chun Lab at the University of Michigan. 
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of tenascin-C termed non-silencing cells. This gives researchers the advantage of elucidating the 
effect of tenascin-C both intra- and extracellularly. Extracellularly, whether or not tenascin-C was 
combined with Fn to form the supported eECM did not appear to have any effect on TC32 Ewing 
sarcoma cell morphology (Fig. 3-21 and 3-22). TC32s were cultured nine days on either ecFn, or 
supported networks of both cFn and tenascin-C. Although no difference in cell morphology was 
observed, with both protein compositions, cells had restructured the morphology of the ecFn by 
day seven (Fig. 3-21 and 3-22). Some degradation of the tenascin-C within the protein matrix was 
also observed by day nine (Fig. 3-22). Future studies will aim to understand whether these cells 
are indeed of a migratory or invasive phenotype as would be indicated by ECM breakdown. 
Notably, no differences in cell proliferation were found between the two protein matrix 
compositions (3-23). In a separate assay focused on intracellular differences in tenascin-C 
expression, the cell type varied between non-silencing cells or tenascin-C knockdown cells and 
the supported eECM composition was fixed to fibronectin only (Fig. 3-24). After four days of 
culture, the non-silencing cells had largely degraded the ecFn network which is characteristic of a 
migratory phenotype. In contrast, without intracellular tenascin-C, the tenascin-C knockdown cells 
left the protein matrix relatively intact (Fig. 3-24 and 3-25). This example serves as another 
demonstration of some of the key advantages of the supported eECM: (1) cells are freely able to 
breakdown the deposited protein which is susceptible to proteolysis and (2) the technology is 
amenable to microscopy techniques allowing visualization of the entire polymer scaffold, the 
presence or degradation of deposited protein, and higher magnification views of cultured cells. 
Future directions in this study will probe the bidirectional relationship between tenascin-C and cell 
response by toggling expression of intracellular tenascin-C and incorporation of tenascin-C 
extracellularly into the protein matrix. 
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Figure 3-21: Ewing sarcoma cells restructure supported ecFn matrix TC32 Ewing 
sarcoma cells were cultured on supported ecFn for nine days. Fn adopted a different 
morphology after cells resided within the matrix for seven days. All images at the same 
scale. Scale bar 25 µm. Channels: cell nucleus (blue), actin (green), fibronectin (purple). 
Credit: TC32 cells contributed by the Lawlor Lab at the University of Michigan in a 
collaborative project including students Elizabeth Pedersen and Allegra Hawkins. 
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Figure 3-22: Ewing sarcoma cells restructure ecFn and appear to degrade tenascin-C 
when cultured on supported eECM comprised of both proteins TC32 Ewing sarcoma 
cells were cultured on supported ecFn either without (Fig. 3-21) or with the addition of 
tenascin-C for nine days. Cells grew confluent on both types of microenvironments. Fn 
adopted a different morphology after cells resided within the matrix for seven days. All 
images at the same scale. Scale bar 25 µm. Channels: cell nucleus (blue), actin (green), 
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fibronectin (purple), tenascin-C (red). Credit: Tenascin-C and TC32 cells contributed by the 
Lawlor Lab at the University of Michigan in a collaborative project including students 
Elizabeth Pedersen and Allegra Hawkins. 
 
 
Figure 3-23: Proliferation of TC32 Ewing sarcoma cells is not affected by 
incorporation of tenascin-C into supported ecFn TC32 Ewing sarcoma cells were 
cultured seven days on supported ecFn (blue line) or supported eECM comprised of both 
cFn and tenascin-C (red line). Fibronectin and tenascin-C were incorporated at a mass ratio 
of 95:5 in solution to form the supported eECM. Luminescence measurements were 
collected over time to represent a relative cell number adhered to the supported eECM. No 
difference between the two types of microenvironments were observed. Credit: Tenascin-
C and TC32 cells contributed by the Lawlor Lab at the University of Michigan in a 
collaborative project including students Elizabeth Pedersen and Allegra Hawkins. 
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Figure 3-24: Time sequence of Ewing sarcoma cells either expressing or knocked 
down for tenascin-C cultured on supported ecFn TC32 Ewing sarcoma cells that were 
either (a) expressing tenascin-C i.e. non-silencing or (b) under a tenascin-C knockdown 
were cultured four days on supported ecFn. Scaffolds were imaged 6 hours after seeding, 
two days, and four days as indicated. Non-silencing cells, having tenascin-C expression, 
had more drastically degraded the protein matrix relative to the tenascin-C knockdown 
cells by the fourth day. Credit: TC32 cells contributed by the Lawlor Lab at the University 
of Michigan in a collaborative project including students Elizabeth Pedersen and Allegra 
Hawkins. 
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Figure 3-25: Supported eECM provides a means of visualizing cell-induced protein 
matrix breakdown in vitro Two groups of TC32 Ewing’s sarcoma cells were cultured on 
supported ecFn, one group expressing the oncogene tenascin-C (non-silencing cells shown 
on the left) and the other having had a tenascin-c knockdown (shown on the right). Shown 
are zoomed out views, and in the insets zoomed in views of the scaffolds after four days of 
culture. Channels: fibronectin in purple; cell nucleus in blue; actin in green. Credit: TC32 
cells contributed by the Lawlor Lab at the University of Michigan in a collaborative project 
including students Elizabeth Pedersen and Allegra Hawkins. 
In addition to Ewing sarcoma and breast cancer cells, supported ecFn has maintained 
successful in vitro cultures of a variety of cell types across projects in the Lahann Lab including 
endothelial cells, human epithelial keratinocytes, human mesenchymal stem cells, induced 
pluripotent stem cells, human embryonic stem cells, pancreatic and prostate cancer cells. Shown 
in Figure 3-26(a-c), MDA-MB-231 breast cancer cells have been cultured on collagen I, and Fn 
to form confluent cultures that can span across entire 3D jet writing scaffold, an area approximately 
5.6 by 6 mm. Various time points were imaged for a Sum159 human breast cancer cell culture on 
supported ecFn. Figure 3-26(d-f) exhibits how these cells proliferated from the adhesion of only 
a few cells at day one to a mass of cells occupying and spanning across each pore of the polymer 
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scaffold by the fourth day. Two types of pancreatic cancer cells were also expanded on supported 
ecFn, enabling analysis of distinct phenotypes in parallel: the UM53 epithelial patient-derived cell 
(Fig. 3-26(g)) and the ASPC1 mesenchymal cell line (Fig. 3-26(h-i)). Beyond cancerous cells, 
another interesting cell type are endothelial cells as the need to vascularize engineered 3D tissue 
constructs persists. Human umbilical vein endothelial cells (HUVECs) were found to require the 
combination of laminin and fibronectin in order to thrive (Fig. 3-26(j-k)). In other studies, 
HUVECs required a fibrillar form of Fn to proliferate and migrate137-139. Unlike the cancer cells 
which form confluent volumes across and within the pores of the polymer support, HUVECs 
remain in lower density bridges (Fig. 3-26(l)). The array of cell types that have been successfully 
maintained in vitro on suspended eECM further validates its versatility and implies that it is a 
technology that can be widely adopted into mainstream biological research across disciplines if 
pushed towards commercialization. 
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Figure 3-26: Cell type versatility of supported ecFn (a-c) MDA-MB-231 breast cancer 
cells on supported eECM of (a) collagen I and (b, c) fibronectin at six days. (d-f) Sum159 
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breast cancer cells on supported ecFn after (d) one day and (e, f) four days of culture. (g-i) 
Pancreatic cancer cells on supported ecFn. (g) Pancreatic cancer cells from the UM53 
epithelial patient-derived cell line after two-day culture. (h, i) ASPC1 mesenchymal 
pancreatic cancer cell line cultured four days. (j-l) Human umbilical vein endothelial cells 
cultured for seven days do not grow on supported eECM composed of (j) laminin only (nor 
fibronectin only – data not shown) but cells thrive well when (k, l) laminin and fibronectin 
are combined. Whereas cancer cells form confluent volumes across the scaffold (c, f, i) 
HUVECS remain in lower density bridged structures as shown in (l). (a, b, d, e, g, h, j, k) 
Scale bars 25 µm. (c, f, i, l) Scale bars 500 µm. (a-l) Channels: cyan, cell nucleus; red, 
actin. (j-l) Channels: blue, polymer scaffold; cyan, cell nucleus; red, actin. Credits: 
Collagen I isolated from rat tail and generously donated by the Chun Lab at the University 
of Michigan. Pancreatic cancer cells generously donated by the Simeone Lab at the 
University of Michigan. 
 
3.4 Conclusions and Implications 
 
A successful 3D cell culture platform will aim to controllably supply cells with the 
environmental signals it would otherwise receive from the native cell niche in vivo. Of these, non-
soluble signals in particular are solely provided by the culture substrate or scaffold. In this regard, 
and considering that the primary purpose of a scaffold is to provide solid structure to the cell 
microenvironment140, the ECM is the key feature of the native cell niche to be recreated on a 
scaffold. Furthermore, for research purposes, a well-designed 3D culture system will offer a means 
to observe how cells are remodeling the ECM19, while preserving the biological activity of matrix 
proteins128. At the same time it should be easily handled, and remain amenable to standard culture 
and characterization techniques19, 24. We have found that gentle shearing (interface velocity: 10.4 
mm/s) of a concentrated pFn solution at the three-phase contact line defined by air, aqueous 
solution, and a tessellated scaffold comprised of 500x500 µm square pores can yield extended 
networks of fibrillar cFn. The ideal scaffold is characterized by a high percentage of open area i.e. 
the ratio of void to total volume. Large open areas not only allow cells to freely migrate and secrete 
their own ECM, but also limit interference from synthetic material on protein conformation, 
cellular function, and formation of cell-cell or cell-ECM contacts. ecFn had suspended within and 
across the square pores of the 3D jet writing scaffold irrespective of pore size (500 µm, 750 µm, 
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and 1000 µm pores tested). ecFn fibrils, like cell-secreted matrix, was characterized by a fibrillar 
architecture, resisted dissolution in detergent, and maintained expression of FnIII. Use of whole 
proteins in this system not only provided cells with non-soluble signals, but also made the protein 
matrix susceptible to remodeling and proteolysis as in the MDA-MB-231 human breast cancer 
culture. Such matrix remodeling was directly observable by microscopy as seen in the TC32 Ewing 
sarcoma cell culture. As will be seen in Chapter 4, supported ecFn is also readily applicable to 
other cell characterization techniques such as flow cytometry, and can be implanted into mice. 
These scaffolds are mechanically stable throughout long term cultures – at least six to eight weeks, 
as longer cultures have not yet been tested – and fit conveniently into a 24-well plate freely 
suspended off the plastic surface for a true 3D culture as opposed to a 2.5D culture. All in all, 
supported eECM advances current cell culture technologies towards greater physiological 
relevance, which is one step closer to ensuring that biological studies are not plagued by artificial 
cell behaviors in response to unintentional external signals. Patent protection has been filed for 
supported eECM, as it is a technology that may be crucial to more reliable cell-based outcomes in 
applications such as cancer biology, fundamental studies of both diseased and healthy states, and 
screening of pharmaceuticals where 3D cell culture has potential to bridge the gap between 
benchtop and animal experiments. 
Based on experimental observations, and a review of literature, the mechanism underlying 
hydrodynamically induced fibrillogenesis is hypothesized as a multi-step process. Submerging the 
scaffold fully into the pFn solution eliminates its contact with the air-solution interface failing to 
result in fibrillogenesis, but securing the scaffold at the interface under hydrodynamic shearing 
consistently induces fibril formation, suggesting that the air-pFn solution interface is required for 
this technique. We have seen in the literature that Fn molecules in a pFn solution forms a sheet of 
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aggregated protein at the air-pFn solution interface13. Interaction between the Fn and both the 
hydrophobic and hydrophilic mediums simultaneously is likely to destabilize the solubilized 
protein which is known to have a hydrophobic core consisting of FnIII which is surrounded by FnI 
and FnII domains4, 77, 102. Hence, the pFn at the interface is expected to have a more open structure 
than that of the bulk solution. Now, the destabilized pFn should require less force to achieve further 
extension and opening of the Fn molecule under applied tension or fluid shearing. As FnI domains 
initiate Fn-Fn interactions4, 107, and FnIII domains are revealed making more self-association sites 
available3, 4, 141, stretched Fn dimers are bound together to form multimers, resulting in the final 
fibril assembly96. Whether dimers are bound by non-covalent intermolecular interactions or 
covalent disulfide bonds is still unclear in the literature4, 91, 142. Although this process is largely 
described for Fn, it is possible that laminin may also undergo a similar process since its in vivo 
assembly within the basement membrane resembles that of Fn where cells assemble the protein 
via required integrin receptors and laminin self-interactions108, 143-146. 
The structure, and therefore function, as well as protein composition of the ECM varies 
depending on the tissue type and should be taken into consideration when recapitulating specific 
tissues on scaffolds22. Researchers need the ability to independently investigate the effects of 
various ECM compositions as the impact of non-soluble signals on cell response is increasingly 
realized across disciplines8, 18, 26, 30. Supported eECM is not limited to fibronectin alone, but 
includes collagen, laminin, and with minor protocol optimizations, can include other protein 
mediums such as Matrigel which is of particular interest to the cancer community. This gives 
researchers the ability to tune the composition of the protein microenvironment, either by addition 
of individual proteins, or combinations of proteins as seen with fibronectin and laminin or tenascin-
C. Hydrogels are commonly used to culture cells in vitro in a proteinaceous environment. 
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However, hydrogels lack mechanical stability, are difficult to handle and transfer, and are not 
easily adaptable to current cell characterization techniques. Additionally, hydrogels couple the 
support of a scaffold with protein composition, implying that if cells were to completely degrade 
the protein matrix, they would be left suspended in solution rather than adhered to a polymer 
scaffold as seen in the MDA-MB-231 human breast cancer culture example. Supported eECM also 
expedites cell expansion as was seen with the fibroblast culture on scaffolds either conformally 
coated with Fn or after hydrodynamically induced fibrillogenesis. Fibroblasts are able to use 
fibrillar suspensions of protein to access the large pores of the polymer scaffold providing 
extensive area for cell adhesion and proliferation. Rapid cell expansion is another advantage of 
supported ecFn, since shorter culture times are more conducive to aggregating results whether in 
a research context or precision medicine. The concept of cell migration along Fn fibrils has more 
recently opened a new focus area in the Lahann Lab where supported eECM is applied in a cell 
migration assay. Since the entire scaffold can be visualized, live cultures of fluorescent cells have 
been maintained under a microscope where migration of single cells and cells in bulk can be 
observed. Current technology for migration assays are largely limited to physiologically inaccurate 
platforms or 2D cultures147, bringing to light yet another possible commercial application of 
supported eECM that is currently under development by students in the Lahann Lab. 
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Chapter 4 
Engineered Fibronectin Networks Applied as a Cancer Microenvironment 
 
 
Some material from this chapter has been adapted with permission from the following 
manuscript in preparation:  
 
S. Ramcharan, L. Solorio, S. McDermott, A. Fox, J.H. Jordahl, C. Dunlay, M. Brown, A. 
Xiao, M. Wicha, G.D. Luker, J. Lahann. “Engineered 3D cellular fibronectin networks 
serve as bioequivalent breast cancer tumor microenvironments for patient derived cells” 
In Preparation. 
 
 
4.1 Introduction 
 
 4.1.1 The epithelial-to-mesenchymal transition (EMT) 
The dissemination of tumorigenic cells from a primary to a secondary tumor has been 
found to be accompanied by changes in phenotype between a proliferative epithelial state and a 
migratory mesenchymal state through a process known as the epithelial-to-mesenchymal transition 
(EMT) and its reverse, MET29, 148. Cells within the primary tumor proliferate until they undergo 
EMT and become ready to migrate29, 148. Upon reaching the metastatic site, these cells can remain 
dormant, undergo apoptosis, or resume a proliferative, tumor-forming state through MET29, 148. 
This phenotypic plasticity has been considered as a means by which a cancer may resist 
treatment149, 150. Several markers have been proven effective in identifying whether a cancer cell 
is of an epithelial or mesenchymal phenotype. CD44, a transmembrane hyaluronan receptor, is 
important to cell migration and cancer invasion as it functions in the degradation of hyaluronan149. 
CD44 is frequently employed as an EMT marker in cancers such as breast and colon149. Fibronectin 
and vimentin expressions are also increased in EMT149. If simultaneously expressed with a lack of 
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CD24, a CD44+ cancer cell is known to have self-renewal properties and is often considered a 
cancer stem cell (CSC) of a mesenchymal phenotype150. In fact, it has been hypothesized that EMT 
may be the mechanism by which differentiated cancer cells are converted into CSCs151. In breast 
tumors, the mesenchymal CSCs are largely found at the edge of the tumor where they can easily 
migrate away from the tumor and become invasive. The opposite phenotype, the epithelial CSCs 
are typically located within the central bulk of the tumor, and are positive for aldehyde 
dehydrogenase (ALDH)150. Although both the CD44+/CD24- and the ALDH+ phenotypes are 
considered tumor-initiating, cells expressing both phenotypes simultaneously were found to have 
the greatest tumor-initiating potential in a patient derived xenograft model152. In addition to strong 
implications in cancer metastasis, EMT also occurs in development153 and in the case of injury154. 
 
 4.1.2 Tumor-initiating cells and the pre-metastatic niche 
Amongst current breast cancer therapeutics are effective strategies against primary tumors, 
but little success has been realized in the prevention of recurrence or metastases. Several studies 
point to a particular subpopulation of cancer cells that have a unique tumor-initiating capability as 
a possible root cause of secondary tumor formation148, 155-157. This subpopulation, considered 
CSCs, is not targeted by conventional therapies150, 158, 159, and further understanding of the 
mechanisms underlying their role in tumor initiation is stunted by the lack of physiologically 
relevant in vitro models24, 156. As with cells in general, the surrounding microenvironment is a 
major regulator of CSC cell fate including self-renewal and differentiation potential160. One of the 
main challenges in cancer research is understanding what are the defining characteristics of the 
pre-metastatic niche, or a specific site within the target organ prepared for the invasion of migrating 
tumor cells and secondary tumor formation28, 132. The concept of a pre-metastatic niche has 
previously been metaphorically described through the soil-seed hypothesis where the niche acts as 
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soil, providing the appropriate microenvironment for the growth of the seeds, or invading tumor 
cells26. ECM composition, tissue stiffness, level of oxygen supply, soluble factors, and the 
assortment of stromal cells are just some features that may be tuned to make the pre-metastatic 
niche a suitable environment for the settlement of invading tumor cells and expansion of tumor-
initiating cells28-31. Fibronectin is a known pre-metastatic niche protein149, 161 and its expression 
has been shown to be upregulated in primary human breast cancer cells of the CD44+/CD24- 
phenotype162. It is the hope that supported eECM can provide a fully-defined in vitro 3D cell 
microenvironment with independently tunable properties for co-cultures of cancer cells with 
stromal cells, probing the effects of various ECM compositions, and possible future combination 
into a bioreactor system where supply of oxygen and soluble factors can be regulated. 
 
 4.1.3 Current in vitro cancer models and expansion of patient-derived cells 
Cancer research and drug screening has largely relied on the physiologically irrelevant 2D 
culture of cancer cell lines leading to results that cannot be directly translated to the treatment of 
cancer in vivo36, 163, 164. Each cancer cell line represents the genetics and biology of only a single 
patient, and even this is unreliable after years of preservation on 2-D plastic165, 166. Furthermore, 
these systems provide no way to accurately model key features of cancer such as metastasis, 
patient-to-patient variability, and inherent tumor heterogeneity165-167. In fact, Vargo-Gogola et al. 
refer to breast cancer as a “collection of diseases” arguing that the diversities observed in different 
breast cancers cannot be captured in a single model requiring a versatile “multi-system” 
approach168. Hence, the development of a cancer microenvironment that faithfully recreates the 
tumor biology of human patients remains a critical task. Towards this challenge, Chapter 4 
demonstrates the application of supported ecFn as a breast cancer microenvironment for cell lines 
and primary patient cells. 
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Tumor grafts are a major component of the current state-of-the-art for patient specific 
models, where tissues removed from a patient’s tumor are implanted in immune-deficient mice for 
cultivation165. In the event that a patient’s cancer cells are obtained from fluids such as a pleural 
effusion, these cells are instead injected into the xenograft166. However, this approach has endured 
extremely low grafting efficiencies, especially in the case of breast and prostate cancer due to the 
hormone dependency of these diseases165, 169; the difficulty in growing tumor grafts from estrogen 
receptor positive (ER+) breast cancers is widely known170 yet about 80% of breast cancers are 
ER+166. DeRose et al. demonstrated the highest currently known breast tumor take rate (the ratio 
of patient implants that formed tumors to all tumor grafts attempted) at 37% irrespective of 
receptor status (whether the cancer is positive or negative for ER, human epidermal growth factor 
receptor 2 or HER2, and progesterone receptor or PR)165. Despite the difficulty, developing 
patient-specific models is imperative, especially in the case of breast cancer, where the success of 
current therapies is largely stunted by the diversity of treatment responses observed in patients165, 
170 leading to an estimated clinical failure rate for new drugs of 90%165. Chapter 4 discusses an 
alternate approach to recreating patient-specific tumor samples ex vivo where rather than relying 
on a mouse to provide a culture microenvironment, supported ecFn is applied as a breast cancer 
microenvironment for expansion of patient-derived cells in vitro. 
 
4.2 Materials and Methods 
 
 4.2.1 Materials 
Triton X-100, Tox-8 mitochondrial activity kit, and 4’6-diamidino-2-phenylindole (DAPI) 
were purchased from Sigma Aldrich and used as received. Dulbelco’s Modified Eagle Medium 
(DMEM), non-essential amino acids (NEAA), antibiotic-antimycotic, and the following antibodies 
were purchased through Fisher Scientific and used as received: PE-EpCAM clone EBA-1 (BD 
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Bioscience, San Jose, CA), APC-CD44 clone G44-26 (BD Bioscience, San Jose, CA), PE-Cy7-
CD24 clone ML5 (Biolegend, San Diegeo, CA), mouse Pe-IgG1 clone X40 (BD Bioscience, San 
Jose, CA), mouse Pe-Cy7-IgG1 clone X40 (BD Bioscience, San Jose, CA), mouse APC-IgG1 
clone X40 (BD Bioscience, San Jose, CA), Biotin-CD45 clone HI30 (eBioscience, San Diego, 
CA), Biotin-HLA-DR clone LN3 (eBioscience, San Diego, CA), Biotin-CD14 clone 61D3 
(eBioscience, San Diego, CA), Biotin-CD31 clone WM59 (eBioscience, San Diego, CA), Biotin-
CD41 clone MEM-06 (Abcam, Cambridge, MA), Biotin-CD19 clone HIB19 (eBioscience, San 
Diego, CA), Biotin-CD235a clone HIR2 (eBioscience, San Diego, CA), Biotin-CD56 clone 
CMSSB (eBioscience, San Diego, CA), Biotin-CD3 clone UCHT1 (eBioscience, San Diego, CA), 
Biotin-CD16 clone eBioCB16 (eBioscience, San Diego, CA), Biotin-CD140b clone 18A2 
(Biolegend, San Diego, CA). Aldehyde dehydrogenase activity assay kit was obtained from 
Cayman Chemicals (Ann Arbor, MI) and used as received. 
 
4.2.2 Mouse breast cancer tumor engraftment assay 
All animal studies were approved by the University of Michigan Institutional Animal Care 
and Use Committee. Briefly, 6-8-week-old female C57BL/6J mice (Charles River Laboratories 
Inc., Wimington, MA) were anesthetized using 1-2% isoflurane at a flowing oxygen rate of 1 
L/min (EZ150 Isoglurane Vaporizer, EZ Anesthesias), and an incision was made to expose the 
mammary fat pad. AT-3 cells cultured on supported ecFn was placed directly into the fat pad5 and 
the incision was closed with wound clips. The number of AT-3 cells on the scaffold was verified 
using luminescence. 15 mg/mL D-luciferin was added to the cell medium at a ratio of 1:100 and 
incubated for 10 min before the relative light intensity was measured using a luminometer (Perkin 
Elmer MLD2300-000), and compared with a standard curve. Tumor engraftment was evaluated 
using bioluminescence imaging5. Tumor histology was evaluated by first fixing the tissue with 4% 
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formalin for 24 h. Then the tissue was prepared for histology by dehydrating in ethanol, sealed 
with paraffin, and sliced for staining with hematoxylin, eosin, and Masson’s trichrome.  
 
 4.2.3 Cell culture and characterization 
Breast cancer patient cell samples were seeded in 1 mL onto supported ecFn with square 
pores 500 μm wide at a concentration of 2x106 cells/mL. Cells were cultured in DMEM containing 
10% FBS, 1% NEAA, 2 mM L-glutamine, and 1% Antibiotic-Antimycotic. Cells were seeded and 
cultured in low adhesion 24 well plates (Corning Inc., Corning, NY) and maintained at 37˚C in 
5% CO2 as previously described. AT-3 mouse breast cancer cells, and human breast cancer cell 
lines T47D and Sum159 were firefly luciferase expressing. Proliferation was tracked over time by 
administering 15 mg/mL D-luciferin to the cell medium at a ratio of 1:100 and incubating for 10 
min before the relative light intensity was measured using a luminometer (Perkin Elmer 
MLD2300-000). The growth rate of the primary patient samples and the MDA-MB-468 cell line 
were evaluated by measuring changes in the mitochondrial activity using a resazurin based assay 
kit (Tox-8, Sigma Aldrich, St. Louis, MO) following the manufacturer guidelines. The initial 
signal was recorded after seeding, and then subsequent mitochondrial activity measurements were 
normalized to the initial time point. If cells were removed from supported ecFn to visualize the 
remaining protein matrix, samples were decellularized in a protocol adapted from Lu et. al.122. 
Samples were washed with PBS, then DI water, and immersed in a solution of 0.1% Triton X-100 
with 1.5 M KCl in 50 mM Tris buffer at 4ºC on a slow-moving shaker for two hours. Samples 
were washed in 10 mM Tris buffer, followed by DI water for one hour each. See Appendix A for 
detailed protocol. 
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4.2.4 Evaluating cell tumorigenicity by flow cytometry 
Cells were stained following a previously established protocol152, 157. Cells were removed 
using 0.25% trypsin, which was neutralized using a 3:1 volume of complete medium. Cells were 
then counted using a Luna-FL dual fluorescence cell counter (Logos Biosystems, Dongan-gu, 
Anyang-si, Gyueonggi-do, South Korea), and re-suspended in aldefluor buffer. Antibodies were 
added and incubated for 30 minutes, and then rinsed with aldefluor buffer. For primary patient 
sample analysis, the cells were first incubated in the lineage cocktail for 30 minutes, before staining 
for EpCAM, CD44, CD24, and ALDH activity. MDA-MB-468 cells were used to establish single 
color channels. Isotype controls were used to establish gating for the CD44, EpCAM, lineage- 
cells, and CD24152, 157. DEAB was used to establish gating for the aldefluor activity assay152. 
 
4.3 Results and Discussion 
 
 4.3.1 Improving mouse breast tumor engraftment efficiency 
Fibronectin is a major ECM protein of the pre-metastatic niche and has been identified in 
micro-metastasis17, 171, 172. As a validation of the bioactivity of supported ecFn, we investigated its 
potential to induce phenotypic changes by enhancing tumorigenicity in an established mouse 
breast cancer tumor graft model. AT-3 firefly luciferase expressing mammary cancer cells, a cell 
line derived from the primary mammary gland tumor of MMTV-PyMT mice5, were cultured on 
supported ecFn. After three days, the AT-3s formed 3D multicellular networks of cell-cell contacts 
(Fig. 4-1(a) and Fig. 4-2(a-b)) at large scale (Fig. 4-1(b)) and were still in a proliferative phase 
(Fig. 4-2(c)). Four groups of AT-3 cells were then orthotopically implanted across three 
immunocompetent C57BL/6 mice for tumor engraftment: (1) 30,000 cells on three-millimeter-
wide disks punched out of supported ecFn (2) 30,000 cells directly injected (3) 200,000 cells on a 
supported ecFn disk and (4) 200,000 cells directly injected. Group 4 is a positive control, being  
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Figure 4-1: Supported ecFn enhances tumor engraftment efficiency in a mouse breast 
cancer model (a) Representative 3D CLSM of AT-3 mouse breast cancer tissue formed in 
vitro after three days on supported ecFn. Section thickness is approximately 70 µm. Scale 
bar 25 µm. (b) Large scale view of AT-3 tissue cultured three days on supported ecFn as 
in a. Cells proliferate and fill the 3D space within the protein network across the scaffold. 
Scale bar 500 µm. (a-b) Channels: cyan, cell nucleus; red, actin. (c) Bioluminescence image 
of immune-competent mice showing tumor formation 21 days after AT-3 cells were 
orthotopically implanted (image exposure time 10 seconds). The two mice on the left have 
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had about 30,000 AT-3 cells on supported ecFn implanted into the mammary fat pads 
indicated by arrows (group 1). The right mammary fat pad received an injection of 
approximately the same number of cells in the area indicated by circles (group 2). The third 
mouse on the right is a positive control having received the group 3 supported ecFn in the 
left mammary fat pad (arrow), and the group 4 injection in the mammary fat pad on the 
right, each delivering 200,000 AT-3 cells. Previous studies have concluded that a minimum 
of 200,000 AT-3 cells are required for tumor formation by cell injection5. (d) Mason’s 
Trichrome staining of a tumor graft that formed after 21 days at the implant site of the 
group 1 30,000 AT-3 cells on supported ecFn; AT-3 cells invaded surrounding tissues. 
Scale bar: 25 μm. (e) Quantification of the CD29+/CD24+ cells identifying the AT-3 
population capable of self-renewal. Cells were cultured three days on TCPS, TCPS with 
fibronectin conformally adsorbed (Fn on TCPS), or supported ecFn. Single star indicates 
that the supported ecFn result is statistically different from TCPS and Fn on TCPS; double 
star indicates that TCPS and Fn on TCPS are statistically similar. P<0.05 (f) Quantification 
of the CD29+/CD24+/CD90.2+ AT-3 cells identifying the tumor initiating population after 
three days of culture on TCPS, TCPS with fibronectin conformally adsorbed (Fn on TCPS), 
and supported ecFn. Single star indicates that the supported ecFn is statistically different 
from TCPS and Fn on TCPS; double star indicates that TCPS and Fn on TCPS are 
statistically similar. Credits: The Luker Lab at the University of Michigan conducted all 
animal studies, and designed and contributed AT-3 cells to this collaboration. Flow 
cytometry done in the Wicha Lab at the University of Michigan. 
the minimum number of cells required to form a tumor by direct injection5. Pre-culture of cells in 
vitro on scaffolds has been shown to enhance cell delivery and engraftment compared to injection 
of free cells in myocardial tissue173, 174, and is essential in bone regeneration33. Injections of free 
cells173, 174 or hydrogel suspensions175 typically result in reduced cell survival, engraftment, and 
retention at the delivery site. Attributes of a successful cell-delivery vehicle include (1) high cell 
density (2) anchorage and integration into a protein matrix and (3) the provision of space for cells 
to spread into their natural morphology, form cell-cell contacts, and secrete endogenous matrix 
proteins33, 175, all features of supported eECM. 
Bioluminescence readings two days after AT-3 implantation indicated that group 1, 
supported ecFn carrying only 30,000 cells, had resulted in the start of tumor formation, whereas 
no signal was detected at the group 2 injection of an equivalent number of cells into the 
contralateral mammary fat pad (Fig. 4-3); this result remained consistent for the 21-day duration 
of the study (Fig. 4-1(c)). As expected, group 4 resulted in tumor formation in the positive control  
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Figure 4-2: Supported ecFn promotes a tumorigenic phenotype in AT-3 mouse breast 
cancer cells (a) LSCM of AT-3 mouse breast cancer cells at the crosshair of the scaffold 
microfibers after three days of culture on supported ecFn. (b) LSCM image after three days 
of culture showing (left) top view and (right) side view of the AT-3s forming multicellular 
structures as they span up into the open pore of the supported ecFn scaffold. (a-b) Channels: 
blue, polymer support; cyan, cell nucleus; red, actin. Scale bars 25 µm. (c) Growth curve 
for AT-3 cells cultured on TCPS (dotted line, criss-cross marker) or supported ecFn (solid 
line, square marker). (d) Quantification of the CD90.2+ population of AT-3 cells after three 
days of culture on TCPS, fibronectin conformally coated on TCPS (FN on TCPS), or 
supported ecFn. Single star indicates that the ecFn network result is statistically different 
from TCPS and FN on TCPS; double star indicates that TCPS and FN on TCPS results are 
statistically similar. P<0.05 Credits: The Luker Lab at the University of Michigan 
conducted all animal studies, and designed and contributed AT-3 cells to this collaboration. 
Flow cytometry done in the Wicha Lab at the University of Michigan. 
mouse, as did group 3, supported ecFn with 200,000 cells (Fig. 4-1(c)). In addition to improved 
tumor engraftment, this study demonstrates the cell-delivery capabilities of supported ecFn. We 
hypothesize that the in vitro formation of 3D cell-protein structures prior to implantation enables 
supported ecFn to serve as an effective cell delivery vehicle. We expect enhanced cell survival and 
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engraftment upon implantation since the cells have pre-formed a thriving tissue element. This is 
in contrast to injection of freely floating cells that may disperse from the target upon injection, fail 
to survive delivery, or fail to integrate into the existing matrix in the target area. The presence of 
the protein matrix on supported ecFn improves localization of cells within the scaffold and target 
implant region as previously reported in other systems176, 177. 
 
Figure 4-3: Supported ecFn shows successful tumor engraftment in AT-3 mouse 
breast cancer model throughout the course of three weeks Bioluminescence image of 
immune-competent mice two, seven, and 21 days after orthotopic implantation of AT-3 
cells. Four groups were examined: (1) 30,000 cells on three-millimeter-wide supported 
ecFn disks (2) 30,000 cells directly injected (3) 200,000 cells on a supported ecFn disk and 
(4) 200,000 cells directly injected as a positive control being the minimum number of cells 
required for tumor formation by direct injection5. The two mice on the left have group 1 in 
the left mammary fat pad as indicated by arrows and group 2 in the contralateral mammary 
fat pad on the right indicated by dashed circles. The third mouse on the right is a positive 
control carrying group 3 in the left mammary fat pad indicated by an arrow and group 4 in 
the contralateral right mammary fat pad. Exposure time for each bioluminescence image is 
indicated. Credits: The Luker Lab at the University of Michigan conducted all animal 
studies, and designed and contributed AT-3 cells to this collaboration. 
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Follow up histological analyses of tumor grafts resulting from group 1 implants of 
supported ecFn showed that AT-3 cells were of an invasive character as seen in Figure 4-1(d) 
where cancer cells are seen invading into the adjacent collagenous tissue. We further investigated 
the tumorigenicity of AT-3s cultured three days on TCPS, fibronectin conformally coated onto 
TCPS (FN on TCPS), or supported ecFn (Fig. 4-1(e-f) and Fig. 4-2(d)). The population of AT-3s 
positive for CD29 (β1 integrin) and CD24 (heat shock protein) retain their capacity for self-
renewal and tumor initiation178, 179; and was found to be significantly increased on supported ecFn 
relative to TCPS and FN on TCPS (Fig. 4-1(e)). Most of these CD29+/CD24+ cells were epithelial 
and metastatic in nature, being also positive for CD90.2 (Fig. 4-2(d))179-182. In fact, CD90.2+ 
marked the largest phenotypic difference between supported ecFn and TCPS or FN on TCPS; 
almost a 30-fold increase was observed for cells cultured on supported ecFn relative to TCPS (Fig. 
4-2(d)). Given the stark increase in tumorigenicity of the AT-3s on supported ecFn, we next sought 
to explore any similar effects on human breast cancer cells with the MDA-MB-468 cell line. 
 
 4.3.2 Enriching the tumor-initiating cell population 
The increased tumorigenicity observed in Figure 4-1(e-f) for the AT-3 mouse breast cancer 
cells after culture on supported ecFn was also seen for human in the triple negative breast cancer 
cell line, MDA-MB-468. Because of the low percentage of cells that express the mesenchymal 
CD44+/CD24- tumor initiating phenotype (less than 3%)156, 170, 183, MDA-MB-468s were selected 
as a model human cell line in which to observe upregulations in the mesenchymal population. 
MDA-MB-468s were cultured four days on supported ecFn, forming a microtissue across the 
entire volume of the polymer scaffold (Fig. 4-4(b) and 4-5(a)) and exhibiting extensive cell-cell 
and cell-Fn contacts (Fig. 4-4(a)). MDA-MB-468s were also cultured on TCPS, and Fn on TCPS. 
The CD44+/CD24- population was highest on supported ecFn with the most significant enrichment 
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on the sixth day (Fig. 4-4(c)). We also quantified the population positive for aldehyde 
dehydrogenase (ALDH), a known marker of mammary stem cells and epithelial-like proliferative 
behavior152, 156, 159, 170, that has been considered a superior indicator of tumor-initiating cells  
 
Figure 4-4: Supported ecFn increases the tumor-initiating population in MDA-MB-
468 human breast cancer cells (a) MDA-MB-468 breast cancer cells cultured four days 
on supported ecFn form cell-cell and cell-ECM contacts. Scale bar 25 µm. (b) MDA-MB-
468 cells form confluent volumes at large scale across supported ecFn scaffolds after four 
days. Scale bar 500 µm. (a-b) Channels: green, fibronectin; orange, laminin; cyan, cell 
nucleus; red, actin. (c-d) Population of MDA-MB-468s on supported ecFn (black solid line 
and square marker), TCPS (black dotted line and criss-cross marker), or fibronectin 
adsorbed conformally onto TCPS (grey line and triangular marker) that are (c) 
CD44+/CD24- and (d) CD44+/CD24-/ALDH+ measured over time via flow cytometry. The 
starred time point is statistically different from the other three time points within the 
supported ecFn dataset. Credits: Flow cytometry done in the Wicha Lab at the University 
of Michigan. 
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relative to CD44+/CD24- alone155, 159. Interestingly, after four days in culture, the difference in the 
ALDH+ sub-population was diminished between supported ecFn and TCPS or Fn on TCPS (Fig. 
4-5(b)) suggesting that the increasing CD44+/CD24-/ALDH+ trend shown in Figure 4-4(d) is 
largely driven by mesenchymal tumor-initiating cells. Furthermore, the MDA-MB-468 population 
expressing the epithelial cell adhesion molecule (EpCAM+) was greater than 99% for all three 
culture systems (data not shown). Taken together this data suggest that supported ecFn induced an 
epithelial to mesenchymal transition in the MDA-MB-468 cells. Further studies aimed at 
understanding the effect of supported ecFn on EMT/MET in breast cancer cells will look at 
additional human cell lines, such as the epithelial T47D and the mesenchymal Sum159 for any 
shifts away from the respective well-known characteristic phenotypes151, 153, 184, 185 (Fig. 4-6).  
 
Figure 4-5: Proliferation trends and ALDH expression for MDA-MB-468 cells are 
similar across different cell culture substrates (a) Normalized proliferation measured by 
net mitochondrial activity of MDA-MB-468 cells shows little to no difference amongst 
supported ecFn and control substrates despite observed changes in tumorigenicity. (b) 
Early timepoints show increased fractions of ALDH+ (aldehyde dehydrogenase) cells on 
supported ecFn relative to TCPS, and FN on TCPS, but ALDH populations across the three 
cell culture substrates converge and increase together from the fourth to sixth day in 
culture. (a-b) Supported ecFn (black solid line and square marker), TCPS (black dotted line 
and criss-cross marker), and TCPS conformally coated with fibronectin or FN on TCPS 
(grey line and triangular marker). Credits: Flow cytometry done in the Wicha Lab at the 
University of Michigan. 
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Figure 4-6: T47D and Sum159 human breast cancer cells proliferate on supported 
ecFn Normalized proliferation gives fold increase in cell number over the course of five 
days in culture on either supported ecFn (black solid line and square marker) or TCPS 
(black dotted line and criss-cross marker). Supported ecFn is able to support growth of 
human breast cancer cells as with (a) T47d and (b) Sum159 cell lines. As with MDA-MB-
468s in Figure 4-5(a), the growth profile on TCPS is similar to that of supported ecFn.  
 
 4.3.3 Expanding patient-derived cells and inducing EMT 
With the observed increases in tumor-initiating potential in the mouse AT-3 and human 
MDA-MB-468 breast cancer cell lines, we hypothesized that supported ecFn would provide 
patient-derived cancer cells a sufficiently tumorigenic environment to enable in vitro expansion. 
Malignant pleural effusion or ascites samples were collected from 14 women representing a 
diverse array of metastatic breast cancers (Table 4-1) and were successfully cultured on supported 
ecFn without prior fractionation (Fig. 4-7(a-c), 4-8(a-d)); of this 8 out of 12 were estrogen receptor 
positive (2 patients had unknown receptor status), a breast cancer subtype that is significantly less 
likely to form a tumor graft169, 170. All 14 patient samples proliferated on supported ecFn but not 
on TCPS or Fn on TCPS as represented in Figure 4-7(c) and Figure 4-10(b). Ki67 staining further 
confirmed that the cells were in a proliferative state150, 169 on supported ecFn but senescent on 
TCPS (Fig. 4-7(c)). This observed ability of supported ecFn to maintain cultures of cells that are  
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Table 4-1: Breast cancer patient data 
Patient* Sample 
type** 
Patient age Receptor 
status*** 
Detected metastases 
   ER PR HER2  
A - IDC AC 47    - - - Lymph node, Bone 
B - ILC AC 76    + + - Peritoneum, Bone 
C - ILC AC 54    + + + Peritoneum, Bone 
D - --- AC 73    ---- ---- ---- Renal, Omental, Peritoneum 
E - IDC AC 61    + + - Endometrial, Uterine cancer 
F - IDC AC 51    - - + Chest wall, Skin, Left axilla, Lymph 
node 
G - IDC PE 51    + + + Skin, Pleura, Bone 
H - IBC PE 44    - - + Pleura 
I - IBC PE 53    + + - Chest wall, Ovaries, Bone 
J - IDC, ILC PE 57    + - - Liver, Bone 
K - IDC PE 56    + + - Skin, Liver, Lung, Pleura, Lymph node 
L - IDC PE 42    + + - Leptomeningeal, Eye, Bone 
M - IDC PE 40    - - + Lymph node 
N - --- PE 62    ---- ---- ---- Bone 
*Patient: Patient sample as arbitrary letter name followed by cancer type. Invasive ductal carcinoma 
(IDC), invasive lobular carcinoma (ILC), inflammatory breast cancer (IBC) 
**Sample type: ascites (AC), pleural effusion (PE) 
***Receptor status: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 
receptor 2 (HER2) 
 
 
otherwise difficult to grow in vitro may be interpreted as another confirmation of superior 
physiological relevance compared to other cell culture substrates. A worthy direction of future 
study therefore is to apply supported eECM to the expansion of other cell types that are difficult 
to culture such as other primary cells186, 187, human embryonic stem cells188, and neurons189. 
Supported ecFn maintained cell proliferative capacity such that patient cell count had increased 7-
fold after eight days in culture (Fig. 4-7(c)). Patient samples could expand throughout the entire 
34.8 mm2 polymer scaffold in under 10 days (Fig. 4-7(b)). Rapid in vitro expansion of patient 
derived cancer cells either for achieving greater cell numbers or formation of a representative 
patient tumor graft ex vivo will prove advantageous in regards to precision medicine and quickly 
attaining personalized drug response results. Interestingly, Patient E cells (patient samples 
arbitrarily named) that were first cultured on supported ecFn for one day, removed and re-seeded  
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Figure 4-7: Supported ecFn enables expansion of patient breast cancer cells and 
enrich the tumor-initiating cell population in an epithelial to mesenchymal transition 
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(a-b) Supported ecFn maintains culture of heterogenous cell populations taken from Patient 
E ascites sample. LSCM volume views taken after four days of culture. Channels: cyan, 
cell nucleus; red, actin; yellow, cytokeratin 5. (a) 3D cell structures form within the pores 
and along the microfiber walls of the scaffold. Scale bar 25 µm. (b) Patient E cells fill 
supported ecFn scaffold at large scale across many 500 µm square pores. Scale bar 500 
µm. (c) Proliferation measured via mitochondrial activity for ascites sample from Patient 
A is far increased on supported ecFn (black solid line and square marker), with little to no 
growth on fibronectin adsorbed conformally onto TCPS (grey line and triangular marker), 
or TCPS (black dotted line and criss-cross marker). Inset shows representative images of 
Ki67 staining of Patient B cells cultured on either TCPS or supported ecFn. Darker color 
indicates that the cells are in a proliferative state on supported ecFn but senescent on TCPS. 
(d) Flow cytometry measurement of CD24 and CD44 in the ascites sample from Patient E 
where the original sample is shown in red and the same sample after six days of culture on 
supported ecFn is shown in blue. Original spread in cell phenotype concentrated towards 
CD44+/CD24- status after culture on ecFn networks. (e-h) Flow cytometry measurements 
of the percentage of lineage negative cells that are (e) CD44+/CD24- (f) EpCAM+ 
(epithelial cell adhesion molecule) (g) ALDH+ (aldehyde dehydrogenase) and (h) 
CD44+/CD24-/ALDH+ within ascites samples from Patients E and F, and a pleural effusion 
sample from Patient G. Grey bars represent the original patient sample and white bars 
indicate result after cells were cultured on supported ecFn in vitro for six days. Credits: 
Patient cells were obtained through the Luker Lab and Hayes Lab at the University of 
Michigan. Flow cytometry done in the Wicha Lab at the University of Michigan. 
onto TCPS, thrived on TCPS thereafter (Fig. 4-10(a)). Although further studies are necessary to 
understand this phenomenon, it leaves open the possibility for various uses of supported eECM in 
expansion and propagation of patient samples starting from a single tissue source. For example, 
supported eECM can provide a culture substrate where patient cells are directly seeded, expanded, 
and formed into a 3D tumor graft representative of a specific patient, as similarly done here. 
Alternatively, the supported eECM can act as a pre-culture system that first conditions cells from 
a patient’s body to make the transition to surviving on any other cell culture matrix of interest in 
vitro where it would otherwise be difficult to culture primary human cells. 
Supported ecFn enabled the co-culture of cell populations that were heterogeneous with 
respect to cell morphology or cytokeratin 5 (CK5) expression (Fig. 4-7(a) and Fig. 4-8(a-d)), and 
had increased specifically the number of cancer cells, represented by the lineage negative 
population, at least 7-fold relative to the original patient sample after only six days in culture (Fig. 
4-9(a)). This shift was also observed by microscopy as shown in Figure 4-8(d) where after five  
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Figure 4-8: Supported ecFn provide a microenvironment for the expansion of patient 
pleural effusion and ascites samples ex vivo while maintaining receptor status (a-c) 
Pleural effusion samples from (a-b) Patient I and (c) Patient H cultured on supported ecFn 
and imaged via LSCM showing heterogeneity, scalability, formation of 3D cell structures, 
and separation of cells by cell type into different areas of the same scaffold. (d) Population 
shifts in favor of cancer cells marked by cytokeratin in ascites sample from Patient J 
cultured either five days or ten days on supported ecFn. Representative LSCM images 
taken at the microfiber crosshair of the 3D jet writing polymer scaffold. (a-d) Channels: 
cyan, cell nucleus; red, actin; yellow, cytokeratin 5. Scale bar (a, c, d) 25 µm, (b) 100 µm. 
(e) Pleural effusion sample from Patient F was made into a cytospin, stained, and quantified 
for positive signals of human epidermal growth factor receptor 2 (HER2), estrogen receptor 
(ER), and progesterone receptor (PR). This analysis was performed on cells from the 
original patient sample (grey bars) and after six days of culture on supported ecFn (white 
bars). Hospital data reported that this patient’s receptor status was HER2+ER-PR-. Error 
bars represent standard deviation of % of receptor positive cells measured from three to 
four microscope fields of view. Credits: Patient cells were obtained through the Luker Lab 
and Hayes Lab at the University of Michigan. 
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days of culture, the CK5+ cells remained in small clusters. By day 10, CK5+ cells had increased in 
population and formed a cell network spreading into the open pores of the polymer scaffold. 
Different cell types were found to spatially separate on the same scaffold as seen in Figure 4-8(a) 
where CK5+ cells formed tight clusters on the supported ecFn while actin-rich cells of a spindle-
like morphology adhered first to the scaffold microfibers and proliferated outwards. Culture on 
supported ecFn inherently removed some cells such as platelets and blood cells which are non-
adherent. These results address several challenges typically faced in breast cancer cell culture. 
Firstly, as previously mentioned, the tumor microenvironment is largely composed of 
heterogeneous cell populations on both the cancer and stromal cell front. The culture of different 
cell types, i.e. co-cultures are known to be more challenging to maintain in vitro, however, 
supported ecFn has successfully expanded all 14 patient samples which always consist of a mixture 
of cell types. The large volume available for cell spreading allows cells to freely assemble into 
distinct 3D cell structures such as clusters or sheets, and to spatially segregate by cell type in 
different areas of the same scaffold. In regards to observing heterogeneity, supported eECM can 
be directly visualized by standard microscopy techniques (Fig. 4-8), or the cells can be removed 
and sorted by flow cytometry (Fig. 4-9). Secondly, as with any patient sample, there always lies a 
challenge in collecting sufficient amounts of material or being able to propagate patient material 
in vitro to have enough samples for experimental or patient treatment purposes. Although the 
amount of patient material collected in the pleural effusions and ascites was relatively substantial, 
the population of cells that are actually cancer can be far less than 5% (Fig. 4-9(a)). Supported 
ecFn helps in concentrating down patient samples to the cells of interest, in this case, the cancer 
cells, by inherently sorting out non-adherent cells through media changes and enriching the cancer 
cell population (Fig. 4-9(a)). This naturally occurring enrichment of the cancer cell population  
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Figure 4-9: Six-day culture on supported ecFn enriches breast cancer cell population 
in patient pleural effusion or ascites samples (a) Percent of total sample that are cancer 
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cells indicated by the lineage negative population as measured directly from the patient 
(grey bars) and after six days of culture on supported ecFn (white bars). (b) Percent of 
Patient E lineage negative cells that are ALDH+ (aldehyde dehydrogenase) after culture on 
supported ecFn or TCPS as compared to the original ascites sample. (c-e) Representative 
flow cytometry scatterplots for Patient E comparing the original ascites sample to cells 
cultured on supported ecFn for six days. The (c) CD24-/CD44+ (d) EpCAM+ (epithelial cell 
adhesion molecule) and (e) ALDH+ cells within the lineage negative population were 
quantified. Credits: Patient cells were obtained through the Luker Lab and Hayes Lab at 
the University of Michigan. Flow cytometry done in the Wicha Lab at the University of 
Michigan. 
after culture on supported ecFn requires future studies of shifting cell populations to be fully 
understood. Are the originally present cancer cells outcompeting the non-cancer cells and 
proliferating at a faster rate? Are the non-cancer cells proliferating more slowly or dying out? Does 
the presence of Fn, being a pre-metastatic niche protein, have any effect on how conducive the 
scaffold is to cancer cell growth and tumor formation?  
Having distinct receptor statuses, patient samples E, F, and G were selected to evaluate cell 
phenotype and tumorigenicity after a six-day culture on supported ecFn. As was seen with the 
MDA-MB-468s in Figure 4-4(c), within the patient cancer cell population, culture on supported 
ecFn enriched the mesenchymal self-renewing CD44+/CD24- subpopulation relative to the original 
patient sample (Fig. 4-7(e) and Fig. 4-9(c)). Shown in Figure 4-7(d), CD24 and CD44 expression 
was disperse across the original patient sample (red) but concentrated towards the CD44+/CD24- 
phenotype after culture on supported ecFn (blue). At the same time, the epithelial-like tumor-
initiating subpopulations indicated by expression of ALDH (Fig. 4-7(g) and Fig. 4-9(b,e)), and 
the overlapping immunotype CD44+/CD24-/ALDH+ (Fig. 4-7(h)) were maintained on supported 
ecFn relative to the original patient sample. A similar result was observed for the ALDH expression 
of the MDA-MB-468s in Figure 4-5(b). For comparison, while the population of ALDH+ patient 
cells was maintained on supported ecFn, after culture on TCPS it had dropped dramatically 
compared to the original patient sample. Finally, when present in the original patient sample, the 
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percentage of cancer cells expressing EpCAM dropped to nearly zero after culture on supported 
ecFn (Fig. 4-7(f) and Fig. 4-9(d)). As determined for the human breast cancer cell line, MDA-
MB-468, these results suggest that supported ecFn induced EMT in patient derived breast cancer 
cells. Still, despite this shift towards a mesenchymal character, the breast cancer receptor status of 
the original sample was maintained (n=1) (Fig. 4-8(e)). Maintaining patient receptor status is 
important to ensure that the ex vivo tumor graft accurately represents the cancer of the patient and 
allows for testing of hormone based therapies such as letrozole or lapitinib on supported ecFn.  
EMT has been linked to cancer metastasis, CSCs, and resistance to therapeutics and 
apoptosis, but much is still unknown regarding the relationships between these concepts and the 
governing cell/ECM mechanisms150, 153, 190. Chapter 4 has shown that supported ecFn has great 
potential to serve as a model in which to study EMT in vitro. Future studies will also explain some 
of the outcomes thus far observed such as the consistent increase in the mesenchymal stem-like 
cell population in the mouse AT-3s, the human MDA-MB-468s, and the patient derived breast 
cancer cells. Are the stem-like tumor-initiating cells seeded from the patient sample proliferating 
faster than the differentiated cancer cells? Or are the differentiated cancer cells de-differentiating 
on the supported ecFn contributing to the enriched tumor initiating cell population? In any case, 
the observed increase in tumor-initiating cell populations suggests another possible application of 
supported ecFn as a pre-culture system, where patient cells are first cultured for about a week, 
removed from the scaffolds, and flow sorted to collect a concentrated fraction of tumor-initiating 
cells. These tumor-initiating cells can then be expanded either directly on scaffolds, or injected 
into a mouse for xenograft formation. The odds of forming a patient derived xenograft (PDX) 
using this concentrated sample of tumor-initiating cells is expected to be significantly higher than 
the original patient sample as collected. Once grafts are developed, they can be serially propagated 
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to generate enough patient-representative samples for personalized or high-throughput drug 
screening, fundamental cancer biology studies, or patient prognoses. 
 
 
Figure 4-10: Patient ascites cells grow on tissue culture polystyrene if first expanded 
on supported ecFn (a) Ascites sample from Patient E cultured first on supported ecFn for 
two days then trypsinized and re-plated onto tissue culture polystyrene (TCPS) dish. (b) 
Brightfield microscope image of cells from the same patient sample as in (a) plated directly 
from the patient onto TCPS. Image taken after one day of culture showing cells do not 
survive. Scale bars 25 µm. Credits: Patient cells were obtained through the Luker Lab and 
Hayes Lab at the University of Michigan. 
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4.4 Conclusions and Implications 
 
Supported ecFn consistently increased the tumor-initiating potential across a mouse model, 
human cell line, and breast cancer patient samples. AT-3 mouse tumor engraftment efficiency was 
improved in parallel with an enrichment of the tumor-initiating population after in vitro culture. 
Notably, the three mice used for this study were mice were immunocompetent – a critical factor 
that is of increasing interest as we begin to understand the role of the immune system in tumor 
progression191. When cultured on supported ecFn for six days, primary human breast cancer cells 
from pleural effusions or ascites showed a distinct upregulation of the mesenchymal stem cell 
phenotype, CD44+/CD24-, which coincided with a downregulation of EpCAM, and maintenance 
of the ALDH+ population compared to the original sample. Cumulatively, these results 
characterize an epithelial to mesenchymal transition, thought to be a pathway for metastasis150. 
Therefore, one possible explanation of the elevated population of CD44+/CD24- cells present in 
the original patient sample is the cell source (Fig. 4-7(e)). All patient samples were collected from 
ascites or pleural effusions, in which case cancer cells have already migrated away from the 
primary breast tumor as if traveling to a metastatic site. Also, CD24 and CD44 have been shown 
in vitro to play a role in anchorage to several ECM proteins including fibronectin192, 193. Could 
integrin activation and cell signaling through CD44 impact cell behavior on supported ecFn? This 
possibility further reiterates the importance of using whole proteins rather than peptides in scaffold 
design and maintaining Fn in its extended state complete with exposure of critical binding sites for 
cell interaction. Going forward, supported ecFn may be used to unravel current uncertainties 
regarding the full effect of CD44, CD24, or ALDH expression on tumor cell behavior, 
understanding cancer cell dormancy, and in the search for additional markers of the tumor-
initiating phenotype. Therapeutic targeting of this elusive subpopulation of cancer cells will largely 
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benefit from a reliable set of identifying characteristics. In addition, as we move towards precision 
medicine, generating a tumor from patient-derived material alone is insufficient. To harness the 
true value of patient specific tumor models, patient cell phenotype must be conserved over time166. 
This implies that the tumor graft should maintain the gene and receptor expression,165, 170 drug 
response,166 and tumor-to-stroma ratios165 of the patient, and if grafted in a mouse, demonstrate 
metastasis to the same sites as those of the patient165. Future work will be aimed at determining 
the bioequivalency of patient tumor grafts generated on supported ecFn to the patient’s tumor. 
Here it has been showed for an n = 1, that the patient’s breast cancer receptor status is conserved 
after a six-day culture on supported ecFn (Fig. 4-8(e)). Therefore, it is hypothesized that the 
scaffold platform herein described reduces phenotypic drift, particularly given the minimization 
of interactions between cells and synthetic material, three-dimensionality, and native-like protein 
matrix.  
It is well known that extrinsic factors play a major role in modulating the phenotype and 
fate of both healthy1 and malignant cells194, 195. Time and resources poured into current cancer 
research can have a far bigger impact if a shift is made to a more physiologically relevant system 
in which environmental parameters can be independently varied; this would enable the decoupling 
of the vast array of cellular and acellular mechanisms underlying cancer32, 167. Studies have shown 
that varying the stiffness194 and both non-soluble196, 197 and soluble factors198, 199 within the cancer 
microenvironment results in cellular phenotypic changes and EMT. This goes beyond breast 
cancer. For example, in adenocarcinoma the specific combination of laminin and fibronectin are 
characteristic of metastatic sites whereas collagen I and IV are more prevalent within the primary 
tumor196. Looking to the future, 3D model microenvironments that faithfully recapitulate the key 
distinguishing features of breast and other cancers will be indispensable in the understanding of 
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metastasis, the identification of cells of a more stem-like or tumor-initiating phenotype, and the 
development of therapeutics and treatment strategies24, 167. Supported eECM can make a major 
contribution to this effort as further studies are done to demonstrate and characterize the capability 
of our scaffold platform to tune protein matrix stiffness, co-culture feasibility, and incorporation 
into bioreactor systems for complete spatio-temporal control. 
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Chapter 5 
Summary and Future Directions 
 
 
 
5.1 Summary 
 
As research shifts away from 2D monolayer cultures, we believe supported eECM is one 
potential solution to address the current need for a new standard, fully defined, 3D cell culture 
system. Supported ecFn has been shown to be a biophysically and biochemically relevant 3D cell 
microenvironment for maintenance of both immortalized and primary cells in vitro, and can serve 
as an implantable tissue engineering scaffold as shown in the AT-3 tumor graft assay. Furthermore, 
the polymer scaffold providing a skeletal structure to the supported eECM are highly tunable 
microfiber constructs fabricated by 3D jet writing. The composition and spatial positioning of each 
microfiber within the construct are now independently tunable properties due to the development 
of the manifold. Together, 3D jet writing, flow control as governed by the manifold, and the native-
like ECM produce a micro-manufacturing platform for customizable supported eECM with 
independently tunable properties. 
The innovation of the manifold has expanded the design space of electrospun fibers. Now, 
relative compartmentalization can be controlled within single fibers and 3D jet writing scaffolds. 
This means the user can dictate how much of each fiber surface presents a certain ligand, or what 
percentage of the bulk material is loaded with a biomolecule or composed of a faster degrading 
material. With the manifold, distinct domains can now be embedded within 3D jet writing 
scaffolds, establishing a complete micro-manufacturing system where different materials are 
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deposited within a single scaffold with spatial control. The applications of this capability are 
endless from cell and protein patterning to spatially targeted cell signaling. Finally, the manifold 
improves jet stability for co-jetting of dissimilar materials. With future work, the library of 
materials optimized to be processed into fibers and scaffolds will be expanded, further extending 
the design space of the synthetic component of supported eECM. Overall, the manifold affords 
intelligently designed, customizable scaffolds with high resolution control of all environmental 
parameters while allowing cells to redefine the cell microenvironment and create an in vitro cell 
niche that mimics the native cell niche as closely as possible.  
Many published studies where cell response is measured against an environmental factor 
must first begin not with the cell culture, but with inventing a 3D culture system that enables the 
researcher to toggle the environmental variable of interest. Not only can inventing a culture system 
pose major challenges such as fabrication and validation prior to conducting the intended cell 
work, but results in a lack of standardization in scientific reports across the biomedical community. 
TCPS remains a ubiquitous benchmark, serving at least as a control in many studies since it is the 
only in vitro culture platform that is widely known and well characterized. The need for a 
replacement that is mindful of the actual in vivo cell microenvironment is critical in order to more 
efficiently utilize resources and progress biomedical research. Reticker-Flynn et al. state that there 
is currently no satisfactory platform to specifically observe cell-ECM interactions in vitro16. 
Supported eECM can be scaled to fit the size of the polymer scaffold, can be made with less than 
5% by volume synthetic material, and unlike any other currently known 3D cell culture systems, 
presents protein in an insoluble fibrillar ECM-like network. Until now, such an in vitro culture 
environment has only been secreted by cells which limits matrix thickness, is bound to a hard 
substrate, and is compositionally undefined. This work reports on the first fully defined freely-
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suspended protein network manufactured in a cell-free system. The free suspension is key to 
maintaining three-dimensionality, ensuring that the scaffold is surrounded only by cell media when 
in culture rather than sitting atop a hard glass or plastic surface (i.e. 2.5D). Finally, cells are able 
to readily infiltrate the scaffold, tethering to and remodeling the protein matrix in vitro as it would 
the ECM in vivo. 
The general need for a physiologically relevant in vitro cell niche persists in bridging the 
gaps between benchtop, animal studies (particularly reducing the number of animals needed) and 
clinical trials for drug screening irrespective of the specific disease8, 200. In the case of cancer, 
tumor grafts can provide a thriving tissue sample representative of a human tumor for preclinical 
drug screening and development165, 169, to serve as a model for fundamental studies165, or as a 
platform for precision medicine170. Unfortunately, expanding patient-derived tumor cells ex vivo 
has been difficult whether in vitro in cell culture or in vivo as in a patient derived xenograft. 
Hypothesized to be due to the more native-like environment and presence of pre-metastatic niche 
protein fibronectin, supported ecFn has allowed for expansion of 14 out of 14 breast cancer patient 
samples collected from pleural effusions or ascites directly on the scaffold. Six-day culture 
enriched the mesenchymal self-renewing cell population while inducing a reduction in EpCAM 
indicative of a possible EMT. This ability of supported ecFn to enrich the tumor-initiating cell 
population was also seen in mouse and human breast cancer cell lines. These studies put supported 
eECM to extensive use in cell culture, serving as a further validation of its utility and commercial 
potential. Practicality must be considered if a 3D cell culture model is to be a competitive choice 
for widespread use in laboratories. Each polymer scaffold is made to fit into the well of a 24-well 
plate, secured to a metal frame with a spacer to keep it off the plastic surface. Supported eECM 
meets scaffold requirements as outlined in literature being biocompatible, biodegradable, easily 
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handled and transferred, transparent and amenable to current imaging and cell-based 
characterization techniques19, 46. It is the hope that future work will further develop and validate 
this platform technology as it moves towards realizing its commercial potential. 
 
5.2 Future Directions 
 
5.2.1 Expanding 3D jet writing material library and design space 
The ultimate goal of this work is to establish a fully functional cell culture system that can 
provide a vast array of independently tunable parameters which can be defined by the user as 
needed for a specific experiment or application. Our scaffolds can be decomposed into synthetic 
and biological elements: the polymer scaffold and the eECM respectively. As further work is done 
to give the user more freedom to assign values to each defining parameter within both elements, 
the more utility will be gained from our 3D cell culture model. This also creates a single controlled 
cell environment for investigation of the effect of nearly any parameter on cellular response rather 
than having to re-invent a new system for each different environmental condition of interest. Thus 
far, capabilities added to the existing 3D jet writing and EHD co-jetting systems include control 
of relative sizes of fiber compartments, elastic modulus of bicompartmental fibers, and deposition 
of distinct materials within certain domains of a microfiber construct. The next steps in developing 
the synthetic element within the supported eECM include expanding the library of possible 
materials, and demonstrating various applications of the capabilities newly established in this 
work. Currently, PLGA both with and without various functionalities is the least challenging 
polymer to process into micro- and nano-fibers whether by EHD co-jetting or 3D jet writing. In 
this study, PLCL was also optimized to co-jet with PLGA in a side-by-side configuration. What 
are the governing parameters that lead to a fluid jet sufficiently stable to produce fibers or 3D 
microfiber scaffolds without defects or unwanted surface features? Although this is a grander 
139 
 
challenge, it would be well worthwhile for expanding the polymer library to take a physical science 
approach to modeling and understanding how to intelligently design polymer solutions for jet 
stability. Typically, our polymers are dissolved in mixtures of solvents, where the ratio of one 
solvent to the others is determined through an experimental iterative process. Estimating viscosity, 
dielectric constant, volatility, and conductivity of solvent mixtures requires more than simply a 
weighted average of each individual solvent property, especially when polymer molecules are 
introduced to the solvent. 
As far as applications of the manifold-produced scaffolds, the possibilities are seemingly 
endless. Firstly, the use of biodegradable polymers in scaffold production opens an avenue for 
controlled release, much like soluble signaling in vivo, and degradation. With the manifold, various 
portions of the scaffold can be made to degrade at a faster or slower rate, either by patterning the 
faster and slower degrading material into distinct 3D domains or by modulating relative 
compartmentalization within each fiber. One could imagine a validation experiment where the 
tunability of fiber compartment size is directly proportional to degradation rate. A similar 
phenomenon has been previously reported for polymer particles201. The ability to controllably 
degrade or release a biomolecule of interest from the polymer scaffold would create another 
independently tunable environmental parameter. Thus far, microfibers with a core-shell 
architecture have been fabricated with a shell comprised of PLGA and a core loaded with stromal 
cell-derived factor 1α (SDF-1α) (Fig. 5-1). Secondly, the ability to pattern materials either within 
single fibers or 3D scaffolds thereby allows for patterning of surface functionalities. This would 
allow for tethering of certain ligands onto only designated areas or make cell and protein patterning 
possible across 3D constructs62. Thirdly, gradients across 3D scaffolds are now feasible, as was 
shown for two PLGA solutions carrying different tracer dyes in Figure 2-21. Future work 
140 
 
implementing such a gradient can be manifested in many ways such as increasing a non-fouling 
effect across the scaffold by PEGylation or changing the fiber elastic modulus. These 
developments would enable our 3D microfiber constructs to exhibit bulk materials, tethered 
ligands, or surface functional groups in a spatially designed manner, which can all be used to direct 
cell behavior much like cell signaling in vivo6, 7, 19, 49. 
 
Figure 5-1: Stromal cell-derived factor 1α (SDF-1α) loaded into core of core-shell 
PLGA microfibers SDF-1α-Cherry fluoresces red in the core of microfibers comprised of 
a PLGA shell labelled blue. (a) Volume view of aligned fibers collected on a rotating wheel 
during the electrospinning process. (b) Single fiber bundle collected on a rotating wheel 
indicating cross sectional views to emphasize the SDF-1α-Cherry core within the PLGA 
shell. All scale bars 25 µm. Credit: Fiber fabrication done by Gokcen Ukuser. SDF-1α-
Cherry generously donated by the Luker Lab at the University of Michigan. 
 
5.2.2 Confirming bioequivalency of supported eECM 
Supported eECM allows cells to enact behaviors that they typically would in vivo such as 
forming multicellular structures with many cell-cell contacts, and depositing and degrading ECM 
protein36. It has been shown that supported ecFn made it possible to culture breast cancer patient 
cells that do not thrive on TCPS. Furthermore, with less than 5% by volume being comprised of 
the polymer scaffold, the remaining volume is occupied by a protein matrix that mimics the 
architecture, detergent insolubility, and in the case of Fn, conformational state of native ECM. 
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Nevertheless it is a continuous effort, as ongoing and future experiments are carried out, to 
consider how supported eECM may be further validated for bioequivalancy to native ECM. For 
example, cell-cell and cell-ECM contacts can be quantified for cells cultured on supported eECM 
as compared to the corresponding protein hydrogel by identifying focal adhesions or adherens 
junctions (cell-cell contacts) and integrin activation due to protein binding. A gene array of cells 
cultured on supported eECM can also be compared to those cultured on TCPS and a decellularized 
matrix, where the decellularized matrix represents a physiological ECM. Finally, of course, the 
ability to culture other “hard-to-culture” cell types such as primary patient cells, neurons, and 
human embryonic stem cells will not only contribute new capabilities to the field, but also serve 
to further validate the physiological nature of supported eECM. 
 
5.2.3 Ex vivo patient-specific tumor grafts  
Without the risk of xeno-contamination, lower costs, higher-throughput, and having thus 
far a “tumor-take rate” of 100%, supported ecFn could provide not only a patient-specific tumor 
element, but by serial propagation, a more physiologically relevant model representing human 
patients at large for screening of pharmaceutical compounds; this could curtail the need for animal 
models8, 19. The next step towards this goal is to ensure that the tumor biology of the patient is 
accurately represented by the tumor graft formed on the scaffold. Here it was shown in Figure 4-
8 that the breast cancer receptor status was maintained on supported ecFn for a sample size of one 
patient; additional patient samples are needed in order to get a statistically significant result. While 
gene and protein arrays are the ultimate techniques for verifying the maintenance of patient 
phenotype, less costly approaches such as histology, flow cytometry, and polymerase chain 
reaction (PCR) can provide valuable information. Histology reveals cell morphology, tumor 
structure, and how stroma is integrated into the tumor169. Epithelial or mesenchymal phenotypes 
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can be quantified by PCR and flow cytometry. However, all of these techniques require access to 
patient specific data beyond receptor status. Any histology of an excised tumor could be used to 
compare to that of a tumor graft formed via supported eECM culture. Observed EMT or MET may 
be explainable by understanding the patient’s prognoses. Finally, knowing the patient’s response 
to various therapeutics will determine whether a similar response was observed when patient cells 
grown in vitro are exposed to the same drugs. 
 Aside from generating patient-representative tumor grafts in vitro directly on supported 
eECM, these cell microenvironments can alternatively serve as a pre-culture system. As shown, 
patient cells did not survive when directly seeded onto TCPS, but grew on TCPS after culture on 
supported ecFn (Fig. 4-10). Future work will determine whether this implies that patient samples 
which would not otherwise form a PDX or survive in vitro, are able to do so after a “pre-culture” 
on supported ecFn. It would also be interesting to investigate the mechanism by which supported 
ecFn is enabling primary cell growth ex vivo. Is it due to the observed enrichment in tumor-
initiating cells after culture on supported ecFn? Or are the cells better able to adapt to surviving ex 
vivo if first cultured on a more native-like ECM? After enrichment of the tumor-initiating cells on 
supported ecFn, a next logical step is to remove these cells, flow sort to obtain the tumor-initiating 
fraction, and either re-seed this fraction onto scaffolds for implantation in mice, or directly inject 
these cells into mice for PDX development. Once implanted, tumor take rate, tumor growth rate, 
serial transplantability, and maintenance of patient phenotype would be evaluated. If direct 
implantation of tumor-initiating cells on supported ecFn improves the odds of PDX formation 
relative to direct injection, this may serve as evidence of enhanced cell-delivery capabilities in 
support of hypotheses that cell integration into a matrix of cell-cell and cell-ECM interactions prior 
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to implantation increases cell survival after implantation and maintains cells until integration with 
surrounding endogenous tissue. 
 
5.3 Further Applications 
 
5.3.1 Cell response to varying protein matrix compositions 
In addition to expanding the array of possibilities on the synthetic front, future efforts to 
expand the protein library available for suspension on our 3D jet writing scaffolds will also aid in 
probing cell responses to certain protein matrix compositions and in modeling specific cell niches. 
For example, healthy mammary tissue growth is mediated by an ECM primarily composed of 
laminin-1, collagen IV, and nidogen29, therefore a scaffold that mimics mammary epithelia should 
include these three proteins. Much of cancer research involves culture on a basement membrane 
extract known by the trade name Matrigel, making this protein mixture an important addition to 
the scaffold protein library for future cancer studies. In fact, utilizing supported eECM to further 
understand EMT is a major application of interest going forward. In Chapter 4 it was shown that 
supported ecFn appeared to be inducing an EMT for mouse and human cell lines, and primary 
patient cells. What are the mechanisms underlying this shift in phenotype? Does the protein 
composition play a role? Shown in Figure 5-2, for cultures of the MCF7 human breast cancer cell 
line on supported eECM, laminin resulted in an increase in the ALDH+ population at 2.34% 
relative to fibronectin at 1.48%; cultures on supported eECM were also imaged for differences in 
cell morphology. This agrees with a previously done study showing laminin-1 promoting E-
cadherin expression, indicative of adherens junctions formation connecting neighboring cells, 
implying an epithelial phenotype29. Another cell type, Sum159, showed a unique affinity towards 
fibronectin where from day one of culture, cells seeded preferentially on the ecFn in the pores of 
the polymer scaffold where they proliferated to form thicker volumes by the fourth day of culture  
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Figure 5-2: MCF7 breast cancer cells show increased ALDH positive population when 
cultured on supported eECM of laminin relative to fibronectin (top) ALDH expression 
increased from 1.48% on fibronectin to 2.34% on laminin for MCF7 human breast cancer 
cells cultured on supported eECM. (bottom) MCF7 human breast cancer cells cultured 10 
days on supported eLAM and imaged in an area of (a) high cell density and (b) low cell 
density. MCF7s were also cultured 10 days in parallel on supported ecFn and imaged in an 
area of (c) high cell density and (d) low cell density. (a-d) Scale bar 25 µm. Cell nucleus 
in cyan, and actin in red. Credits: Flow cytometry done in the Wicha Lab at the University 
of Michigan. 
145 
 
(Fig. 5-3). This is in stark contrast to nearly every other cell type thus far observed where cells 
first anchor to the microfibers and over time migrate into and proliferate within the ecFn-rich 
pores; the result shown in Figure 5-3 also reiterates the benefit of a scaffold with large open area. 
Future work with Sum159s may seek to investigate if this cell type has a similar affinity to proteins 
other than Fn. 
 
Figure 5-3: Sum159 human breast cancer cells show strong affinity towards 
fibronectin immediately upon seeding Sum159 human breast cancer cells preferentially 
seeded onto supported ecFn within scaffold pores rather than the polymer microfibers. 
Cells formed thick volumes within the pore by the fourth day in culture. Volume thickness 
reduced in areas on or near the polymer microfibers. This is a phenomenon was uniquely 
observed with this cell type. Scale bars 100 µm.  
Still, to better understand the effect of the microenvironment on shifts between epithelial 
and mesenchymal phenotypes, additional readouts are necessary. For example, markers other than 
CD24, CD44, and ALDH have been used to identify mesenchymal or epithelial phenotypes (Table 
5-1). Of these, matrix metalloproteinase 2 (MMP2) was briefly considered for its role in the 
behavior observed of MDA-MB-231 human breast cancer cells on supported ecFn. Illustrated in 
Figure 3-18 and 3-19, these cells may be undergoing EMT as they transition from a proliferative 
phase to a state where most of the cells have migrated off the scaffold remaining 98% viable in 
solution. In support of this hypothesis, MMP2 was not expressed in 231s at early timepoints, but 
146 
 
did appear at the 10th day in culture (Fig. 5-4). However, E-cadherin was constantly expressed 
(Fig. 5-4). Future work in understanding 231 behavior on supported ecFn will seek to elucidate 
whether this system serves as a true model of metastasis. As done in this brief study and a previous 
study in colon cancer149, epithelial markers such as E-cadherin should be analyzed in parallel with 
mesenchymal  
Table 5-1: Epithelial to mesenchymal transition markers of interest 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
markers such as N-cadherin. In the 231 study, EMT markers should be analyzed at initial seeding, 
middle of the culture, end of the culture when cells migrate off, and migrated cells should be re-
seeded onto a second scaffold to see whether these cells invade the new environment, reverting to 
an epithelial phenotype as they “form the secondary tumor.” Repeating this series of experiments 
with different protein compositions will shed light on the role of fibronectin in what may be a 
metastatic process. Finally, beyond quantification of various EMT markers, supported eECM 
allows the investigator to observe the physical proteinaceous microenvironment. Observation of 
how cells are degrading protein, or reconfiguring protein conformation can reveal how motile a 
cell is, or what kind of cell niche it is creating. Recent work in the Lahann Lab has led to 
fluorescently labelled Fn, which is then processed into supported ecFn to create an inherently 
fluorescent protein network. Future developments can take advantage of FRET (fluorescence 
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resonance energy transfer) to get a fluorescent indication of cell-induced changes in Fn 
conformation12, 202, 203. Lastly, the versatility of supported eECM is extended theoretically to 
cultures of all adherent cells. Figure 5-5 shows that these cancer studies need not be limited to 
breast cancer. Pancreatic cancer cells, including a patient-derived cell line, have been successfully 
expanded on supported ecFn. 
 
Figure 5-4: Matrix metalloproteinase expression increases at a later timepoint in 
MDA-MB-231 culture when cells have migrated off the scaffold remaining viable in 
solution Matrix metalloproteinase 2 (MMP2) was quantified alongside E-cadherin for 
MDA-MB-231 human breast cancer cells on supported ecFn. MMP2 indicates proteolytic 
activity characteristic of invasive cells and a mesenchymal phenotype. E-cadherin 
expression results from formation of cell-cell contacts, known to be downregulated in 
EMT. 
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Figure 5-5: Study of EMT and MET is not limited to breast cancer – cells cultured on 
supported ecFn for a pancreatic cancer model system (a) ASPC1 pancreatic cell line, 
mesenchymal by nature and (b) UM53 patient-derived pancreatic cells, epithelial by nature, 
at a low cell density area of the scaffold showing how cells proliferate and shirt off the 
polymer microfibers and into the open pore areas at the six-day culture timepoint. Large 
scale scaffold at low magnification showing (c) ASPC1 after four days and (d) UM53 after 
two days of culture on supported ecFn. (e) Zoomed in view showing individual cells from 
(c). (f) Zoomed in view showing individual cells from (d). (a-b, e-f) Scale bars 25 µm. (c-
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d) Scale bars 500 µm. Cell nucleus in cyan, actin in red. Credits: Pancreatic cancer cells 
generously donated by the Simeone Lab at the University of Michigan. 
 
 5.3.2 Cell-sheet stacking and co-cultures 
The need for flexibility in scaffold ECM composition was demonstrated in Figure 3-26 
where human umbilical vein endothelial cells (HUVECs) showed very minimal adhesion to 
supported eECM of laminin or fibronectin, but when cultured with both proteins combined, the 
HUVECs were able to adhere and proliferate, even forming possible lumen-like structures (Fig. 
5-6). HUVECs and other endothelial cells are of great interest with respect to vasculogenesis. In 
an ongoing collaboration with the Levenberg Lab (Technion Israel Institute of Technology), 
growth of human adipose microvascular endothelial cells (HAMECs) is supported by a co-culture 
system with human dermal fibroblasts (HNDF) on either supported ecFn or Fn conformally coated 
onto 3D jet writing scaffolds (Fig. 5-7). Next steps involve determining how to quantify 
differences in structures formed by the HAMECs in order to identify the microenvironmental 
conditions (stromal cell and protein) that best support formation of tubules or cell alignment. 
Vasculogenesis is becoming increasingly important with the growth of the tissue engineering 
field204. Diffusion limitations in thick engineered tissues can be overcome by functioning 
vasculature. Supported eECM is easily amenable to cell-sheet stacking, or the culture of different 
cell types on independent scaffolds that are then “sandwiched” together to form a thicker 3D co-
culture. Stacking sheets of fibroblasts and endothelial cells has proven effective in promoting 
vascularization as well as the introduction of angiogenic factors204-209. Future directions may entail 
similar sandwiching of sheets of endothelial cells between sheets of fibroblast first individually 
cultured on supported eECM. 
Establishing a native-like ECM is crucial for creating an in vitro cell niche for the study of 
cancer, EMT, and other areas. Still, physiologically, much of cell signaling is derived from other 
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cells. Future application of supported eECM will incorporate co-cultures of both cancer cells and 
stromal cells. An early attempt at a co-culture of NIH-3T3 mouse fibroblasts with GFP-MDA- 
 
Figure 5-6: Supported eECM provides cells large open area for formation of 3D cell 
structures demonstrated by endothelial cells (a) HUVECs (human umbilical vein 
endothelial cells) starting to branch out into the center of the scaffold pore. (b) Area of 
scaffold showing higher cell confluency as opposed to low cell density areas shown in (c) 
and (d) where formation of tubular structures are more easily visualized. All scale bars 25 
µm. All supported eECM comprised of fibronectin and laminin. Cells cultured one month. 
Cell nucleus shown in blue; actin shown in green. 
MB-231 human breast cancer cells was done in a similar fashion to the stacking of cell sheets seen 
in the literature for vasculogenesis. Three supported ecFn scaffolds were prepared, two were used 
for fibroblast culture, and the third for 231s. The 231s were sandwiched between the two fibroblast 
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sheets. Imaging was done on a confocal microscope in an attempt to visualize the three sheets of 
cells, however distinguishing individual cell types was difficult, and the thickness of the three 
scaffolds combined far superseded the imaging depth afforded by the microscope working distance  
 
Figure 5-7: Supported ecFn demonstrates potential for vasculogenesis in a co-culture 
system of endothelial cells and fibroblasts HAMEC (human adipose microvascular 
endothelial cells) and HNDF (human dermal fibroblasts) cultured on (a) supported ecFn 
and (b) 3D jet writing scaffolds coated conformally with Fn. (a) Both cell types seeded 
onto scaffold at the same time. Image taken after 14 days of co-culture. Scale bar 100 µm. 
(b) HAMECs seeded first onto scaffold and cultured three days before HNDFs were 
seeded. Image taken after eight days of co-culture or 11 days of total culture time. Scale 
bar 200 µm. Endothelial cells (HAMEC) in green, and fibroblasts (HNDF) in red. Credits: 
Fabrication of 3D jet writing scaffold done by Lahann Lab at University of Michigan. All 
other procedures including protein deposition, cell culture, and imaging done by Ariel 
Szklanny of the Levenberg Lab at Technion Israel Institute of Technology.  
(Fig. 5-8). When repeating this study in future, confluency of individual cell sheets at the time of 
stacking, and a histological protocol for imaging should be considered. Furthermore, this study 
combined mouse fibroblasts with human cancer cells. Future work should look to more applicable 
stromal cell populations, including an analysis of the impact of stromal fibroblasts obtained from 
healthy patients in contrast to breast cancer patients (Fig. 5-9). Stromal cells are a necessary 
component in modeling the breast cancer cell niche and should be considered for supported eECM 
cultures going forward. Previous studies have recapitulated mammary tissue using healthy patient 
fibroblasts, HUVECs, and the breast cancer cell line MCF10 where the addition of HUVECs 
induced an invasive cancer cell phenotype210. In other systems, contact with stromal fibroblasts 
increased MMP expression30 and invasive potential211 in malignant cells. In fact, oncogenic signals  
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Figure 5-8: Co-culture of fibroblasts and human breast cancer cells by layering three 
scaffolds (a) Full top view of three scaffolds stacked onto one another. The two outer 
scaffolds were seeded with NIH-3T3 mouse fibroblasts, which should appear blue under 
the nuclear stain. The center scaffold carries GFP-MDA-MB-231 human breast cancer 
cells which fluoresce green but also contain a red stain for cytokeratin. Scale bar 500 µm. 
(b) Zoomed in angled and side view of scaffold stack shown in (a) at a depth of only 53 
µm which does not encompass the entire thickness of the sample. All cells are marked in a 
blue nuclear stain, while the cancer cells are labelled in both green and red (GFP and 
cytokeratin). All cultures done on supported ecFn. Scale bar 25 µm. 
from tumor derived fibroblasts can change non-malignant epithelial cell populations to malignant 
resulting in tumor progression8. Consulting published studies such as these for guidance on future 
experiments using supported eECM is sure to reveal new information on the effect of various 
stromal populations on cancer cell behavior. Thus far, we have observed the self-assembly of 
T47D breast cancer cells and NIH-3T3 fibroblasts into segregated structures when co-cultured at 
a ratio of 4:1 on supported ecFn at both a five-day and 10-day timepoint (Fig. 5-10). Although the 
T47Ds had formed a confluent volume of cells on the scaffold at five days, by the 10th day, they 
had largely migrated off the scaffold. Any remaining T47Ds on the scaffold by the 10th day had 
also experienced a loss of EpCAM expression. These observations are a start towards future work 
in co-cultures of cancer and stromal cells on supported ecFn. 
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Figure 5-9: Expansion of fibroblasts from healthy and breast cancer patients on 
supported ecFn Fibroblasts obtained from either human breast cancer patients (a) or 
healthy patients undergoing breast reduction surgery (b) were expanded on supported ecFn. 
Future studies on the effect of stromal cells on tumor progression will consider use of these 
cell types. Blue channel marks the cell nucleus, green channel indicates actin. Credits: All 
cells generously donated by the Wicha Lab at the University of Michigan. 
 
 
 
Figure 5-10: Segregation of cell types in co-culture of T47D human breast cancer cells 
with mouse NIH-3T3 fibroblasts on supported ecFn Five and ten day timepoint of a co-
culture of human breast cancer cells of the T47D cell line with mCherry (red) with mouse 
GFP-NIH-3T3 fibroblasts (green) at a seeding ratio of 4:1. The segregation of the two cell 
types is evidenced in these live culture images of a cross sectional view (left) and volume 
view (right). Scale bars 30 µm. 
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Appendices 
Appendix A: Decellularization Protocol 
 
 
 
Decellularization (adapted from Lu et. al. 122) 
For the gentle removal of cells adhered to a substrate or protein matrix 
1. Prepare 50 mM Tris buffer 
2. Use the 50 mM Tris buffer as your solvent to prepare a 1.5 M KCl solution 
3. Prepare 0.1% Triton X-100 (TX100) solution using the 1.5 M KCl solution you prepared in 
step 2 as your solvent. You should now have a solution of 0.1% TX100 with 1.5 M KCl in 50 
mM Tris buffer. 
4. Starting with live cells on the substrate, wash with PBS, then DI water 
5. Immerse the sample in the 0.1% TX100 with 1.5 M KCl in 50 mM Tris buffer solution at 4ºC 
on a slow moving shaker. The original protocol suggested 6 hours for this step, but I have used 2 
hours for cells cultured on glass. The thicker the sample, the longer the time needed immersed in 
solution. 
6. Wash in 10 mM Tris buffer for 1 hour. This step can go for up to 3 hours if needed. 
7. Wash in DI water for 1 hour. This step can go for up to 3 hours if needed.  
 
Cells are now removed. The remaining protein matrix can be used for subsequent culture, or 
fixed and visualized directly. 
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Appendices 
Appendix B: Dehydration Protocol 
 
 
 
Dehydration of cell or protein based samples for imaging under vacuum 
1. Rinse sample in PBS and fix (typically in formalin)  
2. Wash 3x with PBS 
3. Soak in ethanol solutions for 20 minutes in each solution: 
30%, 50%, 70%, 90% 95%, 100%, 100% (percentage of ethanol, the rest is DI water) 
4. Put sample into a microcentrifuge tube with enough tertbutanol to cover it. 
(Tertbutanol may have to be warmed in order to flow as liquid. Immerse the bottle in warm to 
hot water for a couple of minutes.) 
5. Close the microcentrifuge tube and submerge in liquid nitrogen for 2 minutes. 
6. Open the tube, and immediately put in the lyophilizer overnight or until ready to image. 
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Appendices 
Appendix C: Preparation of supported protein networks 
 
 
 
Fibronectin 
Materials 
• Corning, Fibronectin, Human, 5mg (356008) 
https://catalog2.corning.com/LifeSciences/en-
US/Shopping/ProductDetails.aspx?categoryname=&productid=356008(Lifesciences) 
• Gibco DPBS, Calcium and Magnesium free 
• N45 Neodymium 1/4"x1/8"x1/16" Rare Earth Magnets 
http://www.magnet4sale.com/n45-neodymium-magnets-1-4x1-8x1-16-rare-earth-
magnets/ 
• Rubber bands: Neon Latex Orthodontic Elastics - 4.5 oz 1/8" - Medium Pull 
http://www.dentalcorp.com/elastomerics/latex-orthodontic-elastics.html 
• Biotix Microcentrifuge Tube: VWR Microcentrifuge Tube with X-Resin™ 2 mL Clear 
Nonsterile 89511-266 
https://us.vwr.com/store/catalog/product.jsp?catalog_number=89511-266 
• Incubator and rotisserie rotator for microcentrifuge tubes that fits inside incubator 
• Rough or porous support (referred to as “support”) 
• Metal Frames washed in soap and bleach after custom fabrication by Microphoto, Inc 
(Roseville, MI) depicted below: 
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Figure C-1: Dimensions of metal frame used to secure polymer support in 2-mL tube 
during hydrodynamically induced fibrillogenesis or cell culture in 24-well plates. 
 
Method 
Aliquot 
1. Chill DPBS until cold and keep on ice for aliquotting. 
2. On ice, add DPBS to fibronectin bottle as commercially obtained to achieve a concentration of 
1 mg/mL. Gently rotate commercially obtained bottle until all protein is dissolved.  
3. Aliquot 100 uL of protein solution into non-fouling 2 mL microcentrifuge tube. Keep all 
solutions on ice for duration of aliquotting.  
4. Store aliquots at -20°C. 
 
Mount Supports into Frames 
1. Sterilize frames by spraying with ethanol. Holding support with fine tip tweezer, lightly spray 
support with 70% ethanol on both sides to sterilize. The support is easier to mount in frames 
when support and frames are damp. Each support requires two frames (so that support is 
sandwiched in between). 
2. Lay one frame down on sterile surface. Place support, while damp, onto frame such that 
support is aligned with open square area. Using fine tip tweezer, place second frame on top to 
evenly sandwich support in between.  
3. To secure support between frames, place rubber band within grooves on the two ends of the 
frames. Fine tip tweezers are helpful, but there are various ways to achieve this mount. Be sure 
that the support does not shift as you are placing the rubber bands. Also, do not apply too much 
pressure on the frames while the support is in between as this may cut the support or sever the 
fibers. 
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Process: Forming Protein Network on Supports 
1. Thaw one 100 uL aliquot at 4°C for 10-15 minutes or until thawed. Each support requires one 
aliquot. 
2. Add 800 uL of DPBS (Calcium and Magnesium free) to each thawed aliquot without allowing 
the pipette tip to touch the fibronectin. Do not pipette up and down. You don’t want to lose 
protein through adsorption to the inside of the pipette tip. 
3. Gently rock the tube and rotate the tube by hand to ensure the solution is freely flowing under 
rotation in all directions. Be sure that all surfaces within the microcentrifuge tube are able to be 
wetted by protein solution. When tilting the tube in any direction, the solution must flow from 
one end to the other. Flicking the tube may also be helpful. Avoid bubbles as much as possible. 
4.  Place framed support (previously mounted in frame in earlier steps) into protein solution and 
close tube. Make sure the support and frame has completely air dried of ethanol. Flick tube to 
remove any bubbles that form within support pores. Again, avoid bubbles as much as possible. 
5. Place magnet onto side of tube. Holding the tube vertically, slide the magnet up and down the 
outer side of the tube until the middle of the support frame is aligned with air-water interface. 
Turn tube on its side, and make sure that the support frame is level and at the center of the tube. 
Secure magnets with tape to hold support frame in this position. 
6. Mount tubes onto rotator such that the tube tumbles end-over-end at 8 full rotations (360° of 
rotation) per minute. See image for detailed illustration on support orientation with respect to the 
tube and rotator. Green circles indicate proper position. Red cross-outs show incorrect position. 
7. Tumble supports on rotator for 2 hours at 30°C. 
8. Remove protein solution. Rinse three times with DPBS. Store protein supports in DPBS in 
microcentrifuge tube at 4°C. Use within 1 week. 
Troubleshooting 
• If the cFn network is not uniform, the support was not level 
• If the support tears, too much pressure was applied when support was placed in between 
the frames 
• If little or no cFn fibrils form, the support was not at the air water interface 
 
 
 
Laminin 
 
Materials 
• Same as supplies listed for fibronectin, now with laminin instead of fibronectin:  
Mouse Laminin: Life Technologies 23017-015 (comes as a liquid) 
https://www.thermofisher.com/order/catalog/product/23017015 
• Locite super glue (liquid, not gel): Super Glue Longneck Bottle from Loctite Adhesives 
http://www.loctiteproducts.com/p/4/2/sg_bottle/overview/Loctite-Super-Glue-Longneck-
Bottle.htm 
• Deionized Water (DI Water) 
 
Method 
Aliquot 
1. Aliquot 300 uL of laminin solution into non-fouling 2 mL microcentrifuge tube. Keep all 
solutions on ice for duration of aliquotting.  
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2. Store aliquots at -20°C. 
 
Mount Supports into Frames 
1. Sterilize frames by spraying with ethanol. Holding support with fine tip tweezer, lightly spray 
support with 70% ethanol on both sides to sterilize. The support is easier to mount in frames 
when support and frames are damp. Each support requires two frames (so that support is 
sandwiched in between). 
2. Lay one frame down on sterile surface. Run a line of Locite super glue around the outer edge 
of the square opening of the frame. Place support onto the frame such that support is aligned with 
open square area. Make sure the edges of the support are well wetted in the line of super glue. 
Using fine tip tweezer, place second frame on top to evenly sandwich support in between.  
3. Allow super glue to cure for 30 minutes, fixing the support in between the frames. Do not 
apply too much pressure on the frames while the support is in between as this may cut the 
support or sever the fibers. 
4. Rinse the mounted support three times for 10 minutes each in DI water.  
 
Process: Forming Protein Network on Supports 
Same as steps listed in Procedure for fibronectin except in steps 1-2 add 700 uL of DI water (not 
DPBS) to the 300 uL aliquot. Also, in steps 7 and 8, incubate for 2 hours at 26°C (rather than 
30°C). After incubation, wash three times with DI water rather than DPBS. Store laminin meshes 
in DI water at room temperature rather than at 4°C since colder temperatures cause the laminin to 
resolubilize.  
 
Troubleshooting 
Same as steps listed in Procedure for fibronectin. 
 
 
Collagen I 
 
Materials 
• Same as supplies listed for fibronectin, now with collagen I extracted from the tail of a rat 
• 33 mM Acetic Acid 
• 0.34 N NaOH 
• DMEM (as purchased, without additives such as serum) 
 
Method 
Prepare Collagen Stock Solution and Aliquot 
1. Weigh a clean 50 mL falcon tube 
2. Add lyophilized Rat Collagen Type I to tube 
3. Re-weigh the tube that now contains the Collagen 
4. Add 33 mM acetic acid to collagen for a final collagen concentration of 2.7 mg/mL 
5. Stir at 4°C until fully dissolved (2-7days). Store at 4°C until use. 
6. Use directly from this stock, or create 900 uL aliquots in microcentrifuge tubes.  
7. Store stock solution or aliquots at 4°C.  
 
Mount Supports into Frames 
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Same as steps listed in Procedure for fibronectin. 
 
Process: Forming Protein Network on Supports 
Same as steps listed in Procedure for fibronectin except instead of steps 1 and 2, use 1-3 below: 
1. Place DMEM and 0.34 N NaOH on ice 
2. If not aliquotted, add 900 uL of the 2.7 mg/mL stock solution to microcentrifuge tube on ice. 
3. On ice, add 100 uL of DMEM. The solution should be yellow in color. On ice still, add 140 
uL of 0.34 N NaOH to microcentrifuge tube. The solution should now turn pink with the addition 
of base. (DMEM helps to mediate ionic strength of final solution, acts as a pH indicator, and 
helps achieve a more uniform protein mesh.) 
 
Also, instead of step 7, tumble for 4 hours at 27°C. 
 
Troubleshooting 
Same as steps listed in Procedure for fibronectin. 
 
 
 
Figure C-2: Proper positioning of 2-mL tube containing mounted polymer support and 
protein solution on tumbling rotator. 
 
 
 
  
Proper position of support when tube held vertically. 
Green circles are correct. Red cross outs are incorrect. 
Cartoon courtesy of J. Jordahl 
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